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Abstract
Somatic hypermutation o f im munoglobulin genes is a tightly controlled, site directed 
process. The nucleotide changes are targeted in the region surrounding the rearranged V 
gene segment of the heavy and light chain loci. The targeting of somatic mutation does 
neither require V region including the V k prom oter specific features nor a specific 
distance between the C k and the 3' enhancer. On the other hand, removal o f either the k 
3' enhancer or the k intron enhancer/M AR causes a drastic reduction in hypermutation, 
which is particularly marked in the latter case. In the work described in this dissertation I 
have used transgenic mice carrying im m unoglobulin  K transgenes with deleted 
regulatory elements, to make a tighter delineation of which DNA regions within the K 
locus are important for hypermutation. In addition I have used transgenic mice to study 
the role of the primary sequence and the DNA secondary structure in this process.
This thesis describes the generation o f artificial Ig genes constructs to make transgenic 
lines. K transgenes were characterized by Southern blot and by ELISA in the seven 
mouse lines obtained. The role of the 3' enhancer core in the transcription o f the k chain 
was also studied in stable transfected S I07 mouse myeloma cells.
The analysis o f the transgenes carrying deletions o f regulatory elements revealed that 
hypermutation was impaired (but not severely affected) when the intron enhancer was 
deleted. This also was the case when the flanking regions of the 3' enhancer core were 
deleted. Hypermutation was severely affected (but not abolished) when the core o f the 3' 
enhancer was removed. This reflects the relative roles o f both com ponents of the 3' 
enhancer region in gene expression. The matrix attachment region seems to be essential, 
since its deletion abolished hypermutation, but not expression, since abundant K mRNA 
was still produced. Furtherm ore these studies showed that the 3' enhancer can drive 
hypermutation from a position upstream of the VK region.
The m ajor role of the primary sequence in the formation o f hotspots and the mutational 
machinery preferences for AGY encoded Ser and the bias against TCA encoded Ser as 
target for hyperm utation were disclosed with the analysis of the transgenes carrying 
V kO x I gene with modifications in the C D R l sequence. However, whilst hairpin loops 
do not define which base is going to be targeted, they seem to have a role in the 
accessibility o f the 'favoured' nucleotides for hypermutation.
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Chapter One Introduction
1.1 General background
1.1.1 The beginning of modern immunology
The concept o f "protective im m unity" induced by prior contact with disease was 
documented as early as 430 BC by the Greek philosopher Thudydies, who chronicled the 
plague o f Athens, noting that '...no one caught the disease twice or, if  he did, the second 
attack w as never fatal'. This understanding , based on pure observation , was 
independently put into practice at the same time in other parts o f the world. Indeed, the 
ancient Africans, Chinese and Turks practised different types o f smallpox inoculation to 
protect from a recurrence of the disease. A more rational fight against infectious diseases 
began in the late 18th century when Edward Jenner uncovered the principles o f active 
im m unisation and introduced vaccination against smallpox (Jenner, 1789). In 1900, 
Ehrlich proposed that the binding of foreign toxins to side chains on the surface o f cells 
stimulates the cells to produce serum antitoxins (Ehrlich, 1900).
1.1.2 The instructive and selective theories of antibody formation
In the 1930’s, E hrlich 's theory was challenged by Landsteiner’s dem onstration that 
antibodies bind an alm ost infinite num ber o f natural as well as artificial antigens 
(Landsteiner, 1945). The requirem ent o f an enorm ous reperto ire o f pre-existing 
antibodies to recognise the huge variety o f natural and artificial antigens rendered 
E hrlich’s proposal implausible. Instead, it was suggested that the specific binding sites 
of the antibodies gain their three dimensional configuration under the direct influence of 
the antigenic determ inant (M udd, 1932; Pauling, 1940). However, this ‘instructive 
theory’ failed to explain processes such as memory and tolerance.
In 1957, Burnet proposed the clonal selection theory according to which cells producing 
antigen specific antibody are selectively stimulated to proliferate and produce antibodies. 
This theory proposes that the specific antibodies are expressed prior to exposure to the 
antigen. The antigen then selects a cell expressing a single specificity out o f a pool of 
cells com m itted to different specificities. All the cells o f the resulting clone produce 
antibodies with the same specificity.
1.1.3 The structure of immunoglobulins
Early work, based on physicochemical techniques, localized antibody activity to two 
classes o f proteins in the y globulin fraction of serum (Heidelberger and Pederson, 1937; 
Tiselius and Kabat, 1939). The major com ponent o f antibody activity localized to a 
subfraction with a sedim entation coefficient o f 7S w hereas the second com ponent 
localized to the 19S subfraction. Subsequently, a third protein, y lA  was detected by 
im m u n o elec tro p h o resis  (G rabar et al., 1956). T hese p ro te in s w ere nam ed 
immunoglobulins (Heremans, 1960) and the 75, 195 and y lA  fractions were named IgG, 
IgM  and IgA classes respectively (W orld H ealth O rganisation, 1964). Later two 
additional classes of immunoglobulins, IgD and IgE were identified.
Further understanding o f the immunoglobulin structure resulted from the digestion of 
rabbit y globulin with the proteolytic enzym e papain and revealed that the antibody 
molecule can be split into two identical antigen binding fragments (Fab) and another 
fragm ent which easily crystallises (Fc) (Porter, 1959). D énaturation o f m onoclonal 
m aterial (purified from the serum of patients with myelomas) with urea revealed that 
immunoglobulin molecules consist of four separate protein chains. Two identical heavy 
chains (approxim ately  440 am ino acids long) and two iden tical ligh t chains 
(approximately 220 amino acids long) are connected by disulphide bonds (Edelman and 
Poulik, 1961). On the basis o f serological characteristics the light chains could be 
divided into two types: k  and X (Nisonoff et al., 1975), the majority of light chains in the 
peripheral blood being of the k  type.
The variability in the binding of antibody to haptens of different sizes suggested a 
heterogeneity o f antibody com bining sites analogous to the heterogeneity o f binding 
properties (5chlossm an and Kabat, 1962). A key p roof o f the heterogeneity  o f 
im m unoglobulins came from amino acid sequence data. Many patients with myeloma 
excrete Bence-Jones protein (free im m unoglobulin light chain) in their urine. The 
com parison o f a large num ber of those k  light chain sequences showed very little 
variation between the carboxyl term inal constant (C) regions, whereas the am ino 
terminal variable (V) region showed high variability (Hood and Talmadge, 1970). When 
comparing the degree of amino acid variability within the V regions the greatest amount 
o f variability  was evident w ithin the three regions know n as com plem entarity  
determ ining regions (C D R l, CDR2 and CDR3). These CDRs are flanked by less 
variable framework regions (Wu and Kabat, 1970).
The polypeptide chains of immunoglobulins are com posed of repeated homology units 
(Hill et al., 1966; Edelman and Gall, 1969). Each of the units consist o f two stacked anti 
parallel (3 sheets surrounding an internal space filled with hydrophobic amino acid side 
chains (Amzel and Poljak, 1979). Cysteine residues at the flanks of the units form intra­
chain disulphide bonds stabilising the tertiary structures which commonly referred to as 
im m unoglobulin  folds. E lectron m icroscopic studies o f im m unoglobulin-antigen 
com plexes m ade it possible to deduce the structure o f antibody m olecules. The 
polypeptide chains are arranged in a Y shape with the antigen binding site made up by 
both heavy and light chain on the amino terminal side of the Fab fragment (Valentine 
and Green, 1967).
1.2 Affinity maturation
A fter im m unisation, especially  after repeated im m unisations, the affinity o f the 
antibodies in the serum increases dramatically with time. This increase in the quality of 
serum antibody, which focuses the immune response to a particular antigen, is called 
affinity maturation.
One o f the first observations regarding affinity maturation was that the anti-diphtheria 
toxin antibodies in serum progressively increase in avidity over time (Jerne, 1951). 
Several groups reported an increase in affinity over a period of time (Eisen and Siskind, 
1964; Klinman et al., 1966) and also a dependency of the maturation on the original dose 
o f antigen (Eisen and Siskind, 1964; Goidl et al., 1968).
The next m ajor step in the understanding o f affinity  m aturation was to link the 
antibodies bearing the affinity to the cells which produce them. Anti-DNP antibodies 
synthesised by a suspension of lymph node cells, which had been obtained at various 
intervals from immunised rabbits, progressively increased in their affinity (Steiner and 
Eisen, 1967a, b). This led to the suggestion that the changes can be understood as the 
result o f a selection by the antigen, on the basis o f its interaction with pre-existing 
antibody molecules o f those cells synthesising the highest affinity antibody. Low affinity 
cells failing to capture the antigen are not stimulated to proliferate. Consequently they 
disappear from the antibody forming cell population (Siskind and Benacerraf, 1969). 
This suggestion already captured the basis of our understanding o f affinity maturation 
today (see Section 1.5 'Cellular dynam ics o f affinity m aturation'): the preferential 
selection of those B cells which produce antibodies with the best binding characteristics.
1.3 Origins of immunoglobulin diversity
1.3.1 Germline versus somatic theory
Two fundamentally different theories, both attempting to explain the genetic mechanism 
to achieve the high variability of immunoglobulins, were suggested in the 1960’s and 
1970’s. The germline theory postulated that all cells have the same range o f genes, a 
choice of which is expressed in each cell. Consequently every cell must contain all the
genes encoding all the necessary antibodies. The som atic theory rejected  this 
assumption, because it would require millions o f genes. Instead it postulated that the 
immunoglobulin genes evolve by mutation from relatively few germline genes during 
somatic development.
In 1965 Dreyer and Bennett (1965) made a radically different suggestion. They proposed 
that the genetic information for the variable and constant regions are encoded by two 
separate unconnected gene segments. Further they speculated that there are hundreds of 
variable region genes but only a few genes for the constant regions. According to this 
theory one o f the variable genes was brought together with one o f the constant region 
genes by a process of somatic rearrangement.
1.3.2 Recombination of immunoglobulin genes
The first indications of somatic recom bination cam e from  Southern blots in which 
mouse myeloma X light chain cDNA was hybridised with cloned genomic DNA. The 
result showed that the X light chain gene segments were separated in the germline, whilst 
being contiguous on mRNA level (Hozumi and Tonegawa, 1976). Sequence analysis of 
the V (variable) gene segment revealed that a little piece was missing, which led to the 
identification of another group of J (joining) gene segments (Brack et al., 1978). From 
this it was concluded that each X light chain is assembled by a combination o f V, J and C 
gene segments. Shortly afterwards, the k  light chain and the heavy chain were analysed 
analogously (Seidman et al., 1979; Early et al., 1980; Sakano et al., 1980).
A multi step process yields the contiguous information for a functional immunoglobulin 
chain. Initially single V, (D) and J gene segments are brought together. Then the DNA is 
transcribed into RNA which contains a VJ (or VDJ) complex, the C gene segment and 
the intron. Finally, the intron is cut out by RNA splicing and the resulting mRNA is 
translated into protein.
All the recombinationally active gene segments are flanked by conserved recombination 
signal sequences that consist o f a heptam er and an AT-rich nonam er separated by a 
spacer o f either 12bp or 23bp (the equivalent o f one or two turns o f the DNA helix). The 
presence o f a pair o f recom bination signals is all that is required to render a DNA 
m olecule a substrate for V(D)J recom bination (12/23 rule) (reviewed by Tonegawa, 
1983). Together, two lymphoid-specific genes, R A G l and RAG2 (Schatz et al., 1989; 
O ettinger et al., 1990) in itia te  the recom bination process by recognising  the 
recombination signal and cleaving between the signal and the coding border. The joining 
m echanism  is im precise and this innate imprecision generates significant diversity in 
im m unoglobulin polypeptides (Kurosaw a and Tonegawa, 1982; A lt and Baltim ore
1982).
1.3.3 Diversification of immunoglobulin genes during B cell development
The four m ajor sources of immunoglobulin diversity are: i) com binatorial diversity by 
rearrangem ent o f multiple germline segments to build a functional unit, ii) imprecise 
jo in ing  during recom bination leading to the addition or loss o f nucleotides, iii) 
association of heavy and light chain to form the antigen binding site and iv) somatic 
hyperm utation. The first three d iversification  steps take place early  on in the 
development o f B cells and are independent of stimulation by antigen. The fourth step of 
diversification - somatic hypermutation - happens after stimulation by the antigen and is 
thought to be one of the driving forces behind affinity maturation.
1.4. Somatic hypermutation of immunoglobulin genes
1.4 .1 First indications of somatic hypermutation
In 1970 W eigert (1970) analysed the amino acid sequence o f the ^1 light chain of 18 
m urine m yelom as o f mice belonging to the same inbred line. Tw elve o f them  had 
identical sequences. The other six carried different am ino acids at certain residues 
(W eigert et al., 1970). This was the first indication of a mechanism which increases the 
variability of immunoglobulin genes by somatic hypermutation. With the cloning o f the 
X 1 germline gene it was confirmed that the changes were indeed due to somatic mutation 
rather than gene polymorphism (Brack and Tonegawa, 1977).
The first data on somatic hypermutation came from comparing the amino acid (and later 
nucleic acid) sequences of immunoglobulins produced by malignant plasm a cells with 
their germline counterparts (Gearhart et al., 1981; Crews et al., 1981).
Although these studies already demonstrated that somatic hypermutation plays a major 
role in the diversification of antibodies, they did not provide any information about the 
development of antibody genes during an immune response. The hybridoma technology 
(Kohler and Milstein, 1975) combined with fast DNA sequencing (Hamlyn et al., 1981) 
finally m ade it possible to study the genetic events that operate in response to an 
antigenic challenge. This approach was exploited to study various other responses, 
including those to a variety o f haptens such as 2-phenyl-5-oxazolone (Kaartinen et al.; 
1983; G riffiths et al.; 1984; Berek et al., 1985), (4-hydroxy-3-nitrophenyl)-acetyl 
(Bothwell et al.; 1981; Cumano and Rajewsky, 1986; Blier and Bothwell; 1987) p- 
azophenylarsonate (W ysocki et al., 1986) and protein antigens such as influenza 
hemagglutinin (McKean et al., 1984)
1.4.2 The rate of somatic hypermutation
The rate of somatic hypermutation is estim ated as approxim ately 10"^/bp/ generation 
(M cKean et al., 1984; Sablitzky et al., 1985). This is approxim ately ten thousand fold 
higher than the rate o f spontaneous m utation in higher eukaryotes (Adetugbo et al., 
1977; M cKean et al., 1984). This mutation rate seems to allow an adequate accumulation 
o f m utations. A higher rate o f m utation m ight result in the loss o f clones due to 
deleterious mutations, a lower rate would be less efficient in obtaining the desired 
m utations (Allen et al., 1987). Therefore it is not surprising that the estim ate remains 
alm ost the same even if  the calculation only accounts for silent changes (Berek and 
M ilstein, 1988) or has been obtained at different stages of the prim ary and secondary 
response (Rada et al., 1991; Weiss et al., 1992).
1.4.3 Target area of somatic hypermutation
Somatic hypermutation of Ig genes is a tightly controlled, site directed process. The 
nucleotide changes are targeted to the region surrounding the rearranged V gene segment 
of heavy and light chain loci (Gorski et al., 1983). M utations do not extend significantly 
upstream  beyond the prom oter or significantly dow nstream  into the constant region 
exons (Gearhardt and Bogenhagen, 1983; Lebeque and Gearhart, 1990; Both et al., 
1990; W eber et al., 1991; Rothenfluh et al., 1993).
Occasional mutations have been described in a mouse exon, perhaps because in the 
m ouse X locus the C region is c loser to the jo in ing  (J) c luster than in other 
im m unoglobulin loci (M otoyama et al., 1991). More recently the 5' border has been 
located in the intron between the leader peptide and the variable region in k  chains (Rada 
et al., 1994; Rogerson, 1994). A pyrimidine (mostly T) rich m otif occurs at the boundary 
position, but its significance is unknown.
1.4.4 The timing of somatic hypermutation
Somatic hypermutation is switched on very shortly after primary immunisation. The first 
mutations can be detected 4 days after local immunisation in cells o f the draining lymph 
nodes (Leanderson et al., 1992) and six to seven days after immunisation in the cells o f 
the spleen (M cHeyzer et al., 1991). The cells appear to accumulate m utations for up to 
21 days after prim ary im m unisation (Rada et al., 1991; W eiss et al., 1992). 
Diversification by somatic hypermutation occurs in a step-like m anner (Brown et al., 
1992), suggesting that several rounds of mutation occur. Secondary immunisation leads 
to the expansion o f the memory compartment and seems to reactivate the hypermutation 
mechanism (Berek and Milstein, 1988; Blier and Bothwell, 1988; Rada et al., 1991).
1.4.5 Intrinsic features of somatic hypermutation
Large variations in the mutation (basically nucleotide substitutions) frequency at which 
mutants are found within the targeted area. Certain positions form favoured sites of 
mutations (hotspots) and others are rarely mutated (coldspots). Although large databases 
are only available for fewer examples, mutational hotspots were found in all cases even 
when the V region of the transgene was substituted by heterologous sequences (Yélamos 
et al., 1995). In particular the CDRl is usually more strongly mutated than other regions 
(M alipiero et al., 1987; Betz et al., 1993b), m aybe because it contains a large 
accumulation of mutational hotspots. However, hotspot clusters were also found in the 
joining/constant region intron as well as in the CDR2, CDR3 o f the ^1 gene (Gonzalez- 
Fem andez et al., 1994b).
The m utations are also not generated random ly in term s o f the base substitution 
preference. Instead they exhibit a pronounced bias, with purine residues on the coding 
strand being preferred over pyrimidines as target for mutations. This "strand polarity" 
can not be attributed to an uneven base com position o f the targeted area. In addition, 
transversions occur at lower frequency than transitions. The directionality o f mutation 
often allows the discrimination between antigen-selected or intrinsic hotspots (Betz et 
al., 1993a).
A striking feature o f m any coding for serine m ajor intrinsic hotspots is that they 
constituted AGC or AGT triplet (Betz et al., 1993a). A preference for the usage o f AGY 
codons in the CDRs (particularly in the C D R l) and for TCNs in the frameworks has 
been observed in human V genes (W agner et al., 1995). Codon bias has also been 
observed in X enopus and sheep (Schw ager et al., 1989; Reynaud et al., 1995). It 
suggests that the DNA sequence o f germ line V genes has evolved in response to 
selection for appropriately targeted mutability.
The hotspots existence has been attributed to peculiarities o f DNA structure, including 
palindromes, repeats (Milstein et al., 1986; Golding et al., 1987; Kolchanov et al., 1987) 
and primary sequence motifs. The latter category includes the motifs TAA, PuGPyA/T 
(Rogozin and Kolchanov, 1992), CAGCT/A and AAGTT (Betz et al., 1993a). The 
hotspots found in the non-im m unoglobulin sequences also fall within the intrinsic 
hypermutation hotspot consensus (Yélamos et al., 1995).
Mutational hotspots are only in part created by their sequence since they are not found in 
all the positions conform ing to the hotspot consensus. The hotspots found in the non­
immunoglobulin sequences are not located at a conserved distance from the transcription 
start site (Yélamos et al., 1995) and may therefore be a consequence o f neighbouring 
DNA sequence, or structure, such as palindrom es (M ilstein et al., 1986; Gonzâlez- 
Femândez et al., 1994b).
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1.4.6 Sequences needed to recruit hypermutation
Transgenic mouse experiments have revealed most o f what is known about the c/5-acting 
DNA elements required to recruit hypermutation. The rate o f hypermutation was hardly 
affected when the V k promoter was substituted with the prom oter of the (3-globin gene 
(Betz et al., 1994). The V region was replaced by non-im munoglobulin sequences and 
hyperm utation was not im peded (Yélamos et al., 1995). A big part of the sequence 
between the C k and the 3' enhancer as well as a small fragment in the J-C intron were 
removed and hypermutation was not affected (Betz et al., 1994; Yélamos et al., 1995). 
On the other hand, removal of either the K 3' enhancer or the k intron enhancer/M AR 
caused a drastic reduction in hypermutation, which is particularly marked in the latter 
case (Betz et al., 1994). W hether the effect o f the enhancers in hyperm utation is 
secondary to their activity as transcription activator, or w hether they stim ulate 
hypermutation through an independent (but parallel) process is a fundamental question 
that need to be resolved to understand the mechanism of somatic mutation.
1.4.7 Mechanism of somatic hypermutation
The molecular details of how somatic hypermutation works are not yet known. Several 
models have been proposed on the theme of an error-prone repair system (Brenner and 
Milstein, 1966) or misaligned templates (Malipiero et al., 1987). A version o f the first 
model (Fig. 1.1) involves a singlestrand nick in the transcribed strand, in a site upstream 
of the V region (which determ ines the 5' boundary o f hyperm utation) followed by 
exonuclease digestion and replacem ent by an error-prone DNA polym erase such as 
DNA polymerase (3 (Kunkel and Alexander, 1986).
Figure 1.1 Model of somatic hypermutation in k light chain (opposite page).
A version o f the error-prone repair model proposed by Brenner and M ilstein, 1966 
(taken from Milstein and Rada, 1995). A specific single-strand nick is introduced in the 
transcribed strand. This is followed by exonucleolytic trimming o f the nicked strand with 
subsequent error-prone repair. M utations are introduced in one strand and are fixed 
during DNA replication. This accounts for the observed strand polarity, which is 
deduced from the biasses intrinsic to hypermutation. In this version o f the model the 
preferred cleavage site is located upstream of the V region. The exonucleolytic activity 
'falls o ff  after an average o f about 50()-1000bp. A lternatively there could be a large 
number of cleavage sites in the J-C intron of the non transcribed strand and a sharp stop 
of the nucleolytic cleavage in the leader intron.
This model is compatible with the strand polarity, the sharp boundary at the 5' end and 
the decay at the 3' end. It also finds considerable support in the em erging similarities 
between hypermutation and excision repair of damaged DNA, e.g. the preferential repair 
o f the transcribed DNA strand is a recognised feature o f nucleotide excision repair 
(Hanawalt and Mellon, 1993).
Some variations of the model include an RNA intermediate and reverse transcription and 
insertion (Steele and Pollard, 1987) or tem plated gene conversion (M aizels, 1989). 
W hile being the main mechanism of somatic diversification in the chicken (reviewed in 
McCormack et al., 1991) the gene conversion mechanism is unlikely at least in mice and 
m an (G earhart and Bogenhagen, 1983; G onzalez-Fernandez and M ilstein, 1993; 
Milstein, et al., 1992; W ysocki et al., 1990). Thus in these species mutations extend the 
flanking regions 3' of the V, where no donor homologous sequences are present in the 
genom e, and no concordant pattern of somatic mutants with genom ic diversity was 
found. An additional evidence that ought to put to rest this possib ility  is the 
demonstration that several non immunoglobulin sequences (which are not present in the 
mouse) replacing the V segment hypermutate (Yélamos et al., 1995).
A model that links DNA replication with a process that targets somatic mutation has also 
been proposed (Rogerson et al., 1991). H owever, there is no evidence for the 
specifications postulated by this model and it has been unsubstantiated by the finding 
that the somatic hypermutation was affected when the transcriptional enhancers and 
MAR were removed, whereas replication of the transgenes continued (Betz et al., 1994). 
Somatic mutation has been described also in sheep, where it serves to diversify the 
preim m une repertoire (Reynaud et al., 1991) sim ilar to the diversification by gene 
conversion that occurs in the Bursa of chicken. Taken together these observations 
indicate that a sim ilar m olecular m echanism  based on the same basic DNA repair 
m achinery m ight be used at different times during B cell developm ent by different 
species for different purposes.
1.5 Cellular dynamics in affinity maturation
1.5.1 The primary response and the germinal centre formation
In the im mune response against T-cell-dependent antigens the first detectable (48 hours 
after immunisation) expansion o f antigen-specific B cells takes place in the peri arteriolar 
lym phoid shecti^s(Gray et al., 1986; Jacob et al., 1991). These are areas in peripheral 
lym phoid organs (the peripheral lym phatic tissues and the spleen) w here T cells 
accumulate and are organised around specialized endothelial vessels. During this early 
expansion some B cells differentiate into plasma cells and start producing low affinity 
IgM antibodies.
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Figure 1.2 Functional compartments in germinal centres (taken from Liu et al., 1996).
A few days after immunisation B cells begin to migrate into the primary follicles of the 
peripheral lym phoid organs (Kroese et al., 1990) w here they undergo extensive 
proliferation and form germinal centres (GC), which appear towards the end o f the first 
week after challenge and provide the location for hypermutation, antigen selection and 
isotype switching (MacLennan et al., 1992; Liu et al., 1992; Liu et al., 1996).
G erm inal centres are highly organised structures that develop around the follicular 
dendritic cell (FDC) network. Their form ation depends on the presence o f Ag-Ab 
complexes trapped in the interdigitating processes of FDCs (Nossal et al., 1968; Tew and 
M andel 1978; Klaus et al., 1980). Several cellular com partm ents have been identified 
histologically (Hardie et al., 1993) and a num ber o f studies that suggest functional 
differences between them.
1.5.2 Germinal centre - microenvironment for hypermutation, antigen selection and 
isotype switching
A simple model for the maturation pathway of a IgM -expressing B cell in the germinal 
centre is shown in Fig 1.2. An IgM+ B cell migrates to the dark areas o f the GC, where 
they expand exponentially. These cells later become centroblasts, which express little or 
no surface Ig. Centroblasts are thought to be the cells in which the somatic mutation 
occurs (M acLennan et al., 1992; Küppers et al., 1993; Pascual et al., 1994). They 
transform  into nonproliferating centrocytes, which re-express antigen receptor on the 
surface albeit at low levels, m igrate towards the light zone o f the GC and undergo 
apoptosis unless further stimulated by additional signals (Liu et al., 1989). The Ag-Ab 
immune complexes on the FDC are the main signal that prevents apoptosis and selects 
high affinity mutants specific for the antigen. Additional signals as T-cell derived (IL-2, 
IL4 and ILIO) cytokines and those delivered through the interaction of CD40 on B cells 
with its ligand (CD40L) also are involved in preventing apoptosis.
W hile the low affinity and autoreactive mutants die by apoptosis, high affinity mutants 
pick up the antigen and process it on their migration pathway to the apical light zone and 
the outer zone. In these areas the selected centrocytes encounter and present antigen to 
antigen-specific T cells. T cells are induced to express CD40 ligand (Lederman et al., 
1992; Casamayor-Palleja et al., 1995) and secrete cytokines which are both key elements 
for the induction o f isotype switching. This cognate T-B interaction results in the 
expansion and the isotype switch of high affinity centrocytes.
Finally, they differentiate into memory B cells in the presence of prolonged CD40 ligand 
signalling and into plasm a cells when CD40 ligand signalling is rem oved (Liu et al., 
1992; MacLennan et al., 1994; Arpin et al., 1995).
A ntigen selection seems to operate from the very beginning o f germ inal centre 
formation. Somatic mutation, although detectable at day six, peaks somewhat later (well 
into the second week after challenge) and antibodies derived in early stages o f primary
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responses reflect proliferation without hypermutation (Griffiths et al., 1984; Kâllberg et 
al., 1993; Jacob et a l ,  1993).
Isotype switching seems to initiate after B cells have undergone somatic mutation and 
positive selection. This allows the acquisition o f a distinct Ig isotype, which confers 
effector functions, while keeping the high affinity for the selecting antigen. A small 
number o f the cells may undergo isotype switching without somatic hypermutation and 
vice versa (Kaartinen et al., 1983; Cumano and Rajewsky, 1985; Jacob and Kelsoe, 
1992, Pascual et a l ,  1994). This indicates that they are two independent processes.
1.5.3 B cell memory
Memory B cells can be defined as surface Ig expressing B lymphocytes which have been 
selected in a pathway of antigen-driven proliferation and somatic hypermutation. They 
also appear to have already switched their isotype (Okumara et a l ,  1976; Coffman and 
Cohn, 1977). On renew ed antigenic challenge they produce the secondary immune 
response (Kocks and Rajewsky, 1989). Whilst the virgin B cells are characterised by the 
expression o f surface IgM (sIgM) and sIgD, the B cells involved in the secondary 
response usually express antibodies of the IgG, IgA or IgE class. There is increasing 
evidence supporting the hypothesis that m em ory cells recirculate through GCs to 
generate even higher affinity clones and to switch to downstream isotypes (Berek and 
Milstein, 1987; Kepler and Perelson, 1993; Pascual et a l ,  1994; Feuillard et a l ,  1995).
It is still unclear w hether the persistence o f the B cell m em ory requires ongoing 
stimulation and selection by the antigen, or if it simply reflects the generation o f stable 
long-lived memory cells (for review  see Freitas et a l ,  1986; M acLennan and Gray, 
1986). It has been suggested that the bcl2 gene expression possibly plays an important 
role in the longevity o f memory cells (Vongsakul, 1996).
1.6 The immune response against 2-phenyI-oxazol-5-one
1.6.1 A model for somatic hypermutation
The primary response against the hapten 2-phenyl-oxazol-5-one (phOx) in many mouse 
strains is dom inated by one m ajor idiotype (M akela et a l ,  1977). M ost o f the phOx- 
specific B cells utilise a particular combination of heavy and light chain, termed V kO x I 
and V H O xl respectively (Kaartinen et a l ,  1983; Even et a l ,  1985). This conservatism in 
respect o f im m unoglobulin gene usage renders it an ideal model system to study the 
developm ent o f immunoglobulin genes during an im mune response. Somatic mutants 
with increased affinity to phOx can be detected (Griffith et a l ,  1984) from  early on in 
the response.
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1.6.2 Affinity maturation by somatic hypermutation
Early in the response, most o f the V kO x I and V H O xl genes are expressed in their 
unmutated germline form. As the response progresses the V regions start to accumulate 
m utations. W hilst many mutations are specific for the affected im m unoglobulin gene, 
common mutations such as substitutions in His34 and Tyr36 can be observed in most of 
the antibodies o f a secondary or tertiary im mune response to phOx. Substitution of 
Tyr36 to Phe alone does not seem to greatly affect the affinity, but a combination of this 
substitution with the substitution of His34 by Gin or Asn results in a ten-fold increase in 
affinity (Berek and Milstein, 1987). The determination o f the three dimensional structure 
o f the Fab fragm ent (A lzari et al., 1990) o f an anti-phO x m onoclonal antibody 
(NQlO/12.5) revealed that the residues 34 and 36 o f the V k O x I light chain directly 
interact with the hapten. It is therefore not surprising that mutations in these key contact 
residues alter the affinity for phOx. In contrast, mutations in many o f the other residues 
have little effect on hapten binding (Alzari et al., 1990). Together with the silent 
changes, they represent a neutral background resulting from the nature o f the mutational 
process. It has been estimated that only one out of four point mutations has actually been 
selected by antigen (Berek and Milstein, 1988).
1.6.3 Affinity maturation by repertoire shift
Initially, the response against phOx is dominated by the V K O xl/V H O xl combination, 
probably as a result o f its relatively high incidence in the preimmune repertoire (Milstein 
et al., 1992). At later stages o f the prim ary response and particularly after a second 
challenge by the antigen, other germline gene combinations emerge. The V k O x I light 
chain can frequently be found in combination with various different heavy chains (Berek 
et al., 1985) such as members o f group 5 - VHM21 like or group 1 - VHJ558 like 
(Dildrop, 1984). The association of the V k45 light chain with the V H ll  heavy chain is 
another typical com bination found in the secondary response (Kaartinen et al., 1988). 
The antibodies utilising these alternative com binations often do not have a higher 
affinity than the m utated V kO x I based antibodies. Instead, differences in the kinetic 
properties of the binding of the antigen appear to account for their emergence (Foote and 
Milstein, 1991).
1.7 Regulation of the immunoglobulin gene transcription
The regulated transcription of immunoglobulin genes depends, as in any cell system, on 
contributions from multiple c/5-control regions and m ultiple regulatory proteins. The 
analysis o f the Ig transcription is complicated by the gene rearrangements in immature 
cells and by the isotype switching events in m ature cells. The precise regulatory 
mechanisms have not been yet clearly established.
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1.7.1 C/s-acting sequences: promoter and enhancers 
The promoter
The im munoglobulin promoters are only active in B-lineage cells. All heavy and light 
promoters are com posed by two main elements, the octam er and the A/T rich sequence 
(TATATAA) that function as a TATA box (Parslow et al., 1984).
The TATA motif, located 25-30bp upstream  o f the transcription start site sequence, 
directs transcription initiation. This activity result from the binding of TATA binding 
protein  (TBP) w hich is a subunit o f a m ultiprotein com plex com m only called 
transcription factor IID (TFIID).
The "octamer" element consists of nine conserved bases: ATTTGCATNA, with N being 
a variable base at position 9 (Wirth et al., 1987). It is located approxim ately 70bp 5* of 
the cap site in the light chain and in the same position but in an inverted orientation in 
the heavy chain gene. Synthetic promoters containing an octamer site and a TATA box 
can direct accurate an B-lineage-restricted transcription (Dreyfus et al., 1987; Wirth et 
al., 1987). However, the same octamer elem ent drives the expression of a number o f 
ubiquitously expressed genes, including the histone H2B gene (LaBella et al., 1988). 
Two POU domain proteins, the ubiquitous Oct-1 and Oct-2 (expressed prim arily in B 
cells), activate transcription by binding the im m unoglobulin octam er elem ent (Staudt 
and Lenardo, 1991). In addition, a B cell restricted coactivator (OCA-B) provides the B 
cell specificity attributed to the octam er elem ent in the im m unoglobulin prom oter 
(Pierani et a l ,  1990; Luo and Boeder, 1995).
The intron enhancer
The first transcription enhancer elements identified to regulate im m unoglobulin gene 
expression are located in the major intron o f the light and heavy chain loci. W hen put 
under the control o f these enhancers the expression o f heterologous genes became 
lymphoid specific (Baneiji et a l ,  1983; Gillies et a l ,  1983; Neuberger, 1983; Picard and
Schaffner, 1984a; Queen and Stafford, 1984; Reik et a l ,  1987).
The K intron enhancer ( k  Ei) is inactive in the early stages o f B cell development and 
becomes active during the transition from pre-B to m ature B cell (Sen and Baltimore, 
1986; Attchison and Perry, 1987).
The best studied binding site in the intron enhancer is the 10 bp kB site. The constitutive 
binding o f N F-kB to this site in mature B cells and plasm a cells is a critical regulatory 
event in the differentiation from pre-B to mature B cell. Besides kB there are three 
|iE2/5 sites that bind to members of the E2A HLH-transcription factor family (Gimble 
and Max, 1987; Hromas et a l ,  1988). M utational studies indicated that those sites are
crucial for the activity of this enhancer (Lenardo et a l ,  1987).
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A 200bp fragm ent upstream of the N F-kB binding site has/show n to silence gene 
expression in non-B cell. It may act to prevent the inappropriate activation of the K gene 
by NF-kB induced in other cells types (Pierce et al., 1991). An additional component of 
negative regulation at this locus can be ascribed to kNE, a short sequence immediately 5' 
of the NF-kB binding site (Saksela and Baltimore, 1993). Cell type specificity of kNE 
was found to be determined by a short element, kBS, im mediately upstream  of kNE. 
Disruption of the kBS sequence allowed transcriptional repression by kNE in B cells. 
A lthough the k Ei also shares some regulatory sites with the heavy chain intronic 
enhancer (H Ei) they do not function in the same way. Thus the H Ei is active 
throughout B cell development including early stage pro-B and pre-B cells (Gerster et 
al., 1986). In addition, it contains a prom oter for sterile q  transcripts (Su and Kadesch, 
1990) which may be required to generate the sterile q  transcripts for VDJ joining 
(Ferrier et al., 1990; Chen et al., 1993). The H Ei is flanked by two matrix attachment 
regions and their combination acts as locus control region (see MAR below).
The 3' enhancer
The search for this enhancer in the k locus was driven by the observation that high levels 
of K light chain protein continue to be expressed in the plasmacytoma S107, which lacks 
the transcription factor N F -kB (Atchison and Perry, 1987) thought to be an essential 
requirement for k expression. This additional enhancer was found 8.5 kb downstream of 
the constant region exon, is stronger than the k intron enhancer (M eyer and Neuberger,
1989) and active in mature B cells and plasma cells but not in pre-B cells, T  cells or 
other cell types (Pongubala and Atchison, 1991).
Most of its activity can be localised to a 132 bp core (Meyer et al., 1990; Pongubala and 
A tchison, 1991). The 3' enhancer core does not contain k B sites explaining the 
expression of the k genes in S I 07 cells. The involvem ent o f HLH proteins in the 
regulation of this enhancer was substantiated by repression of the enhancer through the 
H LH -inhibitory protein Id (Benezra et al., 1990; Pongubala and A tchison, 1991). 
Transient transfection assays with the core enhancer revealed that it contains at least 
three functional DNA sequences (PU.1/NF-EM 5, E2A and kE3'-CRE) (Pongubala and 
Atchison, 1991; Pongubala et al., 1992; Pongubala et al., 1993; Pongubala and Atchison, 
1995). The flanking regions o f the core enhancer are involved in the developm ental 
control o f the 3' enhancer activity (Pongubala and Atchison, 1991; M eyer and Ireland,
1994). In addition to its function providing further activation o f the chain
promoter in late B cell it may also be important for somatic mutation (Betz et al., 1994). 
Some rearranged mouse heavy chain genes retained full transcriptional activity despite 
deletion o f their intron enhancer (Klein et al., 1984; W abl and Burrows, 1984; Aguilera 
et al., 1985). The search for further enhancer elements in the heavy chain locus led to the
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identification o f the IgH 3' enhancer first in the rat [25kb 3' o f C a ] (Pettersson et al.,
1990) and later in the mouse [12.5kb 3' o f C a  secreted exon] (Dariavach et al., 1991; 
Lieberson et al., 1991). A third transcriptional enhancer, the C a3 ' enhancer, which is 
located very close to the C a  region, was identified but not studied in detail (Matthias and 
Baltimore, 1993).
In contrast to the k  3' enhancer, the H 3' enhancers is considerably weaker than the intron 
enhancer. In addition to providing activation o f VH prom oter in late B cells, this 
enhancer probably plays a role in activating 1-region transcripts that are required for 
class switching (Petterson et al., 1990; Coffman et al., 1993; Xu et al, 1993).
1.7.2 Regulation of chromatin structure
The control regions described above appear to be principally responsible for the precise 
expression level and expression pattern observed for Ig genes. The transcription is 
regulated by a complex array of ubiquitous and cell specific proteins that are capable of 
binding to promoter and enhancer elements. These proteins interact with each other and, 
with the help of coactivators, regulate the formation o f a pol 11-containing preinitiation 
com plex at the transcription start site. But the fact that in eukaryotic cells genes are 
assembled into chromatin can not be ignored. The Ig locus is, most likely, assembled 
into an inaccessible chromatin configuration prior to gene activation (Jenuwein et al., 
1993; Forrester et al., 1994) possibly in the form o f 30nm filament (Ernst and Smale, 
1995).
Many studies on the role o f chromatin in mammalian gene regulation have focused on 
specialized control elem ents like locus control regions, insulators, m atrix attachm ent 
regions and méthylation. However, many of the elements have not been studied in the Ig 
genes. Elements that may influence the chromatin structure within the Ig locus during B 
cell development are discussed below.
Méthylation
DNA méthylation plays a role in the regulation of tissue-specific gene expression, which 
is reflected in the organization of methyl groups in somatic cells o f the organism. DNA 
sequences are generally methylated in most cells types, but are unmethylated in tissues 
in which the gene is actively transcribed (Yisraeli and Szyf, 1984). Thus, the observed 
genome-wide méthylation pattern appears to provide a global mechanism for repressing 
non active genes in all cell types.
The m ouse k  gene has a developmental m éthylation pattern sim ilar to that o f  other
tissue-specific genes. It is highly methylated in the post implantantation embryo (Kafii et
al., 1992) and rem ains m odified in most somatic cells. It undergoes differentiation-
specific dém éthylation only in mature B lymphocytes (M atther and Perry, 1983; Storb
and Arp, 1983; N elson et al., 1984). A better understanding o f the role o f DNA
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méthylation has emerged from studies of the Ig k  gene by Lichtenstein et al. (1994). In 
their studies, an in vitro  m ethylated plasm id containing a rearranged k  gene was 
dem ethylated upon transfection into B cell lines but rem ained m ethylated following 
transfection into pre-B and non-lymphoid cells. Lineage specific and cell stage specific 
déméthylation was induced by a compound cw-acting elem ent contained within a 1.6kb 
domain that is made up of the k  intron enhancer core, the MAR and a sequence located 
dow nstream  to Jk 5. These intronic sequences induced dém éthylation in the apparent 
absence o f activated transcription, strongly suggesting that déméthylation is not simply a 
result of transcriptional activation.
Matrix attachment regions (MAR)
DNA within interphase nuclei and mitotic chromosomes is organised into topologically 
constrained looped domains. Certain DNA sequences remain preferentially associated 
with the matrix fraction, whereas others are released into the soluble supernatant fraction 
after em ploying lithium  diiodosalicilate and high salt extraction protocols. M atrix or 
scaffold attachment regions (MARs or SARs) have been mapped using these procedures 
in and around many different genes in a wide range of organisms (Phi-Van and Stratling, 
1988; Casser and Laemmli, 1986; Cockerill, 1990).
M ARs are typically detected in DNA segments that are AT rich. M ARs contain short 
clusters o f certain characteristic A+T-rich sequences (A AT AT ATTT and variations) that 
seem to be required for matrix interaction. MARs also contain sequences matching the 
consensus for Topoisomerase 11 cleavage (GTNA/TAC/TATTNATNNA/G). MARs are 
often localized close to DNA sequences that play a key role in transcriptional regulation 
(G asser and Laem m li, 1986; Cockerill and Garrard, 1986; Cockerill et al., 1987). 
Structural features in MARs include bending (von Kries et al., 1990), a narrow minor 
grove due to oligo dA tracts (Adachi et al., 1989) and single-strandedness (Probst and 
Herzog, 1985). Indeed, MARs from different species become stably base-unpaired over 
an extended length when subjected to the tortional stress o f negative supercoiling: the 
greater the superhelical strain the more unwinding occurs (Kohwi-Shigem atsu and 
Kohwi, 1990; Bode et al., 1992). This inherent unwinding property was shown to be 
im portant for binding to the nuclear matrix and for the augmentation of gene expression 
in stable transformants (Bode et al., 1992). This property may be im portant in relieving 
negative superhelical strain that would arise in looped DNA and in altering tortional 
stress during transcription. Furthermore, a 1.6kb fragment containing the kE, the MAR, 
and the 5' flanking sequence o f the MAR can induce tissue and cell stage specific 
déméthylation of the rearranged k light gene (Lichtenstein et al., 1994). The removal of 
the MAR element had a marked effect on the déméthylation activity.
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MARs also act as locus control regions (LCR), which effect the accessibility of a genetic 
locus. The Ig |i LCR consists of a core enhancer which is flanked on either sides by 
M ARs (Jenuw ein et al., 1993). The in tact |i  LCR is able to induce DNase-I- 
hypersensitive sites and confer accessibility o f a linked T7 prom oter to the T7 RNA 
polym erase in isolated nuclei. In contrast the core enhancer on its own is sufficient to 
confer T7 promoter accessibility, but does not induce formation of a detectable DNase-I- 
hypersensitive site.
The analysis of the Ig|i LCR was extended to an immunoglobulin transgene (Forrester et 
al., 1994). Like the globin LCR, the intact \x LCR confers position-independent, cell-type 
specific expression of the immunoglobulin reporter. However, when the flanking MARs 
are deleted, the level of tissue-specific expression is substantially reduced in most 
transgenic lines and the gene exhibits a position dependent variability not evident with 
the intact q  LCR. Differences are also observed at the level o f chromatin organization. 
The intact p. LCR induces the form ation o f an extended D N ase-I-hypersensitive 
chromatin domain with hypersensitive sites in the core enhancer and at the |i  promoter. 
W hen the M ARs are deleted, the core enhancer is able to induce only local effects on 
chromatin structure (the enhancer but not the promoter becomes hypersensitive and no 
extended DNase-I-sensitive domain is formed). This suggests that M ARs are required 
either to mediate communication between the core enhancer and the |i  promoter, or to 
propagate an enhancer-induced alteration in chromatin structure throughout the entire 
transgene domain.
The same MARs that flank the p. enhancer core have been also im plicated in negative 
regulation through cell specific anchorage o f expressed genes in a region o f high 
transcription factor concentration around the nuclear matrix (Zong and Scheuermann,
1995).
1.7.3 Regulation of the immunoglobulin loci during the B cell development
The expression o f immunoglobulin genes is unique to and essentially defines the B cell 
lineage. The Igp. locus appears to be activated at a very early  stage o f B cell 
development, preceding V(D)J recombination and possibly preceding commitment to the 
B cell lineage. The initial activation o f the locus results in the change in méthylation and 
DNase I hypersensitivity of Igp, regulatory regions (M ather and Perry, 1983; Storb et al.,
1983). Transcripts initiating within the heavy chain locus are detectable at an early 
p rogen ito r B cell stage (Y ancopoulous and Alt, 1985, 1986). Follow ing gene 
rearrangem ent, m ature transcripts increase throughout the subsequent pre-antigen 
recognition stages o f differentiation (Perry and Kelly, 1979). Ig mRNA is further 
induced in an antigen and T-cell dependent manner.
Im m unoglobulin gene rearrangem ents occur in an ordered fashion during B cell 
development. In mice, DJ heavy chain rearrangements in pro-B cells are followed by V
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to DJ rearrangem ent in immature pre-B cells and finally light chain rearrangem ent in 
mature pre-B cells (Hardy et al., 1991). The membrane bound form o f p. heavy chain is a 
signal for allelic exclusion - the suppression of further VDJ rearrangements in the heavy 
chain locus (Nussenzweig et al., 1987; Reth et al., 1987; M anz et al., 1988; Kitamura 
and Rajewsky, 1992; Papavasiliou et al., 1995).
Usually a B cell expresses a single form of light chain o f either the A, or K type (isotypic 
exclusion). The fact that most k  expressing B cells retain their X loci in germ line 
configuration, whilst most X expressing cells contain two non-productively rearranged k  
loci, indicates that rearrangement o f the k  loci usually precedes rearrangem ent at the X 
loci (Coleclough et al., 1981; H ieter et al., 1981; Korsm eyer et al., 1981; Lewis et al., 
1982).
Isotype switching is another process that occurs in the immunoglobulin loci during the B 
cell development. It moves the variable heavy gene segment (VDJ) to associate with a 
different constant region. The expression of sterile transcripts (ly, la ,  le) is essential for 
the induction of this process (Coffman et al., 1993; Zhang et al., 1993) and it seems to be 
directed by cytokines including lL-4 and by engagement of CD40 with its ligand (Kiihn 
et al., 1991; Clark and Ledbetter, 1994; Delphin and Stavnezer, 1995).
1.8 Methodological approaches for analysing somatic hypermutation
1.8.1 The hybridoma approach
The antibody response was initially studied by direct sequencing o f mRNA from 
immunoglobulin genes in hybridomas at different times after im munisation (Griffith et 
al., 1984; Rudikoff et al., 1984; Sablitzky et al., 1985; Cumano and Rajenwsky, 1986; 
M alipiero et al., 1987; M anser et al., 1987). Direct mRNA sequencing has been replaced 
by procedures involving a polymerase chain reaction (PCR) amplification step followed 
by cloning and sequencing of multiple clones.
This approach still rem ains the best way to relate the affinity and the am ino-acid 
sequence changes (Berek and M ilstein, 1987). In addition, hybridom as provide clear 
evidence o f a common clonal origin of many of the shared mutations found in different 
monoclonal antibodies. They also allow the analysis o f other genes in the same clone, 
for instance the non-expressed Ig genes (Weiss and Wu, 1987), non allelically excluded 
transgenes (Sharpe et al., 1991) or multiple copies o f identical or mixed transgenes 
(Rogerson, 1991; Yélamos et al., 1995). As additional sampling can be taken form the 
same clone, there are no PCR errors in the data bases collected from hybridomas.
This approach, however, is a time and labour consuming process, which generates only 
small data bases. In addition cells are not immortalised at random (blast germinal centre 
B cells seem to be immortalised preferentially). The number of m utations detected by 
hybridomas may therefore be smaller than that present in the memory cell population.
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1.8.2 The PCR approach
Amplified gene fragments from populations of B cells can be directly cloned into M l3 
vectors and sequenced (Orlandi et a l ,  1989). A major advantage o f this approach is its 
speed and simplicity enabling the generation o f a large data bases. In addition it is not 
restricted to any particular cell subpopulation. It has been used to analyse genes form 
selected B cell subpopulations (Weiss and Rajewsky, 1990; Rada et al., 1991; Schittek 
and Rajewsky, 1992), cells taken from histologically defined areas of germinal centres 
(Jacob et al., 1993; Ziegner et al., 1994), and also from single B cells or B cell clones 
(M cHeyzer et al., 1991; Küppers et al., 1993). However, the misincorporation errors and 
artefacts (crossover-like events) produced during the PCR am plification m ust be 
carefully considered. Also, the mutation pattern in the heavy and the light chain can not 
be study in the same clone.
1.8.3 The transgene approach
In the absence o f cell lines that reliably reproduce the somatic mutation seen in vivo, the 
use o f Ig transgenic mice was introduced as a model to study the intrinsic features as 
well as the molecular mechanism of this process (O'Brien et al., 1987). K transgenes are 
subject to somatic mutations at the same rate and with the same characteristics found in 
the endogenous counterparts when the relevant flanking regions are included (Sharpe et 
al., 1991). One m ajor advantage is that there is no question about the origin o f the 
germline gene from which the mutants arise.
To circum vent the labour of sequencing mutated V regions, reporter genes assays were 
developed to permit rapid identification of hypermutated sequences (Umar et al., 1991; 
Azuma et al., 1993). However, those systems do not yet look promising.
Analysis of somatic hypermutation in Peyer's patch B cells
Recently, germinal centre B cells from Peyer's patches of non immunized animals have 
been shown to provide a fast and reliable source to analyse statistically significant 
number of clones, bypassing hybridoma production (Gonzalez-Fernandez and Milstein, 
1993, Betz et al., 1995; Yélam os et al., 1995). PP germ inal centres are found in the 
absence o f specific im munization, probably due to stimulation by naturally occurring 
antigens present in the gut environment. Therefore no antigen specific im mune response 
can be followed by this analysis. All the inconveniences described previously for the 
PCR approaches are also applicable to this m ethodology. However, when short DNA 
(such as V regions) fragm ents are am plified using high fidelity  polym erases 
misincorporation artefacts rates are very low.
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1.9 Aims of this study.
Much of the research in the last few years has focused on the identification o f the DNA 
elements necessary to target hypermutation. Hypermutation was not affected when the 
V k prom oter was substituted with the promoter o f  the (J-globin gene (Betz et al., 1994), 
when the V region was replaced by non-im m unoglobulin sequences (Yélamos et al., 
1995) or when the distance between the C k and the 3' enhancer was shortened (Betz et 
al., 1994; Yélamos et al., 1995). On the other hand, removal o f either the k 3' enhancer 
or the K intron enhancer/M AR causes a drastic reduction in hyperm utation, which is 
particularly marked in the latter case (Betz et al., 1994).
There are striking parallels between the regulation o f som atic hyperm utation and 
transcription. However it is not clear whether the same regions regulate both processes. 
A more detailed definition o f the role of the specific elements within the J-C intron and 
the 3' enhancer (intron enhancer, matrix attachment region, core of the 3' enhancer or its 
flanking regions) is needed to understand the molecular basis of somatic mutation.
The aim o f this study was to establish a tighter definition o f DNA regions within the K 
locus important for hypermutation and to assess the role o f the primary sequence and the 
DNA secondary structure in this process.
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Chapter Two Materials and Methods
2.1 Materials
2.1.1 Chemicals and enzymes
Chem icals and reagents were obtained from BDH, Poole, UK or Sigm a Chem ical 
Company, Poole, UK except for those described below (analytical or 'molecular biology' 
grade). Radioactive nucleotides, DNA ligation system (RPN 1507), Hybond-N+ transfer 
m em brane and 8.2cm  H ybond-N  nylon gridded m em brane w ere obtained from  
Am ersham  International pic, Amersham, UK. D ithiothreithol was from  Calbiochem, 
CA, USA. Sephadex G-50, Ultrapure dNTP set, Ficoll-Paque, T7 RNA polymerase and 
Oligolabelling kit were from Pharmacia, Sweden. 40% acrylamide/bisacrylamide stock 
solution and Tris buffered phenol were from Severn B iotech Ltd., UK. Hydrogen 
peroxide (100 volumes) and acetic acid (glacial) was from Fisons, Loughborough, UK. 
Ultrapure agarose, shark-tooth combs, NACS prepac cartridge and urea were from Gibco 
(B.R.L.), G aithersburg, MD, USA. Saran wrap was from  Dow chem ical Co. USA. 
Acrodiscs (0.2 and 0.45q) were from Gelman sciences, UK. Fetal calf serum was from 
PAA, Linz, Austria. Magic mini-preps, RNasin, RNAgents Total RNA Isolation System 
were from Promega Co, WI, USA. Plasmid maxi and midi kit were from Q iagen Inc., 
Chats worth CA., USA. M ethanol and chloroform were from Prolabo, France. Ethanol 
was from Hayman Ltd, Witham, UK. Centricon microconcentrators (10.000 mw cut off) 
and Centricon filters were from Amicon Inc., MA, USA. Sequenase v2.0 sequencing kit 
and spermidine trihydrochloride were from United States Biochemical, Cleveland, Ohio, 
USA. Dialysis tubing was from Visking, UK. IPTG was from Nova Biochem, UK. Gene 
puiser cuvettes (0.2/0.4cm electrode gap) were from Bio-Rad Labs, CA, USA.
All restriction enzym es, DNA ligase and m olecular w eight m arkers were from New 
England Biolabs, Boston, MA, USA, apart from the following:
C alf intestine phosphatase, Proteinase K and Klenow fragm ent of DNA polym erase I 
were from Boehringer M annheim , M annheim, Germany. Taq DNA polym erase was 
from Cetus, Perkin Elmer, CA, USA and Promega Biotec, Madi son, W is., USA. Native 
Pfu DNA polymerase was from Stratagene, CA, USA. Other reagents are detailed in the 
appropiate sections.
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2.1.2 Standard buffers
All buffers were prepared with M illipore purified w ater (M PW ) and sterilised by 
filtration or autoclaving. Standard buffers and solutions are listed below.
ABTS: 3 tablets o f ABTS were added to 23ml O.IM sodium citrate and 27ml of 0.1 M 
citric acid.
25% AMPS (w/v): 2.5g ammonium persulphate in 10ml H 2O. 
rATP (lOx): lOmM rATP in H 2O adjusted to pH 7.0 with NaOH.
Church buffer for hybridisation (Ix): 0.5M NaH2P0 4 /N a2HP0 4  buffer pH 7.2, 7% SDS, 
2mM EDTA.
Church wash solution: 0.5M phosphate buffer, 1% SDS.
D enhard t's  so lu tion  (lOOx): 2% (w /v) BSA , 2% (w /v) F ico ll, 2% (w /v) 
polyvinylpyrolidone (PVP).
DNA gel loading buffer (6 x): 0.25% bromophenol blue, 0.25% xylene cyanol FF, 15% 
Ficoll 400 in water.
DTT (IM  stock): dissolve 3.09g DTT in 20ml of 0.01 M sodium acetate, pH 5.2. Filter 
sterilise, aliquot and store at -20^C.
Hybridisation solution: 5x SSC, lOx Denhardt’s, 1% SDS, lOOmg/ml heparin.
PBS: 125mM NaCl, 8.4mM NaH2P0 4 , 16.6mM Na2HP0 4 , pH 7.2.
PEG precipitation solution: 20% PEG 8000, 2.5 M NaCl.
Sodium acetate 3M, pH 4.8.
Spermidine 100 mM, pH 7.0.
SSC (20x): 3M NaCl, 300mM sodium citrate, pH 7.0
STE: O.IM NaCl, 10 mM Tris.HCl pH 8.0, 1 mM EDTA (pH8.0)
TAE (50x): 2M Tris-HCl, 4M sodium acetate, 20mM EDTA, pH 7.8 
TBE (lOx): 0.89M Tris-HCL, 0.86M boric acid, 25mM EDTA, pH 8.3 
TE : lOmM Tris pH 7.4, 0.1 mM (Im M ) EDTA
TfBI : 30mM potassium  acetate, 50mM  M nCl2 lOOmM KCl, lOmM CaCl2 and 15% 
(v/v) glycerol, in H 2O.
TfBII : lOmM 3-(N-morpholino)propane-sulphonic acid (MOPS) pH 7.0, 75mM CaCl2 , 
lOmM KCl 15% (v/v) glycerol.
M axam -G ilbert buffer: 0.1% SDS, Im M  EDTA, lOmM M gCl2, 500mM  ammonium 
acetate.
Form am ide dyes: 0.1% bromophenol blue, 0.1% xylene cyanol FF, 10|iM  EDTA in 
deonised formamide.
TNE: lOmM Tris pH 7.5, 5mM EDTA, 300mM NaCl.
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2.1.3 Media
Media and plates for the growth of Escherichia coli were as follows:
Agar plates:
H-top agar: 0.8% bactoagar, 1% bactotryptone, 0.8% NaCl
M inim al glucose agar: 60mM  K 2HPO4 , 40mM  NaH 2P0 4 , 15mM (NH4 )2S0 4 , 14|iM 
ZnS0 4 , 1 |liM  MnS0 4 , 1.2qM H 3BO3 , 0.7qM  CaS0 4 , 2.5|iM  CaCl2, 1.8qM F eC ^, ImM  
M gS0 4 , 0.002% thymine, 30mM glucose, 2% agar.
TYE agar: 1.5% agar, 0.8% NaCl, 1% bactotryptone, 0.5% yeast extract.
Media:
Tryptone broth: lOg tryptone, 5g NaCl in 1 litre H2O, pH 7.4.
2xTY liquid medium: 1.6% tryptone, 1% yeast extract, 0.5% NaCl pH 7.4.
SOB: 2.0% tryptone, 0.5% yeast extract, 0.05% NaCl, pH 7.4.
SOC: To 100ml o f SOB add 5ml 20% glucose, 1ml IM  M gCl2 and 1ml IM  M gS0 4 .
2.1.4 Bacterial strains
All cloning procedures were performed with the TG I strain (Gibson, 1984) which has 
the following genotype: F' traD36 lacIQ A(lacZ)M15 proA"^B"*"/supE A(hsdM-mcrB)5 
(r^'m^'M crB") thi A(lac-proAB).
2.1.5 Origin of plasmids
The following plasmids were used routinely:
Bacteriophage M 13m pl8 and M 13m pl9 (Yanisch et al., 1985), pSV2-neo (Southern & 
Berg, 1982), pUC19 and pUC18 (Yanisch et al., 1985), pBGS19 (Spratt et al., 1986), 
pBluescript KS (+) (Stratagene), L k (Sharpe et al., 1991), L kAB (Yélamos et al., 1995), 
B 10513 and K472 were gifts from A. Betz, pT7CK was a gift from Gareth T. Williams.
2.1.6 Cell lines
All the fusions were perform ed using the plasm acytom a cell line NSO (Clark and 
M ilstein, 1981). All hybridoma cell lines were obtained from the M RC Laboratory of 
M olecular Biology, Cambridge. For transfections the plasm acytom a cell lines NSO and 
S107 (Salk Cell Bank) were used.
2.2 Methods
Unless otherwise specified, all methods were described by Sambrook et al. (Sambrook, 
et al., 1990).
All centrifugations were done in either an MSE Micro Centaur microfuge (for volumes 
up to 2ml), lEC CENTRA MP4 (for volum es up to 50ml and speeds not exceeding 
4000rpm ), a Sorvall RC-5B refrigerated super-speed centrifuge (for volum es greater
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than 50ml or refrigerated runs). All m ethods which involve the handling o f bacterial 
cultures were performed under semi-sterile conditions following the appropiate safety 
codes. C ultures w ere incubated at 37°C with constant shaking in e ither a G24 
environmental incubator shaker (for volumes of up to 5ml) or a controlled environment 
incubator shaker (for volumes up to 500ml), New Brunswick scientific, Edison, USA.
2.2.1 Construction and preparation of plasmids
Preparation of plasmid DNA
For the preparation of plasmid DNA for analytical purposes, a single bacterial colony 
harbouring the required plasmid was inoculated into 5 ml o f 2xTY medium. This was 
left o.n. at 37®C with constant shaking. The culture was transferred to a 1.5ml Eppendorf 
tube and spun at 2(X)0rpm for 10' and then the plasmid was prepared using magic mini- 
prep kit following the m anufacturer's specifications. For large scale preparations the 
Q iagen midi (50ml) and maxi (250ml) kit was used.
Phenol extraction and ethanol precipitation
DNA samples were phenol extracted with an equal volume o f Tris-buffered phenol pH 
7.4. The DNA was precipitated by adding 2.5 volumes of ethanol and 1/10 volumes of 
3M sodium acetate pH 5.2 and placed for 20' on a dry ice/isopropanol bath or at -20°C 
o.n. After centrifugation samples were washed with 75% ethanol to remove salt and then 
air dried and resuspended in TE.
DNA quantitation
lOpl of DNA stock was diluted 1:50 in H 2O and its O .D .260 determined using a quartz 
cuvette. The spectrophotom eter was first zeroed on a sample containing H 2O only. 
O.D.26o=1 was taken to be equivalent to 50|ig/m l for dsDNA, 40|ig/m l for ssDNA and 
20|ig/m l for synthetic oligonucleotides. DNA samples with O.D .26o:O.D.2so ratios below
1.8 contamination were repurified through phenol extraction/ethanol precipitation. DNA 
fragm ents used for the transfection o f m ammalian cells or for m icroinjections were 
quantified by serial dilution o f samples run on an agarose minigel alongside molecular 
weight markers o f known concentration visualised through EtBr staining.
Restriction enzyme digest and gel electrophoresis
Restriction digests were carried out in 50 to 200|il total reaction volumes, depending on 
the amount of DNA being digested (3 to 30|ig) in the recom mended buffer. A four to 
five fold excess of enzym e units was routinely used. The am ount o f glycerol in the 
reaction due to the enzyme added was never allowed to exceed 10% of the total reaction 
volume. The reactions were incubated for at least Ih. Separation of the digestion product
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was achieved by horizontal gel electrophoresis using 0.7-2.0% agarose (depending of the 
DNA fragment size) dissolved in IxTBE. Analytical agarose gels (20ml) were run in 
IxTBE containing Ipg/m l ethidium bromide at 50mA, while preparative gels were made 
up using 100ml o f agarose. These were run at 100mA.
Restriction of PCR products with two enzym es were perform ed using recom m ended 
buffer for the double digestion. These digests were incubated at 37°C for at least 4 hours.
Elution of DNA fragments and ligation reaction
DNA fragments were visualised after ethidium bromide staining by exposing the gel to 
UV light. Purification o f DNA fragments was carried out by cutting the agarose gel on 
the right side of the band of interest. A sandwich o f glass fibre filter paper and dialysis 
tubing was inserted into this cut. The gel was placed back into the tank after turning it 
90°. Electrophoresis was then continued until the DNA had reached the glass filter. The 
sandwich containing the DNA was then placed into a 0.5ml Eppendorf tube with a hole 
in the bottom placed inside a 1.5ml Eppendorf. The liquid containing the DNA fragment 
was spun down into the 1.5ml Eppendorf by a quick centrifugation and the recovered 
material was phenol extracted and subsequently precipitated.
All ligation reactions were carried out to manufacturer's specifications with T4 ligase or 
a DNA ligation system (Amersham Kit). They were incubated for 5 hours or o.n. at 
15°C. Religation o f the vectors was avoided through dephosphorylation using calf 
intestinal alkaline phosphatase following the recom m ended reaction conditions. The 
ligated DNA fragments were used to transform com petent bacterial cells (see below).
Preparation and transformation of competent cells
This protocol is a variant of one developed by M. Scott, Dep. of Neurology (UCSF). The 
transformation efficiency o f these cells was 10^-10^ plaques per |ig  of M 13m pl8. The 
following buffers were freshly made from sterile stock solutions before each batch of 
frozen competent cells was prepared:
25ml of 2xTY in a 250ml flask were inoculated with a single colony of bacteria from a 
minimum glucose agar plate. The culture was grown at 37°C in a shaking incubator to 
midlog phase (O.D.goo = 0.2-0.8), diluted into 100ml 2xTY in a 21 flask and grown again 
until the O.D.^oo = 0.5-0.9. The culture was diluted once more to 500ml with 2xTY and 
the cells were harvested when an O .D .600 o f 0.6 was reached. The culture was then 
pelleted by centrifugation for 15' (4200 rpm) at 4°C. The cells were resuspended gently 
in 100ml o f ice cold TfBI and spun again 8' (4200 rpm) at 4°C, gently resuspended in 20 
ml o f ice cold TfBII and aliquoted in prechilled 1.5ml Eppendorf tubes on dry ice. The 
aliquots were frozen in liquid nitrogen and stored at -70® C for up to 4 months.
The transformation was performed following the standard procedures. After thawing the 
frozen competent cells, 180 |il o f bacteria were incubated on ice with no more than 20 |il
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of DNA solution for 30'. Then they were heat shocked at 42°C for 2' and returned onto 
the ice. In case o f M l 3 transformations cells were then mixed with 3ml o f melted H-top 
agar, which had been cooled to 55°C, and poured on H -agar plates. The plates were 
allowed to settle and incubated at 37°C o.n. B lue/w hite selection was used to help 
identify vector-containing inserts (which will produce white colonies by disrupting the p 
galactosidase gene in the vector). 25|il of 2.5% IPTG and 25|il o f 2% X-gal were added 
to the 3ml of top agar just before plating.
In the case of plasmid vectors, cells were recovered after transformation for 30' to 1 hour 
in 1ml 2xTY at 37°C before plating on agar containing the selective antibiotic. For pUC 
based vectors am picillin (lOOqg/ml) was used. For pBGS derived vectors kanamycin 
(50|ig/ml) was used. Plates were incubated at 37°C o.n.
Preparation and electroporation of 'electro-competent cells'
Electro-com petent cells were prepared from a 1 litre o f bacterial culture in 2xTY 
inoculated with 1/100 volume of an o.n. culture. This was grown to about O .D .600 = 0.5- 
5.7 and then chilled for 15' on ice. The culture was centrifuged at 5000 rpm for 20' and 
resuspended in the original volume o f ice cold Im M  Hepes, pH 7.0. Cells were respun 
and resuspended in half of the original volume of the same buffer. The cells were then 
washed with 20ml 10% glycerol containing ImM  Hepes, pH 7.0, and resuspended in 2- 
3ml 10% glycerol (the cell concentration should be 3x10^^/ml). The cell suspension was 
frozen in aliquots on dry ice and transferred to -70°C
The electroporation was used when high transformation efficiency (10^-10^ colonies /|ig  
o f plasm id) was required. For electroporation the DNA ligation m ixture (500ng 
minimum) was purified through extraction with phenol and ethanol/salt precipitation and 
then resuspended in up to 20ql o f H 2O.
Frozen electro-com petent cells were thawed on ice. 50|iil o f cells were mixed with the 
DNA and transferred to a prechilled 0.2cm cuvette. The cuvette was placed on ice for 2' 
and finally dried before electroporation. A Bio-Rad Gene Puiser (Bio-Rad Lab. Ltd., 
Richmond, CA) was used to deliver 1 pulse o f 2.5kV (to give 25 |iF  with the pulse 
controller set to 200 ohms). Immediately afterwards 1ml of fresh SOC was added to the 
cells for resuspension, which were then incubated for 1 hour at 37°C in an incubation 
shaker before plating onto the appropriate plates.
Preparation of M13 templates for sequencing
Single stranded DNA from recom binants in M 13m pl8  (Sanger et al., 1980) was 
prepared from white plaques, which had previously been identified as positive for the 
relevant gene by colony hybridisation. These were toothpicked into 1.5 ml o f a 1/100 
dilution of a TG I o.n. culture in 10ml tubes and incubated for 4.5 hours at 37°C in a 
shaker. Cultures were then spun at maximun speed for 5' and 1ml o f the resulting
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supernatant was carefully removed and mixed with 200|il o f 20% (w/v) PEG 8000/2.5M 
NaCl. The mixture was left at RT for 10' and then spun for 10' at maximum speed. The 
supernatant was aspirated and the residual PEG solution was rem oved after a second 
spin. The pellet was fully resuspended in 200|il TE and then extracted with an equal 
volum e of Tris-buffered phenol followed by ethanol/salt precipitation. The DNA was 
finally washed with 70% ethanol, dried and redissolved in 50ql of TE.
2.2.2 Preparation of genomic DNA
This protocol was used to prepare genomic DNA from eukaryotic cells (1-2x10^) and 
from mouse tails (approximately 1cm long) for Southern blotting or PCR.
After two washes in PBS the cells were resuspended in 1ml o f Solution A ( 75mM  NaCl, 
25mM EDTA pH 8.0), then 1ml o f Solution B (lOmM Tris/ HCl pH 8.0, lOmM EDTA 
pH 8.0, freshly added 400 qg/m l proteinase K) was added. The mixture was incubated 
for 6 h or o.n. at 55°C. The sample was extracted with an equal volume o f phenol, mixing 
very gently to avoid shearing of the DNA, and later with chloroform. Then, 200|il of 3M 
sodium acetate and 5ml of ethanol were added, inverting the tube gently several times 
until the DNA formed a precipitate. The DNA was fished using a plastic loop and left to 
air dry. It was dissolved in an appropriate volume of TE. If  required, the sample was 
incubated in 20|ig/m l RNAse for 15' at 37°C, to remove unwanted RNA. Repeated 
freezing and thawing was avoided. DNA was stored at 4°C for frequent use and at -20° C 
for long term storage.
Tail samples were collected from mice one week after weaning and placed in 2ml of 
PBS. Samples were homogenised at high speed for 30" (3x) using a Polytron Kinematica 
(PCU). Cell suspensions were centrifuged for 10' at 3000rpm  and the pellet was 
re suspended in 1ml of Solution A and processed as before. W hen m ouse liver was the 
source of DNA it was obtained following the same protocol, but keeping the sample in 
ice all time before the proteinase K digestion.
Isolation of DNA from small numbers of cells
This protocol was used to obtain DNA directly from cells sorted in the FACS tar plus, for 
PCR. Cells (1x10^-10^) were collected into a 0.5ml Eppendorf tube and spun down in a 
m icrocentrifuge at the low speed setting for 2'. The supernatant was carefully removed 
and the cells were resuspended in 10-20 |il of water (depending on the num ber o f cells) 
by vortexing, frozen im mediately in liquid nitrogen and kept at -70°C. The DNA was 
isolated by treating the thaw ed cells with proteinase K (lOOqg/ml) in Ix  PCR 
buffer/0.5 % Tween 20 (20-40|il final volume) and incubated for Ih at 56°C. The sample 
was heated to 95°C for 30' to inactivate the proteinase K and kept at -20°C.
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2.2.3 Production of radiolabelled probes 
Radioactive labelling of oligonucleotides
Oligonucleotides were synthesised by Terry Smith (MRC, LMB, Cambridge, UK) using 
an Applied Biosystems AB380B DNA synthesiser. The oligonucleotides (which do not 
possess 5 ’ phosphate group) were labelled by setting up a standard phosphorylation 
reaction with 10.2|il TE, 4 .3 |il H2O, 2 .5 |il (lOx) kinase buffer, 5|li1 o f  (Y-32p)-dATP 
(1 0 |iC i/iil) , l |i l  o f T4 polynucleotide kinase and 3|il of oligonucleotide at lOpmoles/pl. 
The reaction was carried out for Ih at 37°C and stopped with lOOfil o f TE. The labelled 
probe was separated from the radioisotope non incorporated by chrom atography over a 
Sephadex G50 column before it was used for hybridisation.
Radiactive labelling of DNA fragments
Gel purified DNA fragments were labelled with (a-^^P)-dC TP (10 |iC i/|il) by primer 
extension using a Pharm acia oligolabelling kit, according to the m anufacturer's 
specifications. The probe was purified by Sephadex G50 chromatography before it was 
used for hybridisation.
Spin column preparation and use
Glass wool was siliconized by putting the glass wool in a beaker in a hood, adding silane 
solution, covering the beaker with aluminium foil and leaving for 4h to dry in a oven at 
150°C. A 1ml plastic syringe was plugged with siliconized glass wool and a 0.9ml 
Sephadex G50/TE (pH8 ) spin column prepared in the following way. Sephadex G50 was 
poured (carefully to avoid bubbles) into the column to the 1.3ml mark. The column was 
then placed into a 15 ml conical bottomed tube with an Eppendorf inside and spun for 2' 
at 1500rpm. The column was repeatedly topped up and spun until the final packed 
volume was 1ml. The sample was then applied to the top of the column. The eluate was 
collected in a fresh Eppendorf at the bottom of the 15ml tube.
2.2.4 Screening of bacterial clones
The Buluwela protocol for screening bacterial colonies or M l3 plaques (Buluwela, et al., 
1989) was routinely used. 0.45|i, 82mm circular Hybond-N  filters were used to lift 
bacterial colonies or M l3 plaques and markings made with a needle. A fter the standard 
fixation procedure filters were prehybridized for 10' at 65°C and then hybridised for at 
least 4h at 65°C. First washes were carried out in 4xSCC at RT, further washes in 
2xSSC /l% SD S for 15' increasing the tem perature up to 5°C below  the m elting 
temperature for the specific oligonucleotide, until the negative control could no longer
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be detected. The filters were then wrapped in Saran and exposed l-2h  or o.n. placing 
Stratagene glowing markers to allow orientation.
2.2.5 Southern Blots
For each digest 20qg o f DNA were used and digestions were carried out o.n. Then the 
samples were phenol extracted and ethanol/salt precipitated. A fter resuspension the 
digestion products were separated on a 250ml 0.7% agarose (dissolved in IxTA E) gel 
which was run o.n at 45mA, side by side with the appropriate mw markers. The gel was 
run until the fast blue was out of the gel and stained for 15' with EtBr. A photograph was 
taken with a fluorescent ruler by the side of the gel to mark the positions o f the markers, 
also, an exact replica o f the gel was drawn on a transparent sheet for an easier location of 
the relevant bands. The presence of satellite DNA indicated that the digestion had gone 
to completion. The gel was placed in 0.25N HCl until the dyes changed colour and then 
for another 10'. Then the HCl was washed away with distilled H 2 O and the DNA was 
denatured for 15' in 0.5M  NaOH. Hybond N+ m embrane was cut to size, soaked in 
0.5M NaOH for 5'. Two 0.5M NaOH soaked strips o f 3MM paper were placed on a glass 
plate so that they overhung into a tray full o f 0.5M NaOH. The gel was placed on top of 
the glass plate and the Hybond N+ membrane was then placed on top o f the gel and 
rolled to rem ove air bubbles. A piece of 0.5 M NaOH soaked 3MM paper was then 
placed on top of the Hybond N+ membrane and the paper strips on the glass plate still 
exposed to the air were covered with parafilm  to prevent evaporation through these 
areas. Three more dry 3MM pieces were placed on top of the gel letting them get wet 
and taking care to avoid air bubbles. A large stack o f paper towels was then positioned 
on top of the 3MM paper. The gel was left to blot for 16-24 h at RT with a change of 
paper tow els and several top ups 0.5M  NaOH as required. Before rem oving the 
membrane from the gel, the position of the DNA slots was marked. The filter was then 
peeled from the gel and neutralised in 1.5M NaCl/0.5M  Tris-HCl pH 7.4 for 15' at RT, 
then the DNA was cross linked to the membrane in a Stratalinker (Stratagene) at the 
standard settings before storage at RT in foil. The membrane was then placed in a glass 
rolling bottle and prehybridised for 10' at 65°C in 10ml Church hybridisation buffer. The 
probe was boiled for 5' and put on ice for 10'. This was then added to new preheated 
hybridisation fluid in a Falcon tube. The prehybridisation fluid was then discarded and 
the probe/hybridisation fluid mixture added to the membrane. After o.n. hybridisation at 
65°C, the radioactive hybridisation fluid was decanted into a 50 ml Falcon tube for 
future use (such mixtures were used up to 5 days after initial preparation, boiled before 
re-use). Filters were then washed 2x for 15' at RT with Church wash buffer, 2x for 20' at 
50°C monitoring the counts until the background was reduced to a minimum. The filter 
was then wrapped in Saran and put into a cassette with two Fuj i RX medical X-ray film 
(Fuji Photo Film Co. Ltd., Japan) (one on each side of the filter) for autoradiography o.n.
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at -70°C  using an intensifying screen. The developing process was carried  out 
automatically using a Kodak RP X-OMAT Processor.
2.2.6 DNA sequencing
All sequencing of ds and ssDNA was done using the Sanger dideoxy chain termination 
method (Sanger et al., 1977). A Sequenase Version 2.0 sequencing kit (United States 
B iochem ical) was used for all sequencing reactions follow ing the m anufacturers 
instructions, with the exception that extension was done at 18°C. and termination was at 
42°C. Sequencing was carried out in m icrotiter round-bottom ed plastic plates. Only 
1.5ql from the sequencing mix were loaded to improve the resolution o f the bands in the 
gel.
Preparation of acrylamide gradient sequencing gels
To produce a 6 % acrylam ide gradient sequencing gel the follow ing stock working 
solutions were made:
5xTBE m ix: 15ml 40% acrylam ide, 50ml lOxTBE, 46g urea and a pinch of 
bromophenol blue.
0.5xTBE mix: 75ml 40% acrylamide, 25ml lOxTBE, 230g urea and H2O to top up to 
500ml.
The two solutions were filtered through a 0.45 |i Nalgene filter and kept at 4°C for up to 
1 month. Two glass electrophoresis plates for sequencing (one with a bevelled end) were 
washed with detergent, rinsed with H 2O and then with ethanol. The one with a bevelled 
end was siliconated. Spacers were put at either side between the plates and the plates 
were then taped together tightly with water proof tape. 13|il o f 25% AMPS was added to 
7.5ml of the 5xTBE and 8 8 |il o f 25% AMPS to 50ml o f the 0.5xTBE. Finally 13|il of 
TEMED was added to the 5xTBE and 88ql of TEMED to the 0.5xTBE. 6ml o f 0.5xTBE 
was taken up in a 25ml pipette and 7ml of 5xTBE (blue) was taken up in the same 
pipette. The gradient was achieve by allowing three air bubbles to pass through the 
pipette. The electrophoresis plates were held at 45° and the gradient poured down the 
middle of the plates followed by the rest o f the 0.5xTBE solution. The shark-tooth comb 
was placed in an inverted position to create a mould and the plates clipped together. The 
gel was left to set for a minimum of Ih. Before use, the com b was extracted, the surface 
o f the gel edge was cleaned with H 2O and the shark-tooth com b inserted to touch the 
surface of the edge of the gel. Gels were pre-run for 30' before the samples were loaded. 
Gels were run at 37 W for approximately 3h in IxTBE buffer and fixed for 15' in 10% 
methanol/10% acetic acid, blotted on to 3MM paper and dried under vacuum for 45' at 
80°C. Autoradiography was performed o.n. at RT.
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2.2.7 Polymerase chain reaction (PCR)
PCR conditions were optimised for each set o f primers. Primers for PCR were adjusted 
to lOpmoles/ml. It was sometimes necessary to gel purify some prim ers (see below). 
Reactions were perform ed in 0.5ml Eppendorfs and overlaid with light m ineral oil 
followed by heating to 94°C for 10' in a thermal cycler (PHC-2 from Techne or Biometra 
PCR machine) to denature the DNA. The enzym e was added under the mineral oil and 
the m ixture was then therm al cycled (30x). U nless otherw ise noted, the cycle was: 
denature for 2' at 92°C, anneal for 1.5', and extended for 2' at 72°C. An initial annealing 
tem perature was selected based on the m elting tem perature o f the oligonucleotide 
primers and it was decreased 5°C if the amplification failed. An extra extension step was 
carried out for 10' at 72°C.
E ither 5pg o f plasm id DNA or O .l- lq g  o f genom ic DNA was em ployed for each 
amplification. W hen cell lysates (from Peyer's patches cell sorted cells) were used 3, 6 
and 10|il from the mixture were utilised to standardise the PCR conditions. From 1992 to 
1994 the Cetus Taq polymerase was used, the standard reaction was performed in a total 
volum e o f 50|i,l following the m anufacturers conditions. From  1994 Native Pfu DNA 
polym erase (S tratagene) was used since the frequency o f  errors in troduced  is 
considerably low er than the other polym erases. In this case the am plification was 
perform ed in a final volum e o f lOOql according to the enzym e m anufacturers 
specifications. Usually multiple amplifications were performed at the same time for a 
single sample.
C ontam ination during PCR from  previously cloned D NA was a m ajor concern, 
particularly when PCR from PP cells from transgenic mice was carried out to analyse 
somatic hypermutation . To avoid contamination, the following measures were taken: 1) 
gloves were worn at all the time, 2) PCR reactions were set-up in a bubble cham ber 
using a set of separate pipettes kept exclusively for PCR, 3) all reagents were aliquoted, 
used once and discarded, 4) a negative control replacing the DNA with H 2O was always 
included to ensure that inadvertent contamination had not occurred, 5) plugged pipette 
tips were always used, 6 ) gel boxes and combs were depurinated o.n. with 0.25M  HCl
PCR screening of recombinant clones
PCR was used to analyse recombinant clones for the presence of the correct insert, after 
a DNA ligation, directly from bacterial colonies (Gussow and Clackson, 1989). A PCR 
reaction m ixture was m ade up containing Prom ega Taq polym erase buffer, 200qM  
dNTPs, 20pmol of each of the oligonucleotide primers flanking the insert o f interest and 
0 .3 |il o f Taq polym erase per 20|il of reaction mixture. Tem plate for amplification was 
transferred into the tube by touching the bacterial colony with a small plastic inoculating 
loop. The reaction mixtures were overlaid with 50ql o f light mineral oil and denatured at 
94°C for 10' followed by thermal cycling using the specific conditions for the set or
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primers chosen. 20 cycles were performed usually. Clones containing the correct insert 
were identified either by the size o f the insert, or when necessary, by digesting the 
amplified DNA with restriction enzymes and examining the restriction fragment sizes on 
an agarose gel.
P u rifica tio n  o f  sy n th etic  o lig o n u cleo tid es
Small glass plates (40x20cm) were cleaned and prepared as for sequencing gels. The 
percentage of acrylamide used depended on the size o f the oligo being purified. A useful 
guidance follows: for 25 nt or less 20% acrylamide gels were used; for 25-40 nt 16% 
acrylam ide gels were used. A 45ml 7M  urea IxTB E acrylam ide gel m ixture was 
prepared and 90[il o f 25% AMPS and 90|il TEM ED added to this im mediately before 
pouring. Gels were allowed to set for Ih 8|il of neat oligo (approx. 4 O .D .260 units) were 
mixed with 8 |il of loading buffer and heated at 80°C for 5' to disrupt any secondary 
structure before being loaded. The gel was run in IxTBE buffer at 34W. until the fast 
blue had run approximately two thirds of the length o f the gel. The position o f the oligo 
was estim ated from the position of a control oligo of known length. The gel was then 
transferred onto Saran and the bands UV shadowed using long wave UV (the DNA 
absorbs UV and so appears black against the uniform fluorescent background o f a F254 
silica gel 60 fluorescence indicator chrom atographic plate). The highest mw band 
representing the undegraded oligo was circled with a felt tip pen and cut out. The gel 
slice was then placed in a Eppendorf tube and reduced to small pieces with a scalpel , 
then 200|il o f H 2O was added and this was shaken 5h or o.n. at 37°C. A fter a short 
centrifugation the supernatant containing the eluted oligonucleotide was ethanol/salt 
precipitated and resuspended in 50ql of H 2 O, its O .D .260 determined and then adjusted 
to 10pm oles/|il. G reat care was taken throughout the w hole m anipulation to avoid 
contamination o f the oligonucleotide with cloned DNA.
2.2.8 Construction of plasmids
L k a s  b asis  fo r  fu rth er  co n stru cts
All the constructs used in this work are based on the original L k construct assembled by 
M. Sharpe (Sharpe et al., 1990), encoding a rearranged mouse (BALB/c) V k gene, 
specific for the hapten phenyl-oxazolone (V kO x I), linked to a rat C k gene. The presence 
of the rat constant region m eant that the transgene could be distinguished from  the 
endogenous k at the protein level using anti-rat k antibodies and at the nucleic acid level 
by a ribonuclease protection assay. The transgenes consist of mouse k sequences except
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for the region from the Hpa I site in C k to the Bgl II site im mediately 3' of C k , which 
has been substituted by sequences from the LOU rat strain and a deletion o f 27nt 
flanking the X ba I site dow nstream  of Jk5. This difference allows unam biguous 
discrimination o f the transgene from the endogenous loci by differential hybridisation 
with the oligonucleotides P I400 and AFR3 (see Appendix II), which hybridise with the 
wild type and deleted forms respectively. The L k transgene is known to be a good 
substrate for the hypermutation process (Sharpe et al., 1991) as well as a short version of 
this construct L kA[3'F] (Betz et al., 1994). For cloning conveniences L kAB, a short 
version of the L k where the DNA fragment between the BamH I sites 3' of the C k was 
deleted (Yélamos et al., 1995), was also used to make other constructs.
The construction o f individual plasmids used to create transgenic mice and those used in 
the transfection studies are described in the following sections. The structure of the 
transgene in those constructs are shown in the Fig. 2.1.
Figure 2.1 Structure of transgenes (opposite page).
The structure o f the different transgenes used are depicted. In the structure o f the
transgenes, carrying the C D R l mutated, the V k segm ent containing the m utations is 
depicted. The nature of the mutations (which are shown in red) in each transgene are 
indicated. The restriction endonuclease cleavage sites are abbreviated: R, EcoRI; B, 
BamHI; Xb, Xbal; Xh, Xhol; SI, S ad ; SII, SacII; H, H indlll; Hp, Hpal; N, Notl.
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2.2.8.1 The Lk-CDR1 mutated constructs
A series of oligonucleotides was synthesised in order to replace the original DNA 
sequence at the C D R l of V kO x gene without changing the am ino acidic sequence (see 
Appendix I A). This was achieved by designing them in pairs: one o f them is the coding 
region carrying the mutations and the other is its com plem entary sequence. W hen they 
were hybridised they acted as a double stranded DNA synthetic fragment with cohesive 
ends ready to ligate.
50pmol of each oligonucleotide was phosphorylated using the standard protocol with the 
PN Kinase, followed by heat inactivation and ethanol precipitation. Each oligo was 
resuspended in 10|il o f H 2O and mixed with its complementary. The mixture was boiled 
for 5' in a water bath and hybridisation was allowed to occur for 40' by letting the water 
bath cool to room temperature. The tubes were place on ice and 4 |il o f the mixture was 
used to ligate with 2qg  of vector using the Amesham kit. After o.n. incubation at 15°C 
half o f the ligation was used to transform and the recom binant clones were analysed by 
digesting with restriction endonucleases and by sequencing the V k O x gene with 
V kO x212 oligo (Appendix II ).
Firstly the Pstl/Kpnl fragment o f the plasmid pB10513 (pUC19 containing the EcoRI- 
H in d lll L k  fragm ent) was replaced by the synthetic fragm ent com posed o f the 
oligonucleotides C D R l M3 and CDR1M4, which were degenerated in several positions 
allow ing the form ation o f different variants of mutants. The individual clones were 
selected from the "library" by double stranded sequencing with V kO x212  oligo and by 
restriction enzyme digestion, since some of the mutations were m eant to generate new 
restriction enzym e cuts in order to facilitate the identification o f each copy (see in 
Appendix I for the list o f the selected clones carrying the m utagenised C D R l). The 
fragment EcoRI-SacII from three mutants (pBEA25, pBEA28 and pBEA31) were used 
to replace the original L k  sequence in the plasm id pK471 (pUC19 containing the 
EcoRI/Bam H I L k  fragment) since EcoRI-BamHI fragm ents carrying m utations were 
required for microinjection.
The oligonucleotides C D R IM I and C D R l M2 (carrying seven m utations) were 
em ployed to replaced the original fragm ent in pB10513 and pK 471. The mutant 
EcoRI/SacII fragment cloned into pB10513 (pBEA7) was used to replace the original 
sequence in the L k w hilst the m utant EcoRI-Bam HI fragm ent cloned into pK471 
(pKBEA7) was used to replace the original sequence in the L kBAB (derivative of L kAB 
with the BamHI site in the pSV2neo destroyed to facilitate the cloning procedures). The 
L k7M, and the L k AB7M were used to purify DNA fragm ents em ployed in the egg 
injection and they were used extensively as a basis for further constructs, since they 
carry three new restriction sites in the CD Rl region making the identification o f new Lk 
derivatives simpler.
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A nother C D R l m utated construct (LkABTCA) was m ade replacing the Pstl-K pnl 
fragm ent of pB10513 with a synthetic analogue com posed by the oligonucleotides 
CDR1M7 and CDR1M 8. The plasm id pBEA60 was used then, to take the fragment 
EcoRI/SacII, containing the "TCA" mutation, and ligated into the L kAB.
The last o f the C D R l m utants (LkA B7M /TCA) was generated by replacing the 
X hol/K pnl fragment from pBEA6  with the synthetic analogue made with the CDR1M5 
and CDR1M 6 oligo com bination. This construct (pBEA72) was used to obtain the 
EcoRI/SacII fragment containing the "7M/TCA" m odifications and ligated back into its 
original place in the LkAB construct.
2.2.S.2 The k  3' enhancer dissection constructs
Three independent deletions were produced in the k  3' enhancer region (M eyer and 
Neuberger, 1989). One includes the whole 3' enhancer, the other its core (M eyer et al., 
1990; Pongubala and Atchison, 1991) and the third, the flanking regions o f the 3' 
enhancer core.
LkABA[3’E]
The construct carrying the com plete deletion of the 3' enhancer region (LkABA[3'E]) 
was made by digesting the plasmid L kAB with Xhol and Notl, followed by filling in the 
protruding 5' ends with the Klenow fragment o f the DNA polym erase I. In this way the 
Notl site was destroyed and the Xhol was reconstituted after religation.
LkA[FI3’EC] and LkABA[FI3'EC]
The deletion of the flanking regions o f the 3' enhancer core from position 12580 to 
13058 and from 13200 to 13966 (Appendix II B) were made by PCR. The amplification 
of the core enhancer was made with the oligonucleotides D IN O l and D IN 02  (Appendix 
II), which introduced a Xhol and a Notl site (respectively) in each side o f the core. The 
142bp PCR product was N otl/Xhol digested and then ligated back, into its original place 
in the L k and L kAB constructs.
LkABA[3'EC]
The LkABA[3'EC] construct is a derivative of LkAB which lacks k  3' enhancer core. The 
first step of the construction was to clone the 1.3kb Xhol-Notl fragment containing the k  
3' enhancer into pB luescript II KS (-). This plasm id (pBDino5) was NcoI/BspM I 
digested and the protruding 5' ends filled in with the Klenow fragm ent o f the DNA 
polym erase, followed by self-ligation. The insert o f this plasm id (pBDino5.11) was 
sequenced with the M l3-20 prim er (see Appendix II A) to confirm  that it carries the 
177bp deletion (form position 13072 to 13249, see Appendix II B) which includes the 3'
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enhancer core. The X hol-N otl fragm ent of pBDino5.1 was then ligated back, into its 
original place, in the L kAB construct.
2.2.8.3 The k  intron enhancer deletion construct (LKABA[Ei])
The LKABA[Ei] construct is a derivative of L k A B  carrying a deletion in the k  intron 
enhancer region. (Queen and Baltim ore, 1983 ; P icard and Schaffner, 1984a). The 
deletion includes basically the core enhancer (Fulton and Van N ess, 1994) (see 
Appendix II B).
The first step in the construction was the subcloning o f the L k  EcoRI-Bam H I fragment 
into the Km resistant vector pBGS19.5(4-) (which H indlll site was destroyed). In parallel 
the L k  H indlll-H pal fragment, carrying the k  M AR/Ei elem ents was subcloned into 
pBGS19(-t-) H indlll/H icII digested. Thus, this plasmid (pMED3) was used to purify the 
535bp A flll-H incII fragm ent w hich, together with the PCR product w ith the 
oligonucleotides M ARI and M AR2 (containing the M AR region; see Appendix II) 
digested with H indlll and A fill, were assembled by a three way ligation with the vector 
p B G S -L k [E -B ] , H idlll/H pl digested.
The clones carrying the intron enhancer deletion (from position 1932 to 2306, see 
Appendix II B) were identified by PCR screening with the oligonucleotides M ARI and 
M ARBSEQ (see Appendix II), since the positive clones gave a 0.457kb amplification 
product and the negatives a 0.831 kb. In addition the clones were sequenced to confirm 
that the assembly was correct. Finally the EcoRI-BamHI fragm ent from pBGS-LK[E- 
BA[IE]] was ligated back into its original place in the L kBAB7M.
2.2.8.4 The MAR deletion construct (LkABA[MAR])
The MAR region (Cockerill and Garrad, 1986) was removed after amplification with the 
oligonucleotides lE l and RCKN127 (see Appendix II). The 1.020kb PCR product 
obtained was digested with Hind III and Hpa I, and ligated in place of the equivalent L k 
fragment, in the pBGS-LK[E-B] vector. The clones carrying the M AR deletion (from 
1572 to 1863, see Appendix II B) w ere identified by PCR screening with the 
oligonucleotides IE5 and lEBSEQ (see Appendix II A), since the positive clones gave a 
0.597kb am plification product and the negatives a 0.888kb. Some positive clones were 
sequenced with M AR2 prim er (see Appendix II) to confirm  that no m istakes were 
introduced during the replacement. Lastly the pBGS-A[MAR] was digested with EcoRI 
and BamHI and the Lk-A[MAR] segment was ligated in place of the equivalent L kBAB- 
7M fragment.
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2.2.9 Cell culture techniques 
Freezing and thawing cell lines
To freeze cells, 5x10^ cells or more were taken from a healthy logarithmic culture and 
spun at 1200rpm for 5'. The supernatant was aspirated and the pellet resuspended in 1ml 
o f sterile freezing medium (90% FCS, 10% DM SO at 4°C) and kept on ice. The cells 
were transferred to 2ml freezing vials, put at -20°C for 2h and then transferred to -70°C. 
A fter a few days, the cells were transferred for long-term storage under liquid nitrogen. 
To thaw cells, vials were warmed quickly to 37°C in a water bath until only a little ice 
remained. Cells were washed in 10ml o f DMEM/20% FCS and re suspended in 1.5ml of 
the same medium and seeded into 24 well plate by making serial dilutions. After some 
days cells were transferred into flasks with 10% FCS/DM EM . All cell lines and 
hybridomas were grown in 10% FCS/DMEM at 37°C in humidified incubators under 5% 
CO2
2.2.10 Isolation and analysis of Peyer's patches cells 
Isolation of cells
Unless otherwise specified all transgenic mice used to collect Peyer's patch cells were 
between four and five m onths old. PP were recovered by dissection from  the small 
intestine. Single cells suspensions were prepared by pressing PPs through a nylon mesh. 
The cell suspension was centrifuged and washed (2x) in 15ml cold DMEM. Clumps of 
dead cells were eliminated with a Pasteur pipette after each wash.
Fluorescence activated cell sorting
Cells were resuspended in 250|il DM EM  and incubated with PNA FITC labelled (Dil. 
1/60) and mAb to mouse CD45R (anti B220) PE labelled (Dil. 1/250) for 30' on ice. The 
labelled cells were then washed with 15ml of cold medium and resuspended in 3ml of 
cold PBS. The cell suspension was finally passed through a nylon mesh to avoid cell 
clumps which could block the sorting machine.
B220+ PNA^igh and B220+ PNA^°^ cells w ere sorted on a FACStaiP^"^ (Becton 
Dickinson) sorter by David Gilmore and Andrew Riddell.
2.2.11 Transfection of mammalian cells and analysis of gene expression 
Generation of stable transfectants
Stable transform ants were generated by electroporation as described by Potter et al. 
(1984) The DNA (50|ig) was linearized with Pvul, phenol extracted, ethanol
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precipitated, and resuspended in 50 |il sterile PBS. Approximately 1.5x 10^ cells were 
spun down, washed in PBS and resuspended in 200pi o f PBS. The DNA and the cells 
were placed in to a sterile electroporation cuvette (0.4cm gap), mixed by flicking and 
placed on ice for 20'. A Bio-Rad Gene Puiser (Bio-Rad Laboratories Ltd.) was used to 
deliver a pulse o f 0.2kV (960pF, t = 50ms) to the cuvette, which was then placed on ice 
for another 20'. The cells were seeded into 24 well plates using D M EM /10% FCS. The 
transform ants were selected 24h after transfection by resistance to G418 at an initial 
concentration o f 0.5mg/ml and this selective concentration was increased to 1 mg/ml 
(S107) or 2mg/ml (NSO) six days after transfection.
Pools from ten different well established clones were used for each transfectant line in 
order to purify the cellular RNA. The RNAgents Total RNA Isolation Kit (Promega) 
was used following the manufacturer's instructions. Volumes were scaled down when it 
was necessary.
Ribonuclease protection assay
The radioactively labelled RNA probe for detecting rat C k  was generated by T7 RNA 
polym erase transcription of the plasmid pT7Cx, a Bluescript vector into which a 300bp 
BamHI fragment overlapping the start site o f the rat C k  has been cloned. In order to 
obtain the antisense probe the plasmid was linearized so that a transcription from the T7 
prom oter w ill generate an RNA probe o f 360bp that is com plem entary to the C k  
transcript. A fter hybridization of the probe and the total RNA, a double stranded RNA 
molecule is formed with a 5' and a 3' overhang. Treatment with RNAase removes these 
overhangs and, generates a fragm ent o f 300bp w hich can be v isualised  by 
electrophoresis and subsequent autoradiography.
Transcription from the linearized plasmid with H ind lll was carried out using 2pl lOx 
transcription buffer (400mM Tris pH 7.5, 20mM spermidine, 60mM M gCl2), Ip l rNTP 
solution (lOmM  each), Ip l 250mM DTT, Ip l RNAsin, 5pl [a^^P] UTP (lOpCi/pl) and
31.5 units of T7 RNA polym erase in a total volum e o f 20pl for 30' at 37°C. A fter the 
incubation IGpl form am ide dyes were added. The probe was purified on a 4% 
denaturing polyacrylam ide gel as described and eluted in 1ml M axan-Gilbert buffer 3h 
or o.n. at 37°C.
For the ribonuclease mapping, the radioactive probe (5xl0^cpm ) was added to lOp-g of 
RNA which was then ethanol/salt precipitated, washed, vacuum dried and resuspended 
in 30 |il o f hybridization buffer (80% formam ide, 0.4M  NaCl, lOmM PIPES pH 6.4, 
Im M  EDTA). Samples were denature for 10' at 85°C in a water bath followed cooling 
the water to 46° and hybridization was allowed to occur o.n. Then 300|il of ice cold 
RNAse mix (l |ig /m l RN A se-Ti, 40 |il'/m l RNAse A in TNE) was added and single 
stranded RNA was digested by incubation at 30°C for 30'. To stop the reaction 20|xl o f
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20% SDS and 7 .5 |il o f proteinase K (20mg/ml in TNE) were added and incubated at 
37°C for 15'. Samples were treated with phenol/chloroform/isoamyl alcohol, ethanol/salt 
precipitated, washed and dried before separated on a 4% denaturing polyacrylamide gel. 
A H aelll digest of (j)X174 which was labelled with [y^^P] ATP served as size markers. 
The gel was fixed, transferred, and dried as described before and an autoradiographic 
image was obtained after several days of exposure at -70°C.
Northern blot analysis
The cytoplasm ic RNA (~10 |ig) was fractionated in 1% form aldehyde/agarose gel 
(Lehrach et al., 1977). The gel fractionated RNA was transferred by capillary forces to 
H ybond N+ m em brane in 20xSSC buffer and was then UV cross-linked to the 
membrane. The membrane was pre-hybridized for 30' in Church hybridization buffer 
and hybridized with radioactively labelled oligonucleotides in the same buffer overnight, 
at 42°C. The blot was washed twice for ten minutes in Church wash buffer.
The oligonucleotide used for the detection of the transgene (RATCk IS) was specific to 
rat sequences within the constant region on the transgene, whilst the oligonucleotide 
used as a control for mRNA loading (MOUSEACT) was specific to p-actin.
2.2.12 Enzyme-linked immunoabsorbent assay 
Inhibition assays for detection of transgenic k  expression
This assay was developed by M. Sharpe to screen transgenic mice carrying a rearranged 
mouse K light chain tagged with the constant k  region of the Lou rat. This allows easy 
serological detection o f the transgenic light chain in the serum o f the transgenic mice. 
This assay was also used to titrate supernatants of transfected S I07 and NSO cells and 
hybridom as. The strategy is based on an inhibition assay in which the test serum is 
incubated with an anti-rat k  reagent and the rem aining free antibody is quantitated. 
Serum containing transgenic light chains rem ain uncoloured w hilst serum lacking 
transgenic light chains resulted in a positive signal. The assay relies on the amplification 
step introduced with the biotin-streptavidin developing system. Falcon flat-bottom ed 
microtiter plates were coated with 5-10 qg/m l o f an irrelevant rat antibody (in this case 
P4C1/13-11, fraction I) and left at 4°C o.n. This was then blocked at least for Ih at 37°C 
with PBS/5%FCS or o.n. at 4°C and stored for up to 3 months in PBS, 5% FCS , 0.01% 
azide in a moist chamber. Two dilutions o f test serum (1:50 and 1:250) were incubated 
at 4°C o.n. with an equal volume o f a 1:7000 dilution (of 1 mg/ml) of mouse anti-rat k  
antibody MARK-1 (Serotec). Several serial dilutions were made when quantitative 
analysis were performed. The mixture then was transferred to the plate coated with rat 
Ab and incubated 90' at 37°C. The plate was then washed 3x in PBS and the amount of
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MARK-1 Ab bound was assayed by incubation with biotinylated sheep anti-m ouse 
antiserum (1:6000) (Amersham) for 45' at RT. The plate was washed 3x in PBS and of 
streptavidin-H RP com plex (1:2000) (Amersham) was added for 15' at RT and then 
washed 2x in PBS, before adding the substrate solution (0.55m g/m l ABTS, 0.001% 
H2O2, O.IM citrate buffer pH 4.3). The optimal coloration was achieved, approximately 
after 10', and the reaction was stopped by adding 50pl o f O.IM citric acid, 0.01% sodium 
azide per well. The O.D. was read in an automatic plate reader (Titertek Multi scan) at 
414 nm. For quantitative ELISA serial dilutions o f purified P4C1/13-11(F-I) or Y3 
(Bence-Jones protein) of known concentration was used.
Inhibition assays to quantitate mouse k  expression in supernatant o f stable 
transfected S107 cells
Falcon flat-bottomed microtiter plates were coated with 10 qg/m l o f O xl4-B SA  and left 
at 4°C  o.n. This was then blocked at least for Ih at 37°C with PBS/5%FCS or o.n. at 4°C 
and stored for up to 3 months in PBS, 5% FCS 0.01% azide in a m oist chamber. In 
parallel several serial dilutions were made o f test supernatants were incubated at 4°C o.n. 
with an equal volume o f a 1:800 dilution o f anti-mouse supernatant MCCIO (this is a 
bispecific Ab that recognises mouse K and horse radish peroxidase).
The next day, the plate was washed 3x in PBS and then incubated with a 1:1000 dilution 
of a mouse k  anti oxazolone NQIO.12.5.17 supernatant for Ih at 37°C. The plates were 
washed again, and the mixture containing the samples was transferred to the plate and 
incubated 90' at 37°C. The plate was then washed 3x in PBS and the amount o f MCCIO 
Ab bound was assayed by incubation with Peroxidase (1:50) for Ih at 37°C. The plate 
was washed 3x in PBS and the substrate solution (0.55mg/ml ABTS, 0.001% H 2O2, 
O.IM  citrate  buffer pH 4.3) was added. The optim al coloration was achieved, 
approxim ately after 10', the reaction was stopped by adding 50|il o f O.IM citric acid, 
0.01% sodium azide per well. The O.D. was read in an automatic plate reader (Titertek 
M ultiscan) at 414 nm. Serial dilutions o f  purified  9E10 m ouse Ab o f know n 
concentration was used as standard curve.
2.2.13 Transgenic mice and hybridomas
Preparation of the DNA fragments for microinjection
The constructs were digested with the appropriate restriction enzym es and the vector- 
free fragments were purified from the agarose gel as described before. The eluted DNA 
was chrom atographycaly purified with NACS columns, following the m anufacturers 
instructions. The eluted DNA was ethanol precipitated and washed several times until 
the white pellet can no longer be seen, then the DNA was dissolved in 20|il of MPW  and 
quantitated as described before. Once the DNA concentration was known, the fragments
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were either injected by them selves at the suitable dilution or a m ixture o f several 
fragments was prepared at equim olar ratio and a new quantitation, now o f the DNA 
fragment mixture, was made. The microinjection was carried out by T. Larson and J. 
Jarvis.
Founder anim als w ere identified by Southern blot analysis o f tail's DNA and by 
serological detection of the transgenic K light chain in the serum of mice. Founders were 
bred with F I mice (CBA x C57BL/6J).
Immunisation protocols
All im m unisations were perform ed using the same standard protocol. For prim ary 
immunisation lOOfig of aluminium-potassium sulphate precipitated antigen (phOx-CSA) 
was injected intraperitoneally together with 10^ units o f heat inactivated B o rd e tella  
pertussis (Wellcome, UK). Secondary immunisations were done six weeks later with an 
intra-venous injection o f lOOqg of soluble antigen. Three days after this the splenic 
lymphocytes were isolated and used for fusion.
Hybridomas were established from immunised adult mice by fusion o f spleen cells with 
the plasm acytom a cell line NSO (Galfré & M ilstein, 1981). All fusions and cloning in 
soft agar were made by Richard Pannell.
2.2.14 Computer analysis
Computer analysis of sequences was performed using the Staden programs on an Aliant 
mainframe com puter. The program AFRICA used for this task is an extension o f the 
program  NIPF written by Roger Staden. Further data handling was carried out on 
M acintosh personal com puters using the program s Excel (M icrosoft), W ord 5.1 
(Microsoft), Illustrator v5.0 (Adobe) and Cricket Graph III.
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Chapter Three Transgenes
3.1 Introduction
T ransgenic anim als are ex tensively  used to analyse hyperm utation. Transgenes 
containing relevant immunoglobulin sequences mutate (O'Brien et al., 1987) and the rate 
of hypermutation is of the same order o f magnitude as the endogenous genes when the 
elements in the 3' flank o f the k  locus are included (Sharpe et al., 1991). So far this is the 
assay system  m ost w idely used to analyse the regulatory  elem ents controlling  
hypermutation.
Transgenic constructs containing modified versions o f the relevant K chain transgene 
have been used to identify putative regulatory sequences essential for hypermutation 
(Betz et al., 1994; Yélamos et al., 1995). These studies have shown that the 3' enhancer 
and K intron enhancer/m atrix attachm ent region are crucial to obtain high levels o f 
mutation and that the lymphoid-specific promoter elements and the V k  gene fragment 
are not essential to recruit hyperm utation. However, the essential regions (3'E and 
Ei/M AR) have not been further dissected to obtain a tighter definition o f the d^-acting 
DNA sequences required to target somatic mutation.
Transgenic mice also have been valuable in the study o f the intrinsic properties of the 
hyperm utation machinery. The analysis of somatic m utation in passenger transgenes 
makes it possible to scan all positions within the V gene for inherent mutability, since 
they do not contribute to the antigen specificity of the B cell (Betz et al., 1993b; Sharpe 
et al., 1991). These studies showed that the mutations that are not distributed randomly 
along the V gene. Instead certain positions are favoured sites for mutations (hotspots) 
while others are rarely mutated (coldspots).
M utational hotspots in im munoglobulin genes are only in part created by their DNA 
sequence since they are not found in all positions conforming to the hotspot consensus. 
The contribution o f the local DNA secondary structure and the primary sequence of and 
close to the hotspots remains unresolved.
In the absence of an in vitro system, transgenic mice which carry modified rearranged 
im m unoglobulin genes represent the only system currently available to identify the 
elements that regulate and target hypermutation. Several lines o f transgenic mice were 
generated to analyse which DNA segments within the k  3' enhancer and MAR/Ei regions 
are required to target somatic mutation and how the local DNA secondary structure and 
the primary sequence effect hotspots. The description o f the constructs, used to generate 
those lines, can be found in Materials and Methods.
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3.2 Transgenic lines to study the role of the DNA sequence and secondary structure 
in hypermutation: Lk(WT&7M), LkNG and LK7M/TCA&A[Li]
Three transgenic mouse lines were produced to exam ine w hether the DNA secondary 
structure and the primary sequence are im portant for hypermutation. The lines contain 
synthetic V k  domains with modifications in the secondary structure and the consensus 
sequences in the C D R l. This region was chosen because it is usually more strongly 
mutated than other regions (Malipiero et al., 1987; Betz et a l ,  1993b). It contains a large 
accumulation o f mutational hotspots including the residue Ser31, which is the hotspot 
most frequently identified in some of the V genes analysed. This Ser31 is encoded by a 
ACT triplet, which falls within the hypermutation hotspot consensus Pu-G-Py-A/T.
The transgenic lines were generated using a non conventional approach. An equimolar 
m ixture o f different transgene fragments was injected in the same mouse zygote. The 
transgenic mice created in this way contain m ultiple, distinctly m odified transgene 
copies. Several transgenes could therefore be tested in the same animal and can served as 
internal control for each other.
3.2.1 Lk(WT&7M) line
An equim olar mixture of eight different DNA fragments was used for microinjection of 
mouse eggs. Seven of them (7M, M25, M28, M31, M30, M36 and M52) carry several 
silent distinguishable mutations in the C D R l (see Appendix I B). The eighth was the 
control L kWT. These mutations were designed to disrupt the consensus sequence and 
the secondary structure in this region.
One transgenic founder was obtained. The number of copies o f the integrated DNA was 
estim ated by Southern blot using tail DNA digested with Bam HI. The blot was 
hybridised first with the X bal-SacII fragment of the J-C intron and then rehybridised 
with the XhoI-EcoRI fragment that includes the 3' enhancer region (Fig. 3.1). The two 
endogenous gene copies in the germ line configuration allow ed the estim ation o f 
transgene copy number.
Figure 3.1 Genetic map of transgenes in L k(WT&7M) line (opposite page).
a) Diagram of L kW T  and L k7M transgenes. The LK7M encodes a V k region containing 
7 silent m utations (denoted in red) in the C D R l. DNA fragments used as probes are 
indicated. Restriction sites are abbreviated: R, EcoRI; B, BamHI; Xb, Xbal; Xh, Xhol; 
SI, S ad ; SII, SacII; H, H indlll.
b) The genetic map deduced by Southern blot analysis o f tail DNA  from  the 
L k(W T& 7M ) founder (F) and from a non transgenic litter mate (C). The DNA was 
digested with BamHI. The blot was hybridised first with the J-C intron probe and then 
rehybridised with the 3' enhancer probe. The 8.9kb fragment derived from head-to-tail 
(H-T) junctions. The germline configuration (G) is indicated.
47
Southern blot analysis disclosed that in addition to the fragment which originates from 
the germline there is another fragment that originates from the head-to-tail (H-T) (the 
head corresponds to the 5' end and the tail corresponds to the 3' end o f the constructs) 
junction o f the transgenes. The transgene is seen as a 8.9kb fragment after hybridisation 
with both, the J-C intron and the 3'E probes. The intensity of the band corresponds to 
two H-T junctions (Fig. 3.1).
Southern blots using tail DNA digested with several restriction enzymes confirmed that 
there were three copies o f the transgene in the two H-T junctions. Two o f the copies are 
incomplete, one lacking the 5' region and the other lacking the 3' region o f the transgene 
(Fig. 3.1).
The sequence analysis o f hybridom as revealed that the two V k segm ents present 
originate from the L kW T  and the Lk7M. Due to the particular symmetry o f the tandem 
array it was not possible to determine which of the two was the complete copy. 
Comparison of the tail blots of the founder with those of its transgenic offspring showed 
that the transmission of the introduced DNA followed simple Mendelian rules.
3.2.2 LkNG line
An equim olar m ixture o f six different vector-free DNA fragments was used to inject 
m ouse zygotes. F ragm ents w ere obtained  from  L k AB7M , L kABTCA (M 60), 
L kAB7M/TCA (M72), LK-Vgpt*, LK-Vneo* [XS]i and the control L kABWT. The first 
three constructs carry several silent d istinguishable m utations in the C D R l (see 
Appendix I B).
The constructs LK-Vgpt* and LK-Vneo* [XS]i were designed to determine whether non 
Ig sequences can be a target for hypermutation (Yélamos et al., 1995). The analysis of 
these two constructs was not part o f my work and is not included in this thesis. This 
transgenic line is a good example how different transgenes can be analysed in a single 
mouse, and how one set of constructs can provide an internal control for another.
One founder was obtained. Southern blot analysis revealed that it carries several copies, 
o f which some are in H-H, T-T or T-H configuration (data not shown). In addition there 
were several copies in head to host DNA arrangement. This suggests that not all o f them 
belong to a unique multi-copy array. The number o f copies estimated by the Southern 
blot revealed with the J-C intron probe (about 10) does not correspond with the number 
estim ated when the blot was revealed with the 3' enhancer probe (about 6 ). This 
indicates that several copies are truncated.
The sequence analysis of hybridomas shows that in addition to the LK-Vgpt* and LK- 
Vneo* [XS]i two L kAB7M and three L kABWT copies are present. One o f the W T 
copies carries a germline point mutation (G for A) introduced fortuitously at position 54 
o f the V region.
48
a
CDR 1 (7M/TCA)
GCG AGC TOG AGC GTT TCATAT ATG CAT
1 kb
R 'X b
LkAB7M/TCA h o
LVJ
H B
-OCHB— ^
MAR Ei Ck
Xh XbN
J-C intron probe 3' enhancer probe
R
- m -
B N
F 0 F 0
J-C intron probe 3' enhancer probe
Figure 3.2 Schematic representation of LkAB7M/TCA transgene and genetic map of 
transgenes in LK7M/TCA&[Li] line, a) D iagram of LkAB7M/TCA transgene. The 
silent mutations introduced in the C D R l are shown in red. DNA fragments used as probes 
are indicated. Restriction sites are abbreviated; R , EcoRI; B, BamHI; Xb, Xbal; Xh, Xhol; 
N, Notl; H, H indlll. b) The genetic map deduced by Southern blot analysis of tails DNA 
from LK7M/TCA&[Li] founder (F) and a non transgenic litter mate (C). The DNA was 
digested with BamHI. The blot was hybridised first with the J-C intron probe and then 
rehybridised with the 3' enhancer probe. The 8.9kb fragment is derived from head-to-tail 
(H-T) and the 10.6kb fragment derived from head-to-head (H-H) configurations. The 
additional two bands are thought to be T-host genome fragments. The germline fragment 
(G) is also indicated.
3.2.3 LK7M/TCA&A[Li] line
The founder of this transgenic line was obtained by microinjection with the equim olar 
mixture of the vector free fragments obtained from the L kAB7M /TCA (Fig. 3.2), which 
carries 9 silent mutations in the C D R l, and the L kA[L1] constructs. The L kA[L1] is an 
L k derivative carrying a deletion in the 5' leader intron (C. Rada, unpublished). Its 
analysis is not included in this thesis.
Southern blot analysis o f the founder and its offspring disclosed that in addition to the 
germline V k  fragment there is a fragm ent that corresponds to the head-to-tail (H-T) 
configuration of the transgene. The fragment is seen as a 8.9kb band after hybridisation 
with both, the J-C intron and the 3'E probe. The intensity o f the band corresponds to two 
H-T junctions (Fig. 3.2). There is also a 10.6kb band after hybridisation with the J-C 
intron probe that corresponds to one H-H junction. Two additional bands are disclosed 
after hybridisation with the 3' enhancer probe. They are big enough to include the 
complete BamHI fragment which contains the 3' enhancer and are therefore probably tail 
towards host genome fragments.
These results suggest that there are at least 4 complete copies of the transgene. Sequence 
analysis o f hybridom as disclosed at least one copy o f L kAB7M /TCA transgene in 
addition to LKA[Li]. The genetic map deduced from the analysis o f the fragm ents 
obtained in the Southern blot is shown in Fig 3.2b. In the generations inspected so far the 
transgenes were transmitted with the predicted M endelian frequency.
A lthough the distance between the V and the leader region is different in the two 
transgenes o f this line, it is not big enough for discrim ination by Southern blots. 
H ow ever both transgenes could easily  be d istingu ished  by appropria te  PCR 
amplification (see Chapter 4). They could also be identified due to specific restriction 
sites introduced in the C D R l o f L k7M/TCA. In the sequence analysis, both V regions 
could be recognised by the mutations specific for L k7M/TCA.
All these factors are im portant for the design o f mixtures with different constructs to 
enable the analysis of the independent transgenes.
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Figure 33  Schematic representation of LkABA[F13'EC] transgene and Southern blot 
analysis of LkA[F13’EC ] line, a) Diagram o f LkABA[F13'EC] transgene. Fragments used 
as probes are shown. Restriction sites are abbreviated: R, EcoRI; B, BamHI; Xb, Xbal; Xh, 
Xhol; N , Notl; H, H idlll. b) Southern blot analysis o f tails DNA form LkA[F13'EC] 
founder (F), two non transgenic litter mates (C), and two of the founder offspring (O I and 
0 2 ). The DNA was digested with BamHI. The blot was hybridised first with the J-C intron 
probe and then rehybridised with the 3 'enhancer probe. The 7.7kb fragment is derived 
from the head-to-tail (H-T) and the 10.6kb fragment derived from the head-to-head (H-H) 
configurations. The germline fragment (G) is also indicated. The additional bands are 
thought to be H-host genome integration.
3.3 Transgenic lines to study the role of the 3' enhancer core and its flanking
sequences: L kA[3'EC] and L kA[FI3'EC]
3.3.1 LkA[FI3'EC] line
This line was made by pronuclear m icroinjection with the vector free fragm ent o f 
LkABA[F13'EC] (Fig. 3.3), which carries the deletion o f the 3' enhancer core flanking 
regions. Tail DNA digested with BamHI was used in Southern blots and hybridised with 
the J-C intron probe and the Xhol-N otl fragment containing the 3' enhancer core region. 
The approxim ate copy num ber estim ation was done as described in the previous 
sections, by comparing the intensity of the fragments with the band obtained for the two 
endogenous copies in germline configuration.
There is a 7.7kb band after hybridisation with both the J-C intron and 3'E probe, which 
corresponds to a head-to-tail (H-T) configuration (Fig. 3.3). The fragm ent is seen with 
the same intensity of the germline band when probed with the 3' fragment. However it is 
4-6 fold stronger when the J-C intron probe was used. This difference may be due to the 
presence of other fragments which contain only the J-C intron region and migrate very 
close to the H-T band.
There is also a 10.6kb band after hybridisation with the J-C intron probe, which 
corresponds to tw o H -H  junctions. Tw o additional bands are d isclosed  after 
hybridisation with the J-C intron probe. They are big enough to include the complete 
BamHI fragment o f the V k region and therefore they may be head oriented towards host 
genome fragments.
The presence of many fragments (at least 10) after the J-C intron probe is used and the 
absence of the corresponding amount of fragm ents after probing with the 3' region, 
suggests the presence o f many incomplete transgenes which contain the 5' region but 
lack their 3' region o f the construct. These results suggest that there are only two 
complete copies o f the transgene.
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Figure 3.4 Schematic representation of LkABA[3'EC] transgene and Southern blot 
analysis of LkA[3’EC] line, a) Diagram of LkABA[3'EC] transgene. Fragments used as 
probes are shown. Restriction sites are abbreviated: R, EcoRI; B, BamHI; Xb, Xbal; Xh, 
Xhol; SI, S ad ; N, Notl; H, H indlll. b) Southern blot analysis of tails DNA from the 
LkA[3'EC] founder (F), a non transgenic litter mate (C) and seven o f the transgenic offspring 
(0(1-7)). The DNA was digested with BamHI. The blot was hybridised first with the J-C 
intron probe and then rehybridised with the 3' enhancer probe. The 8.7kb fragment is derived 
from the head-to-tail (H-T), the 10.6kb fragment is derived from the head-to-head (H-H), and 
the 6 .8kb fragment derived from the tail-to-tail (T-T) configurations. The germline 
fragment (G) is also indicated. The additional bands are thought to be tail and head towards 
host genome integration.
3.3.2 LkA[3'EC] line
This line was made by pronuclear m icroinjection with the vector free fragm ent o f 
L kABA[3'EC] (Fig. 3.4), which carries the deletion of the core enhancer. Southern blots 
o f tail DNA digested with BamHI were hybridised with the J-C intron probe and the 
Xhol-Not fragment containing the 3' enhancer flanking regions.
There is a 8.7kb band after hybridisation with the J-C  intron and 3'E probes which 
corresponds to the head-to-tail (H-T) configuration (Fig. 3.4). This fragment is 4 times 
more intense than the endogenous band. There is also a 10.6kb band after hybridisation 
with the J-C intron probe that corresponds to a H-H junction. In addition a 6 .8kb band is 
disclosed when the 3'E probe is used that corresponds to a T-T junction. Additional 
fragments are thought to be transgene-host genome junctions (four tail-to-mouse and two 
head-to-mouse) suggesting that the transgenes are in different m ulty-copy arrays. These 
results suggest that the transgenic LkA[ 3'EC] founder carries at least ten complete copies 
of the transgene.
Comparison of the tail blots from the founder with those from its transgenic offspring 
shows some differences. The fragment which corresponds to the tail-to-tail junction was 
missing in 20% of the transgenic mice analysed. One of the four fragments thought to be 
tail-to-host genom e integration was lost in 13% of the transgenic m ice and both 
fragm ents were m issing in 10% of the transgenic offspring. Therefore, 43% of the 
transgenic mice in this line lost at least one fragment. One o f the bands thought to be 
head-to-host genome integration was also lost in some o f the offspring.
The copy loss was corroborated by breeding experim ents. A founder descendent 
containing all the copies was crossed with FI (CBAxC57BL/6J). 50% o f the transgenic 
offspring contained deletions. In addition, each deletion variant was crossed with F I 
mice and the progeny analysed by Southern blotting. The results show that the progeny 
retains the expected parental phenotype. The number of mice analysed however is so far 
not large enough to conclude that all the deletion variants are stable.
The instability of long inverted repeat structures (such as head-to-head and tail-to-tail), 
which occurs upon transgene integration, has also been observed in other transgenes 
(Collick et al., 1996). The mutation process involved can lead to both insertions or 
deletions resulting in the stabilisation o f the transgene.
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Figure 3.5 Schematic representation of LkABA[MAR] transgene and Southern blot 
analysis of LkA[MAR] line, a) Diagram of LkABA[MAR] transgene. The fragments used 
as probes are shown. Restriction sites are abbreviated: R, EcoRI; B, BamHI; Xb, Xbal; Xh, 
Xhol; N, Notl; H, H indlll. b) Southern blot analysis of tails DNA from the LkA[MAR] 
founder (F), a non transgenic litter mate (C) and three of the transgenic offspring (0(1-3)). 
DNA was digested with BamHI. The blot was hybridised first with the J-C intron probe 
and then rehybridised with the 3' enhancer probe. The 8 .6kb fragment is derived from the 
head-to-tail (H-T) integration, the lOkb fragment is derived from the head-to-head (H-H) 
and 7.2kb fragment is derived from the tail-to-tail (T-T) configurations. The germline 
fragment (G) is also indicated. The additional bands are thought to be tail and head towards 
host genome integrations.
3.4 Transgenic lines to study the role o f the DNA elements within the J-C intron:
L kA[MAR] and LKA[Ei]
3.4.1 LkA[MAR] line
This line was made by microinjection with the vector free fragm ent o f L kABA[MAR] 
(Fig. 3.5), which carries the deletion of the MAR.
Tail DNA digested with BamHI was used in Southern blots and hybridised with the J-C 
intron and 3' enhancer probes. Southern blot analysis revealed that the LkA[MAR] 
founder has a 8 .6kb band after hybridisation with both probes which corresponds to the 
head-to-tail (H-T) configuration (Fig. 3.5). This fragment is at least 4 times more intense 
than the endogenous band. There is also a lOkb band after hybridisation with the J-C 
intron probe that corresponds to a H-H junction. In addition a 7.2kb band is disclosed 
when the 3'E probe is used which corresponds to two T-T junctions. A dditional 
fragments of different size are probably transgene-host genome junctions (three tail-to- 
mouse and two head-to-mouse) suggesting that the transgenes are in different multi-copy 
arrays. These results suggest that there are at least 11 complete copies o f the transgene. 
The transm ission of the transgene was studied by Southern blotting o f the founder 
offspring. It was found that 15% of the transgenic mice had deleted three fragments: the 
fragment diagnostic for the head-to-head integration, one o f the tail to mouse and one of 
the head-to-mouse fragments (see offspring O3 in Figure 3.5). These results demonstrate 
the instability of head-to-head integrations, possibly originated by the inverted repeat.
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Figure 3.6 Schematic representation of LKABA[Ei] transgene and Southern blot analysis 
of LKA[Ei] line a) Diagram of LKABA[Ei] transgene. The fragments used as probes are 
shown. Restriction sites are abbreviated: R, EcoRI; B, BamHI; Xb, Xbal; Xh, Xhol; N , Notl; 
H, H indlll. b) Southern blot analysis of tails DNA from LkA[E1] founder (F), a non transgenic 
litter mate (C) and three of the transgenic offspring (0(1-3)). The DNA was digested with 
BamHI. The blot was hybridised first with the J-C intron probe and then rehybridised with the 
3' enhancer probe. The 8 .5kb fragment is derived from the head-to-tail (H-T), the 9.8kb 
fragment is derived from the head-to-head (H-H) and the 7.2kb fragment is derived from the 
tail-to-tail comfigurations. The germline fragment (G) is also indicated. The additional bands 
are thought to be tail and head toward host genome integrations.
3.4.2 LkA[Eî] line
This line was obtained by microinjection o f the m ouse zygote with the vector free 
LKABA[Ei] fragm ent (Fig. 3.6), which carries the deletion o f the k  intron enhancer 
region.
Southern blot analysis o f tail DNA digested with Bam HI revealed that the LkA[E1] 
founder has a 8.5kb band after hybridisation with the J-C intron and 3 E probes, which 
correspond to the head-to-tail (H-T) configuration (Fig. 3.5). This fragment is twice as 
intense as the endogenous band. There is also a 9.8kb band after hybridisation with the J- 
C intron probe which could correspond to a single H-H junction, although it is slightly 
weaker than the endogenous band. It may be that part o f the J-C intron fragment used as 
a probe has been lost as a consequence of a rearrangem ent with the host genome. In 
addition a 7.2kb band is disclosed when the 3 E  probe is used that corresponds to two T- 
T junctions. Additional fragments of various size are presumably transgene-host genome 
junctions (six tail-to-mouse and three head-to-mouse) suggesting that the transgenes are 
in different multi-copy arrays. These results suggest that there are at least 8 complete 
copies o f the transgene.
The transgene transmission was studied by Southern blotting of the founder offspring. It 
was found that all the transgenic progeny had deleted the fragment in the head-to-head 
configuration, one o f the head-to-host and three tail-to-host fragments. In addition the 
band corresponding to T-H configuration was weaker (it has the same intensity as the 
endogenous gene in the germline configuration) than in the founder. These results 
further confirm the instability of the inverted repeat structures.
3.5. Expression analysis
The level o f expression o f the transgenes is usually determ ined in the serum o f the 
transgenic mice, in the NSO cells stably transfected or in hybridomas derived from the 
transgenic line. The analysis of expression o f immunoglobulin transgenes is complicated 
by a number of interrelated phenomena peculiar to the immune system.
Several reasons could disguise the real effect o f the m odifications that the transgene 
carries on the expression. The expression can be affected by the chromatin status in the 
site o f the transgene integration, by the number and type of cells that are expressing the 
transgene and or by the efficiency of the transgene in m ediating allelic exclusion. Also, 
the chrom osom al rearrangem ents that occurs in fusions can up or down regulate the 
im m unoglobulin gene expression of hybridom a cells. The age o f the mice when the 
serum is collected is also important. In the transfected NSO cells the SV40 enhancer 
present in the vector can promote expression of the immunoglobulin gene. Therefore, the 
quantitative results derived from these systems should not be taken as an absolute 
measure of the effects that the constructs incur.
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3.5.1 Transgene k  chain expression in hybridomas derived from the transgenic lines
Hybridomas were produced for all the transgenic lines obtained (except for LKA[Ei]). 
Mice were im munised and boosted with phOx-CSA (see M aterials and M ethods). The 
proportion o f hybridom as expressing only the transgenic rat k  chain, the endogenous 
mouse K or both the endogenous mouse and the transgenic rat k  chains were determined. 
This gives an indication whether or not the level o f transgene expression are effective in 
mediating allelic exclusion of the endogenous k  gene.
The L kA B transgene allowed effective feedback inhibition o f the endogenous k  chain in 
all the hybridomas analysed derived from L kN G  transgenic line. Similar result (80-90%) 
was found in hybridom as obtained from the L k 6 line, which carries the L k  construct 
(M eyer et al., 1990).
However, only 36% of the hybridomas obtained from the Lk(W T&7M ) mediated allelic 
exclusion. Hybridomas derived from LkA[F13'EC] line were also relatively ineffective in 
m ediating allelic exclusion (31%). These results may be a consequence o f the low 
number of intact copies found in those lines (1 and 2 respectively).
In hybridomas derived from L kA[3EC] and LK7M/TCA&A[Li] a relatively good allelic 
exclusion (76 and 60% respectively) was observed.
3.5.2 Transgene k  chain expression in the serum of the transgenic mice
As a first step towards quantitation of transgene expression the levels o f rat IgK  in the 
serum of the transgenic mice were analysed by ELISA calibrated using P4C1/13-11 
(fraction I) antibody. In this inhibition assay the test serum is incubated with an anti-rat k  
reagent and the rem aining free antibody is quantitated. D ilutions o f test serum were 
incubated o.n. with a mouse anti-rat K antibody (M ARK-1). The m ixture was then 
transferred to the plate coated with rat antibody (P4C1/13-11, fraction I). The amount of 
MARK-1 Ab bound was assayed by incubation with biotinylated sheep anti-m ouse 
anti serum, which was detected with a Streptavidin-HRP conjugate. Samples were taken 
from mice at the age of approximately 4 weeks.
The results o f the ELISA performed with the founder sera are shown in Fig. 3.7a. This 
data originates from one assay with duplicate samples. These results have been repeated 
and confirm ed (data not shown). The serum o f five offspring was pooled and analysed 
several times, always in duplicate. The results are shown in Fig. 3.7b. The standard 
deviation is indicated.
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Figure 3.7 Transgene expression in the mouse sera for each of 
the transgenic lines. The sera (diluted 1/5; 1/25; 1/125 and 1/625) was
tested for k  rat expression by ELISA. Serial dilutions of known concentrations 
of P4Cl(txg/ml) were used as standard curve. The broken pink horizontal line 
shows the OD corresponding to 50% inhibition. The equivalent concentration 
for this OD value is 2p.g/ml.
a) Founders.
b) Pooled offspring.Values represent the mean of several assays. The standard 
deviation is indicated. The results from Lk 6 and LK A [Ei/MAR] mice are 
shown for comparison.
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Figure 3.8 Average transgene expression in the mouse sera for 
each of the transgenic lines.
The average of the transgene expression in the mouse sera (diluted 1/5; 1/25; 
1/125 and 1/625) of the founder and their offspring is shown. The broken pink 
horizontal line shows the OD. corresponding to 50% inhibition (0.85). The 
equivalent concentration for this OD is 2|ig/ml.
The analysis o f the k  rat expression revealed that the titre of serum antibody differs 
between the founder and its descendants in some transgenic lines. In LkA[M AR] and 
LKA[Ei] the offspring expressed only slightly more (2.5 and 7 times respectively) but in 
the case o f LkA[3'EC] line the difference is more significant (30 times). The detailed 
reasons for this phenomenon are unknown, but it is important to note that these are the 
same transgenic lines, for which the copy loss was observed. It is possible that the 
expression of the transgene has been upregulated as a consequence o f the stabilisation 
process. Fig. 3.8 shows the average pooled titres o f the serum of founders and its 
descendants.
The transgene is expressed in all the lines analysed, but only in the L kNG  line - which 
carries 5 copies o f the L kAB transgene - expression is com parable to that o f the L k 6 
line, which carries 5 copies of L k. The estimated titre of transgenic K chains in the L k6 
mice is higher than 1 mg/ml (extrapolated in Fig. 3.7b) which agrees with the previously 
determined values of 1-4 mg/ml (Meyer et al., 1990).
For the L k(W T&7M) line, which contains only two V k regions (one belongs to an intact 
copy; the other is truncated, while having the 3'E in a 5' position with respect to the V), 
the estimated titre is 400pg/m l. This value is 2.5-10 times lower than that of the L kNG 
and L k6 lines.
In the transgenic line carrying the deletion o f the 3' enhancer core flanking regions the 
expression o f the transgenic K chain was only reduced about 3 to 13 times with respect to 
the values observed in LkN G  and Lk6 lines. The level o f transgene expression in the 
founder o f the line containing the deletion of the core 3' enhancer was significantly 
reduced (250-1000 times lower) than that of the LkNG and Lk6 lines.
This large reduction in the transgene expression however was not observed when the 
pooled serum from the founder's offspring was assayed, in which it was only about 10 
times low er than in the L kNG  and L k6 lines. As I explained before, the transgene 
expression in the offspring may be upregulated, therefore it is essential to obtain and 
analyse more founders to confirm these results.
The level o f transgene k light chain expression in the lines containing deletions o f MAR 
and Ei, are lower than that of L kNG and Lk6 lines. The values are 19-77 and 71-286 
times low er respectively for the founders and 7-30 and 10-40 times lower respectively 
for the descendants.
These results indicate that all the regulatory elements analysed, particularly the core of 
the 3' enhancer, are required to achieve high levels of K light chain expression.
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Figure 3.9 E xpression o f the LxA[Ei] and LkA[MAR] 
transgene in NSO stable transfectants.
Northern blot assay of RNA from the transfected k  gene o f NSO cells stably
transfected with LKA[Ei] and Lk A[MAR] constructs. For each construct
transcripts of the transfected k  gene and the endogenous p-actin were assayed in 
samples of RNA prepared from pools of 10 wells each of which contained multiple 
clones. Quantitation by densitometric analysis were made and the values for rat are
plotted relative to actin. LKA[Ei] and Lk A[MAR] are NSO transfectants and 
Lk (WT&7M) are hybridomas.
3.5.3 Transgene k  chain expression in stably transfected NSO cells
The transgene expression in supernatants from NSO cells stably transfected with the 
constructs LKA[Ei] and L kA[MAR] were also determ ined. A lthough quantitative 
analyses were not done, signs were given as indication o f the relative O.D. in the 
assays. The level of expression found in the LKA[Ei] transfectants was very low (+) (it 
was only detectable in the neat supernatant) on the contrary the L kA[MAR] transfectants 
expressed well (+++).
The transgene expression in NSO cells stably transfected with LKA[Ei] and L kA[MAR] 
transgenes was also analysed on the RNA level by Northern blots. Quantitation by 
densitom etric analysis o f the transgenic k chain were perform ed and the values were 
corrected by the corresponding actin values (Fig. 3.9). The results for NSO cells and two 
L k(W T&7M) hybridomas are included for comparison. Two independent transfectant 
pools were tested for each transgene. The results indicate that the expression levels in the 
case o f the transfectants carrying the deletion of the Ei are hardly significant and lower 
than after deletion o f MAR. Both are lower than in the L k hybridoma.
These results further confirm that the Ei and MAR elements are required for high level 
o f expression. The characteristics o f all the transgenic lines described in this study are 
summarised in Table 3.1.
Table 3.1 Summary of the characteristics of the transgenic lines .
Transgenic
line
DNA 
copy ^ 
number
Transgene
instability
Transgene expression * Allelic 
exclusion in 
hybridomas
mouse sera Titre 
(F) (D)
stablell
transfectants
L k(WT&7M) 1 NF ND 400 (++++) 36%
L kNG 10 ND >1000 ND (++++) 100%
L K 7M /T C A & A [L i] 4 NF ND ND (++++) 60%
L kA[F13'EC] 2 NF 250 333 ND 31%
L kA[3'EC] 10 + <4 308 ND 76%
L kA[MAR] 11 + 52 133 (+++) ND
LKA[Ei] 8 + 14 100 (+/-) ND
L k6§ 5 ND - 1000-4000 - 90%
^  Approximate number o f complete copies of the transgene.
~ Copy loss is indicated ND stands for not determined. NF stands for not found.
* Titres are given as the concentration o f the transgene in the mouse sera (pg/m l) 
required to sequester 50% of the anti-rat antibody used in the ELISA in the serum of 
founders (F) and their descendants (D).
H Transgene expression in the supernatant of the NSO cells stable transfected was tested 
by ELISA, the number of crosses refers to the relative O.D. in the assays.
§ Data from L k6 line (Meyer et al., 1990) are provided for comparison.
64
a)
S 1 0 7 M
(bp)
3 1 0
2 8 1 -
2 7 1 -
2 3 4  
1 9 4  -
b)
1 -L k
R H Hp B
hHHUl— C^X]“
LVJ
2-LkAB
R
I—O'
MAR Ei Ck 
H Hp#oW
LVJ MAR Ei Ck 
3-LkABA[FI3'EC]
hHHJ
H Hp B
- * O R — -
LVJ
4-LkABA[F13'EC]
H Hp B
LVJ
5-LkABA[3'E]
R
|— II"
H Hp B
LVJ
B B
XhSI X N 
3'E
Xh N
4 )
3'E core
B B
Xh
K rat
(tr a n s fe c te d )
K mouse 
(endogenous)
1 kb
B
XhSI Xb R 
3'E
Xh Nd
3'E core
Figure 3.10 Expression of the k  transgenes transfected into S107 cells, a) Ribonuclease 
protection assay of transcription from the transfected k gene of S I07 cells stable transfected 
with the constructs shown in panel b. The experiment was performed several times, and 
representative data are presented. The position of size markers (a Hae III digest of (|)X174) 
are shown in the lane marked "M". b) The map o f the constructs used is shown.
3.5.4 Transgene k  chain expression in stably transfected S107 cells
The role o f the w hole 3' enhancer in the im m unoglobulin  gene expression was 
previously analysed in transgenic mice carrying a rearranged k  gene with or without the 
K 3' enhancer. Its omission leads to 20-40 fold lower expression of the k  transgene and to 
poor allelic exclusion (M eyer et al., 1990). However, the experim ents that lead to the 
definition o f the 3' enhancer core were done in transient transfection assays using 
reporter genes. The contribution of the 3' enhancer core on its own to the k  expression 
therefore remains unresolved. To address this question the role of the core enhancer was 
tested in stably transfected S I07 cells.
To study the contribution o f the 3' enhancer core to the k  expression a series of stable 
transfection experiments was carried out using the S I07 plasm acytom a cell line, which 
lacks functional N F - kB. This cell line provides a good system to test the k  rat expression 
driven by the k  3' enhancer and its derivatives w ithout the interference o f the K intron 
enhancer activity. The presence o f the SV40 enhancer in the vector is not able to 
com pensate for of the lack o f the 3' enhancer or its flanking regions since the SV40 
enhancer is very weak in these cells, possibly because o f a dependency o f SV40 
enhancer activity in plasmacytoma cells on N F - kB (Atchison and Perry, 1987).
A number o f constructs with and without the 3' enhancer flanking regions were used for 
transfections. The intact Lk construct (Meyer et al., 1990) was used as a positive control. 
Two constructs (LkA[F13'EC] and LkABA[F13'EC]) carrying the deletions o f the 3' 
enhancer core flanking regions (see M aterials and M ethods for detailed description of 
the constructs) were prepared. A construct (LkABA[3'E]) without the 3'E was made as 
control. The short construct LkAB (Yélamos et al., 1995), which carries the deletion of 
the DNA fragm ent between the BamH I sites 3' o f the C k , was also included in these 
experiments.
The plasm ids were transfected into S I07 cells and rat k  expression in pools of stable 
transfectants was m easured by ribonuclease protection assays. Transcripts from  the 
endogenous mouse K gene of S I07 partially hybridized with the rat k  probe and served 
as internal control (Fig. 3.10). The expression level was quantitated by densitometry and 
the values for k  rat were normalised for equal RNA amounts given by the endogenous 
m ouse K value. The ratio (rat k  /  m ouse k ) obtained for the L k  transfectant was 
considered as 100% of expression. It should be noted that the expression o f  the 
endogenous k  was higher than the expression o f the transgenic k  rat in all the 
transfectants. This difference was also observed for a construct carrying the rearranged K 
gene stably transfected into S I94 cells (Blasquez et al., 1989). The relative rat k  
expression for all the constructs tested is shown in Table 3.2.
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Table 3.2 Expression of transfected and endogenous k  genes in S107.
Construct Titre* Titre^ Relative rat k  exp.J Relative rat k  exp.J
and controls rat K exp. mouse K exp. (ELISA) (RNA prot. assay)
L k 2.5 1:80 100% 100%
L kAB 1.5 1:211 63% 80%
L kAB[F13’EC] 6 1:111 30% 52%
LKA[F13'EC] 7 1:143 20% 30%
L kABA[3'E] No inhibition^ 1:81 <0.01% 0%
S I07 No inhibition^ 1:500 <0.01% 0%
N QN l B9.6 1:62 1:90
P4C1 as K chain 10-8m -
Y3 0.5x1 0-9m -
9E10 as K chain - 2.5x1 0-9m
* Titre of rat K expression is given as the dilution (values < 1 )  or concentration (values
>1) o f supernatant required to sequester 50% of the anti rat K antibody used in the 
ELISA. For P4C1 and Y3 the values are given in molar concentration, 
t  No inhibition was detected when supernatant was concentrated 10 times.
^ Titre of endogenous k  expression is given as the dilution of supernatant required to
sequester 50% of the anti mouse k  antibody used in the ELISA. The value for 9E10 is 
given in molar concentration.
J Rat K expression (rat k  /  mouse k ) of L k  was defined as 1(X)%, and all numbers are 
expressed relative to this value.
Supernatant from N Q N l B9.6, an anti-phOx hybridoma from L kA[F1] (Betz, 1994), was 
included as a control in the ELISA.
P4C1 is the purified fraction I containing rat K associated with IgG l o f P4C1 antibody 
(Suresh et al, 1986).
Y3 is a purified k  rat light chain (Bence-Jones protein).
9E10 i s  a p u r if ie d  m o u s e  a n tib o d y  c o n ta in in g  a K lig h t  ch a in .
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The core enhancer was able to direct expression o f the k  gene in stably transfected S107 
cells, but only up to 30% of the activity of the full enhancer. In previous experiments the 
core enhancer was linked to the CAT reporter gene in transient transfected S I94 cells 
(Pongubala and Atchison, 1991), where it retained approxim ately 75% of the entire 
enhancer activity. It is possible that this discrepancy is due to the differences between 
the assays used to measure the expression.
The construct LkABA[F13'EC], in which the core enhancer has been brought closer to 
the C k exon, gave a higher level of k  transgene expression (52%) than the LkA[F13'EC] 
construct (30%). D ifferences were also found for the expression o f L k  and LkAB 
carrying the intact enhancer, but in this case the LkAB construct expressed slightly less 
(80%) than the L k one. As expected, expression was not detectable when the 3' enhancer 
was removed.
Rat K expression in pools of stable transfectants was also m easured by ELISA. The 
supernatant was pooled and the titres o f rat and mouse k  were analysed (Table 3.2). The 
titres are given as the dilution or the concentration o f the culture supernatant required to 
sequester 50% of the anti rat or mouse k  antibody used in the ELISA. The results are 
given as the mean o f several experiments.
The core enhancer in the L kABA[F13'EC] construct retained only 30% o f the expression 
while the core enhancer in the L k A[F13'EC] construct only retained 20% o f the 
expression. The short construct carrying the intact 3' enhancer (LkAB) expressed slightly 
less (63%) than the L k one. These data confirm  the results obtained by the RNA 
protection assay.
To ensure that the expression levels seen by both ribonuclease protection assays and by 
ELISA using mixed cell populations are not biased due to differential outgrowth of 
specific clones, supernatant titres of rat and mouse k  in individual wells were analysed 
for specific clones by ELISA. The results reflect those seen in the ribonuclease 
protection assays and in ELISA with the pools (data not shown).
An intriguing feature of the inhibition of ELISA assays was detected in the controls. The 
concentration o f rat K forming part of an antibody (P4C1) required for 50% inhibition 
was 20 fold lower than that observed when the Bence-Jones free k  chain protein (Y3) 
was used. The reasons for this phenomenon are unknown but may affect the accuracy 
(but not the essential features) of the experiments described above.
3.6 Discussion
Seven transgenic lines were obtained to study the role o f different DNA elements in 
hypermutation. In three of those lines a different approach was employed. In these lines 
the derived mice contain multiple, distinctly modified transgenes. This strategy allows
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several transgenes to be tested at the same time, and one o f them can serve as internal 
control for the others.
The configuration of the integrated transgenes in all lines was studied by Southern 
blotting. The analysis o f the transgene copy num ber in the offspring revealed the 
intrinsic instability of inverted repeats structures present at so called "head-to-head" or 
"tail-to-tail" joining of transgene monomers. The instability was detected as deletions of 
those configurations (and DNA fragm ents flanking them). H igh rate o f structural 
instability  associated with the presence o f an inverted repeat has been observed 
previously in two transgenic lines (Collick et al., 1995).
The analysis of the transgene expression in the mouse sera revealed that the same high 
levels o f expression produced in L k6  line was only achieved in LkNG line. The 
Lk(W T&7M ) line, which carries only one intact copy o f the L k  construct, the transgenic 
K expression was about 2.5-10 fold low er than in the L k6  and LkN G  lines. This 
difference may be due to the lower copy number o f the transgene in the Lk(W T&7M ) 
line (5 copies in the first two lines).
In the LkA[F13'EC] line, which lacks the 3' enhancer core flanking region, the transgenic 
K expression was reduced but not as much as when the whole enhancer was deleted 
(Meyer et al., 1990; Betz et al., 1994). Even lower transgenic K expression was observed 
when the transgene lacks either the 3' enhancer core or the intron enhancer.
The data showed here are in agreement with observations from  transients and stable 
transfection assays using artificial reporter gene constructs as well as rearranged 
genomic transgenes (Blazquez et al., 1992; Fulton and Van Ness, 1993; Fulton and Van 
Ness, 1994). These studies proved the requirement of both enhancers for maximal gene 
expression in a synergistic manner.
The transgene expression in L kA[MAR] line was also reduced. This is in line with 
previous observations in stably transfected plasm acytom a cells harbouring a construct 
containing the k locus carrying deletion of the MAR (Blasquez et al., 1989). In this study 
it was also shown that the effect is eliminated when the same construct was coupled to a 
transcribed selectable marker. In addition, transient expression assays employing vectors 
containing linked active genes failed to detect any effect o f deleting the MAR on RNA 
levels (Bergman et al, 1984; Queen and Stafford, 1984). These observations suggest that 
the ro le o f the M AR may be to set up a favourable chrom atin environm ent for 
transcription, perhaps by targeting the chrom atin to a specific subnuclear location 
enriched in the transcription machinery.
The results for the expression of the L kA[MAR] and LKA[Ei] transgenes in the serum of 
the mice are supported by the expression analysis in NSO cells which have been stably 
transfected. This is not in agreem ent with pervious results for the transgenic line 
LKA[Ei/MAR] (Betz et al., 1994) where both Ei and M AR were deleted and the 
expression o f the im m unoglobulin gene was not affected. This discrepancy could be
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caused by a site-integration and gene dosage effects. Thus, LicA[Ei/MAR] transgenes 
maybe have been integrated in a actively open chromatin locus, which compensates the 
deletion o f MAR. On the other hand a high copy number and/or rearrangem ent within 
the LKA[Ei/MAR] transgenes may lead to higher levels o f transgene expression.
The experim ents performed with the S107 cells, which have been stable transfected, 
showed that the core of the 3' enhancer was able to drive K expression in the absence of a 
functional N F-kB . The 3' enhancer core retained up to 30% o f the whole enhancer 
activity as measured by RNA protection assays and up to 20% measured by the protein 
present in the supernatants of the transfected cells. This value increased to 52% and 30% 
respectively when the 5kb fragment between the BamHI sites was removed.
This increase however was not observed when the intact 3' enhancer was tested. On the 
contrary, the expression level obtained for the L kAB construct was low er than that 
observed for the L k construct in both assays. One possible reason for this observation 
could be the presence o f a silencer in the deleted fragment which acts in conjunction 
with the 3’ enhancer core but not with the full enhancer.
Transcriptional suppression o f Ig expression was also observed w hen the IgH 3' 
enhancer was brought closer to the |i  intron enhancer. This effect was also observed 
when the 3' enhancer was placed 5' end o f the V gene, but not when the intron enhancer 
was deleted in the 3'E at 5' end o f the V construct. These results indicate that the 
transcriptional suppression can not be ascribed to the proxim ity o f the transcription 
initiation site, but rather to the close juxtaposition o f the |i  intron enhancer (M ocikat et 
al., 1995). Therefore, the IgH 3' enhancer may be a novel type of c/5-regulating element. 
It can cooperate with the Ig |i  intron enhancer, but its synergy is differentially regulated 
by the distance separating the two elements. These effects are similar to the ones found 
here for the K 3' enhancer and the 3' enhancer flanking sequences may therefore be 
necessary for cooperation.
A  distance effect in the transgene k  expression have been observed also by M eyer et al. 
(1990). The same L k construct used here and another version L kA B construct (carrying 
deletions of the sequences between the EcoRV sites) containing the intact enhancer were 
tested for k  expression in transfected NSO cells. In these experiments the construct with 
the 3' enhancer closer to the V elements gave higher level of k  transgene expression than 
the L k  construct. However k  transgene expression in NSO cells may be affected by the 
SV40 promoter, which is also able to direct the transgene expression. Therefore this may 
not provide a good example to compare with S I07 transfectants.
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Chapter Four Influence of DNA structure and primary sequence
in somatic hypermutation
4.1 Introduction
The C D R l has a large accumulation o f hotspots and is usually more mutated than other 
regions. The hotspots in the CD R l of the V kO x I gene (the most frequently used in the 
im m une response against the hapten 2 -phenyl-axazol-5-one) has been studied 
extensively. It is well known which hotspots are antigen selected or which are intrinsic 
to the hypermutation process. The V k O x I is therefore a very attractive system to study 
the intrinsic features of the mutational machinery.
The intrinsic hotspots in CD Rl of the V kO x I gene (second base of Ser31 and third base 
of Ser26) exemplify the consensus: PuGPyT/A, with G being most frequently mutated. 
However, not all the hotspots conform  to this consensus. For exam ple, V al30 (third 
base) and Tyr36 (second base) are intrinsic hotspots that have in com mon a TA' core 
with A being the mutated base.
Intrinsic hotspots are only in part created by local DNA sequence since they are not 
found in all the positions conforming to the hotspot consensus. Thus, other structural 
features, such as palindromes, may well be important.
The analysis o f the C D R l in the V kO xI gene reveals several possible palindrom ic 
structures which may give rise to hairpin loops. The thermodynamically most stable are 
shown in Fig. 4.1. These different structures may be in a equilibrium. The palindromic 
structure which contains the Ser31 is very stable, and the hypermutable G is at the tip of 
the postulated hairpin.
Figure 4.1 DNA sequence and predicted secondary structure in the C D R l of the
V k O x I gene (opposite page). The most stable hairpin loops are shown. Triplets are 
alternatively overprinted for a easier amino acid identification.
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4.1.1 Modifications introduced in the C D R l of the Vk transgenes
To assess the effect o f the local DNA secondary structure and the prim ary sequence in 
the position of hotspots several silent mutations were introduced in the C D R l o f the 
V k O x gene o f the k  transgene (see M aterials and M ethods). These m utations were 
designed to change the DNA sequence in the hotspot consensus and to disrupt or modify 
the secondary structure in the C D R l. The DNA sequence and the proposed secondary 
stmcture o f two mutants are shown in Fig. 4.2.
The contribution o f those mutations on hotspots was studied in three transgenic mouse 
lines: L k NG  (w hich contains L k AB and LKAB7 M transgenes am ong others), 
L k(WT&7M) (which contains L k and L k7M transgenes) and LK7M/TCA&A[Li] (which 
contains L kAB7M/TCA and LKA[Li] transgenes).
H yperm utation was studied in germinal centre PNA^i B cells from  Peyer's patches 
(collected from several mice about 5 month old), and in hybridom as generated from 
phOx-CSA immunized mice (see Materials and Methods).
H ypermutation was analysed as described in M aterials and M ethods by am plification 
with the oligonucleotides VKOXFOR and VKO X BACK  (A ppendix II) using Taq 
polym erase. The sequencing prim er was the oligonucleotide JK5. The PCR error 
frequency (0.4 x lQ-3 per base) was determ ined by sequencing L kAB and L kAB7M 
transgenes from hybridomas of the L kNG line.
In the LK7M/TCA&A[Li] line PCR amplification o f the L kAB7M /TCA transgene was 
carried out with the oligonucleotides VKOXFOR and BEALEADER. These prim ers 
allow a specific amplification o f the 7M/TCA copies as BEALEADER hybridises in the 
leader region that was deleted in the A[Li] construct (see Appendix II). The amplification 
was done with Pfu polymerase, and the PCR error frequency (0.13 x lCf3 per base) was 
determined by sequencing L k7M/TCA transgenes from hybridomas.
Figure 4.2 The predicted secondary structure in the C D R l of the VkOxI mutated 
gene (opposite page). The possible most stable hairpin loops are shown. Triplets are 
alternatively overprinted for a easier amino acid identification, a) C D R l DNA sequence 
o f the wild type and the mutants. The m utations are shown in red. The underlined 
sequences correspond to the hotspot consensus (PuGPyT/A). b) Secondary structure of 
the mutant 7M. c) Secondary structure of the mutant 7M /TCA. d) An alternative hairpin 
o f both mutants.
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LkW T  in Lk (WT<Sc7M) Lk 7M  in Lk (W T « 7 M )
Lk AB7M  m Lk NG
LkA BW T  in LkNG
PCR error (Taq polymerase)
LKAB7M/TCA PCR error (Pfu polymerase)
4.2 The K 3' enhancer drives hypermutation from a position 5' of the target area
L k(W T&7M) carries two V k segments (WT and 7M) o f which only one belongs to an 
intact transgene copy. The other is part o f a truncated copy that contains the Ei/MAR-CK 
region but not the 3' enhancer. Southern blot analysis o f tail's DNA digested with several 
restriction enzymes was performed to try to identify the complete copy. However, due to 
the symmetry of the transgene this was not possible.
The sequence analysis o f the transgenes in the L k(W T&7M ) line revealed that both 
transgenes had been substrate for hypermutation (Table 4.1 and Fig. 4.3). The sequences 
with one or more mutations of the L k and L k7M are shown in the Appendices III E and 
F respectively.
The number of mutations per clone found in 7M and W T copies is very similar (3.5 and 
3.7 respectively). Amongst the 7M clones sequenced 29.6% were unmutated. A higher 
num ber of W T clones (40.9%) were unmutated. The overall frequency of mutations in 
the 7M copy is slightly higher (9.2 x 10*3 mutations per base pair) than that found in the 
W T copy (7.4 x 10*3 mutations per base pair).
However, this is not the case in the L kNG  transgenic line which also carries 7M and WT 
transgenes. On the contrary, in the L k NG line the 7M copies m utate at a frequency 
slightly low er (7.1 x 10*3 mutations per base pair) than the W T copies (11.8 x 10*3 
mutations per base pair) and the number of mutations per clone in the W T is higher than 
in the 7M copies (4.6 and 2.9 respectively).
Figure 4.3 Mutations in the transgenic V regions (opposite page). Each pie chart 
depicts the proportion of sequences with the specified number o f mutations. A pie chart 
show ing the control for PCR errors is included for com parison. PCR with Taq
polym erase (Lk, L k7M, L kAB, L kAB7M), the PCR error was measured by sequencing
L kAB and L k AB7M transgenes from  characterized hybridom as. PCR with Pfu
polym erase (L k7M /TCA), the PCR error was measured by sequencing L kAB7M /TCA 
transgenes from characterized hybridomas.
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Table 4.1 Lk, Lk7M, LkAB, LkABTM and LkAB7M/TCA transgene mutations in 
PCR clones derived from Peyer's patch B cells (PNA^i).
Transgene ...
Clones^ 
Total =1 >1
Mutations*
Total
M ut./clone° 
>1 >1
Mutations/103 base pairif 
MFt MF(>1)
L k(WT) 88 18 34 184 3.5 4.9 7.4 (7) 17.3
L kAB(WT) 59 10 33 197 4.6 5.7 11.8 (11.4) 20.1
WT (Average) 147 28 67 381 4 5.2 9.2 (8.8) 18.7
L k(7M) 81 13 44 211 3.7 4.5 9.2 (8.8) 16
L kAB(7M) 26 6 12 52 2.9 3.8 7.1 (6.7) 13.6
7M (Average) 107 19 56 263 3.5 4.4 8.7 (8.3) 15.4
PCR error0 245 27 1 29 0.9 2 0.4 7
L K A B 7M /T C A 172 17 48 267 4.1 5.2 5.5 (5.4) 18.5
PCR e r r o r t 52 2 0 2 1 0 0.13 0
L k3^ 76 9 44 267 12 21
L k6(5 m onth)t37 123 11
PCR e r r o r 0.7
# Total number o f PCR-generated clones and the number of those carrying one (=1) or 
more than one (>1) mutations.
* Sum of mutations in all clones.
□ The num ber o f mutations per clone was calculated using either the number o f clones 
carrying mutations (>1) or only those carrying more than one mutation (>1).
If The frequency o f mutations per 10^ base pair was calculated using either the total 
number of clones (MFt) or only those clones carrying more than one mutation (MF(>1)). 
The values after correction of the PCR error are given in parentheses.
+ Clones obtained from hybridomas of LK7M/TCA&AfLi] transgenic line.
0  Clones obtained from hybridomas o f L kNG  transgenic line.
(Average) D ata from  either W T or 7M transgenes which originate from  L kNG  and 
L k(W T&7M) lines were used for the average.
J Data from Gonzalez-Femandez and Milstein, 1993.
^ Data form Gonzalez-Femandez et al., 1994a.
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The 3' enhancer of the neighbour copy must be able to act from the 5' position with 
respect to the V k  region because both V k  segments mutate. It was previously shown that 
the 3' enhancer can drive hypermutation both when moved closer to the V-C elements 
and when present in the opposite orientation (Betz et al., 1994). The results shown here 
indicate that the downstream position of the 3' enhancer with respect to the prom oter 
elements is not important for hypermutation.
4.3 The modifications in the DNA sequence and secondary structure did not affect 
the rate or the nucleotide substitution preferences of hypermutation
The hyperm utation analysis o f the modified 7M and 7M /TCA transgenes showed that 
they mutate at a level comparable to that observed in the L k  (WT) transgenes (Table 4.1, 
Fig. 4.3). The sequences of the LkAB, LkAB7M  and LkAB7M /TCA with one or more 
mutations are shown in the Appendices III G, H and I respectively.
As described in the previous section, differences in the overall m utation frequency and 
mutation per clone between the W T and 7M transgenes in the L k(W T&7M) and L kNG 
lines were found. This is also observed in the hybridom as generated from  both lines 
(section 4.6). The variations are not caused by the mutations introduced in the C D R l of 
the 7M  V k gene. They rather may be produced by a differential targeting o f the 
transgenes.
The reasons for this differential targeting are unknown. It may be a result o f a poorer 
transcription of some transgene copies. In the L k(W T&7M) line this could be caused by 
the different position o f the 3' enhancer in one of the copies. In the L kNG  line may 
contain truncated copies, as the number o f transgene copies estimated from the Southern 
blot probed with the J-C intron fragment did not correspond to the num ber estimated 
when the 3'E probe was used (see Chapter 3).
The m utation frequency amongst L k7M clones carrying more than one m utation (16 x 
10*3 m utations per base pair) is very similar to that observed in L kW T  (17.3 x 10 3 
mutations per base pair) clones in the L k(WT&7M) line (Table 4.1).
In the LkN G  line the frequency of m utations o f the W T and 7M transgenes are also 
comparable, although the mutation frequency of clones carrying more than one mutation 
in the wild type ( 2 0 . 1  x 10*3 m utations per base pair) is slightly higher than in the 
mutated transgene ( 1 3 . 6  x 10*3 mutations per base pair).
In the LK7M /TCA&A[Li] line the clones carrying m ore than one m utation in 
Lk7M /TCA transgene mutate with a frequency of 18.5 x 10 3 mutations per base pair. 
However, when the overall mutation frequency is taken into consideration, only the 
LkAB(WT) has a similar frequency ( 1 1.8 x 10*3 ) to the one found previously in the Lk3 
and L k6 transgenic lines (11-12 x 10-3 mutations per base pair). The largest difference 
was found for Lk7M /TC A  transgenes, w here the m utation frequency (5.5 x 10-3 
m utations per base) was 2 times lower. This is due to the low percentage o f mutated
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clones (Fig 4.3). About 59 to 73% of the sequences were mutated in all the transgenes 
analysed except in L k7MTCA where only 38% of the sequences carried mutations.
The proportion of mutated clones carrying more than one mutation is very similar for all 
the lines (65-77% ). Therefore, the low er overall m utation frequency observed in 
L k7M/TCA transgenes can not be due to a decreased number o f highly mutated clones.
The nucleotide substitution preferences o f mutations in L k , L k7M  and L k 7M/TCA 
Peyer's patches (Table 4.2) is com parable to the previously defined substitution data 
from L k6 Peyer's patches (Gonzalez-Fem andez and M ilstein, 1993). The predom inant 
substitutions show the typical bias of transitions over transversions (Table 4.2) as well as 
the typical bias against mutations in pyrimidines residues on the coding strand.
Thus there is no feature specific neither to the secondary structure nor the DNA 
sequence in the CD R l that is essential for recruiting hypermutation.
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Table 4.2 Nucleotide substitution in L k  and L k  mutated transgenes from Peyer's 
patch PNAh! B cells.
L k To
T C A G Total Corrected
From mutations*
T 30(0.58) 15(0.29) 7 (0.13) 52 0.15
C 80(0.81) 8 (0.08) 10(0.10) 98 0.23
A 34 (0.28) 25(0.20) - 64 (0.52) 123 0.32
G 8 (0.07) 14(0.13) 86(0.80) - 108 0.30
L k7M To
T C A G Total Corrected
From mutations* % 1
T - 18(0.40) 12(0.27) 15 (0.33) 42 0.18
C 61 (0.83) 4 (0.05) 8 (0.11) 73 0.25
A 21 (0.29) 12(0.16) - 40 (0.55) 73 0.28
G 5 (0.07) 15(0.21) 52(0.72) - 72 0.28
LK7M/TCA To
T C A G Total Corrected
From mutations*
T 13(0.31) 18(0.43) 11 (0.26) 42 0.16
C 45 (0.78) 2 (&03) 10(0.17) 57 0.19
A 34 (0.34) 22(0.22) - 45 (0.44) 101 0.38
G 9 (0.13) 15(0.22) 43(0.64) 67 0.26
The figures in the three sections give, for each of the four bases in the V k sequence, the 
num ber o f times and the proportional distribution (in parenthesis) with which it is 
mutated to one of the other three bases.
L k data originate from L k and L kAB transgenes. L k7M originate from L k7M and 
L kAB7M transgenes.
* Total number of times that the four bases were found mutated.
II The proportion o f m utations in each base corrected for the base com position of the 
region analysed.
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4.4 The DNA sequence has a major influence on hotspots
The distribution o f somatic mutations along the modified and wild type L k  transgenes is 
shown in Fig. 4.4 and 4.5, where the variability is given as the percentage o f sequences 
that carry a m utation at each particular nucleotide o f the V k  region. The segment 
analysed includes 282bp using as the starting point the first coding nucleotide for the 
mature variable region.
A large com pilation o f transgenic Lk (WT) sequences from Peyer's patch B cells was 
constructed with 95 sequences from Lk and LkAB (see Appendices III E and G); 107 
sequences from  Lk6 and Lk3 (G onzalez-Fem andez and M ilstein, 1993; Gonzalez- 
Fem andez et al., 1994a); 20 sequences from Lk in ENG (Gonzalez-Femandez, personal 
com m unication) and 17 sequences from LkA[3'F1] (Betz et al., 1994). This extensive 
database o f Lk (239 sequences with a total o f 1112 mutations) was used for comparison 
to assess whether the distribution of mutations is affected when the Lk transgene carries 
a modification.
Figure 4.4 Distribution of mutations on Lk7M and L kABTM transgenes (opposite 
page). The distribution of mutations amongst the transgenic V regions clones isolated
from  Peyer's patch PNA^^ B cells form LkNG and Lk(WT&7M) transgenic lines is 
shown. V ariability  at each nucleotide position is com puted as the percentage of 
sequences carry ing  one or m ore m utations which are m utated at that position. 
Nucleotides are numbered from the first base of the initiator ATG codon. Hotspots are 
indicated with the name and position of the amino acid. The distribution o f mutations on
Lk transgenes is provided for comparison.
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The com pilation o f m utations in the L k7M and L k7M /TCA transgenes shows the 
expected non random  distribution  o f  m utations and the presence o f  hotspots 
preferentially around C D R l. It is possible to find some o f the most dominant intrinsic 
hotspots previously identified in the large data base for the same gene: the second base 
o f Ala60, the second base o f Ser77, the first base of Ser93, the first base o f N94. 
However, in the modified CD Rl substantial differences were found.
4.4.1 A new intrinsic hotspot in Ser31
The percentage o f sequences that carry a mutation at each particular nucleotide in the V k  
region o f the 7M  m utant was com pared with that in the wild type. This analysis 
disclosed several differences in C D R l region associated with the DNA sequence 
modifications. Higher number of mutations in Ser31(II) were observed. The second base 
of Ser31 A GT (the major recognised hotspot in several V genes) was found mutated in 
16.3% of the clones sequenced in the V k  wild type database, while the same position in 
the V k  7M, Ser31 AGC was found mutated in 22.6% of the clones (Fig. 4.4 and Table 
4.3). A much larger change was found in the third base o f Ser31. Contrasting with the 
0.4% found in wild type AGT, 21.3% of the clones were mutated in the third base of the 
m utant Ser31 AG£I. D ifferences were also observed in M et33(I) and Val30(III) and 
W35(III).
Figure 4.5 Distribution of mutations on LkAB7M/TCA transgene (opposite page).
The distribution o f m utations amongst the transgenic V regions clones isolated from
Peyer's patch PNA^^ B cells of the LK7M/TCA&A[Li] transgenic line is shown. 
Variability at each nucleotide position is com puted as the percentage o f sequences 
carrying one or more m utations which are m utated at that position. N ucleotides are 
numbered from the first base o f the initiator ATG codon. Hotspots are indicated with the
name and position o f the amino acid. The distribution o f mutations on L k  transgenes is 
provided for comparison.
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Table 4.3 Mutations, variability and Chi-square test for the CDRl nucleotides in 
the L k  WT and the mutated L k  transgenes.
WT m u t . V ( % ) 7M m u t . V ( % ) TCA m u t . V ( % )
G 0 0 0 0 - 0 0 -
A 2 5  C 1 1 4  . 6 1 1 . 3 0 . 9 0 0 1 . 7
C 0 0 G 1 1 . 3 0 . 4 G 0 0 -  .
A 1 0 . 4 1 1 . 3 0 0 0 0 . 5
S 2 6  G 1 6 6 . 6 7 9 . 3 0 . 3 8 1 3 . 1 1 . 9
C 2 3 9 . 6 3 4 1 . 7 2 3 . 2 1 . 8
T 1 0 . 4 0 0 0 . 4 0 0 0 . 5
S 2 7  C 2 0 . 8 1 1 . 3 0 . 1 0 0 0
A 8 3 . 3 G 0 0 1 . 4 G 0 0 1 . 0
A 4 1 .  6 3 4 0 . 5 1 1 .  6 0 . 3
S 2 9  G 7 2 . 9 2 2 . 6 0 . 1 6 9 . 8 4 . 0
T 2 0 . 8 c 3 4 1 . 9 C 1 1 . 6 0 . 0
G 1 4 5 . 8 1 1 . 3 1 . 6 4 6 . 5 0 . 0
V 3 0  T 6 2 . 5 0 0 0 . 8 1 1 . 6 0
A 1 5 6 . 2 T 0 0 3 . 6 T 2 3 . 2 0 . 3
A 8 3 . 3 0 0 1 . 4 T 1 1 . 6 0 . 1
S 3 1  G 3 9 1 6 . 3 1 7 2 2 . 6 1 . 1 C 0 0 1 0
T 1 0 . 4 C 1 6 2 1 . 3 4 4 . 8 A 0 0 0 . 5
T 7 2 . 9 1 1 . 3 0  . 1 4 6 . 5 0 . 9
Y 3 2  A 9 3 . 7 1 1 . 3 0 . 4 4 6 . 5 0 . 3
C 8 3 . 3 T 2 2 . 6 0 T 2 3 . 2 0 . 1
A 3 1 . 2 4 5 . 3 2 . 7 5 8 . 1 6 . 5
M 3 3  T 1 0 . 4 0 0 0 . 4 0 0 0 . 5
G 2 2 9 . 2 7 9 . 3 0 2 3 . 2 1 . 5
C 1 0 4 . 1 3 4 0 . 7 0 0 1 . 5
H 3 4  A 6 2 . 5 1 1 . 3 0 2 3 . 2 0
C 8 3 . 3 T 2 2 . 6 0 T 2 3 . 2 0 . 1
T 3 1 . 2 0 0 0 . 1 1 1 . 6 1 . 1
W 3 5  G 1 0 . 4 1 1 . 3 0 1 1 . 6 0
G 1 6 6 .  6 0 0 3 . 9 6 9 . 8 0 . 3
T 8 3 . 3 3 4 0 2 3 . 2 0 . 1
Y 3 6  A 2 1 8 . 7 4 5 . 3 0 . 5 9 1 4 . 7 1 . 3
C 1 0 4  . 1 3 4 0 . 1 7 1 1 . 4 3 . 5
G 1 4 5 . 8 4 5 . 3 0 2 3 . 2 0 . 2
A 6 0  C 1 5 6 . 2 8 1 0 . 6 1 . 0 5 8 . 1 0
T 3 1 . 2 0 0 0 . 1 0 0 0 . 0
A 3 1 . 2 2 2 . 6 0 . 1 2 3 . 2 0 . 3
S 7 7  G 2 1 8 . 7 6 8 0 3 4 . 9 0 . 5
C 2 0 , 8 1 1 , 3 .  , 0 , 1 1 1 . 6  . 0 . 0
The number of mutations (mut.), variability (V), and the results for the Pearson's Chi-
square test (%2) for each nucleotide in the C D R l region o f the L kW T, L k7M and
L k7MATCA are shown. Other major hotspots are also included for comparison. The wild 
type amino acid and DNA sequence is indicated (WT). The silent mutations carried by 
the mutants 7M (7M) and 7M/TCA (TCA) are shown overprinted. The variability was 
calculated as the percentage o f sequences that carry a m utation at each particular 
nucleotide. The Pearson's Chi-square test (on 1 degree of freedom) was calculate for the 
number of mutations of each mutant versus wild type. For significance at the 5% level, 
the Chi-square has to be greater than 3.84.
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In order to assess whether these differences were significant a Pearson's Chi-square test 
(on 1 degree of freedom) was performed with the 7M database versus the W T database. 
The results show that the differences found are significant only for the third base of 
Ser31 AGC (Fig. 4.6, Table 4.3).
Therefore, Ser31 as AGC has not altered the major hotspot (second base). However the 
m utation produced an even more "attractive" m otif (AGCT), w hich creates a new 
hotspot (in the third base). The maintenance o f the G as hotspot and formation of a new 
intrinsic hotspot in Ser31 as AGC occurs in spite o f the fact that the relevant hairpin is 
more unstable than that predicted for the wild type. The major hotspots in other regions 
of the V gene, like Ala 60 and Ser77 were not significantly altered.
4.4.2 Ser 31 as TCA is not a hotspot
W hen the AGT triplet in Ser31 was changed fo  TCA the classic major hotspot of the V 
genes did no longer exist. No mutations were found in the second or third bases and only 
one mutation was found in the first base of Ser 31 as TCA in 61 clones sequenced (Fig.
4.5 and Table 4.3). This contrasts with the 16.3% of clones carrying the Ser31 (second 
base) mutated in the W T V k  gene. Along with this change other differences were also 
observed in Ser29(ll) and M et33(l) and no large differences were found in the other 
hotspots outside the C D R l. The significance o f these difference was assessed with the 
Pearson's Chi-square test and the results are shown in Fig. 4.7.
Figure 4.6. Pearson's Chi-square statistic test for the differences (increase/decrease) 
in the mutability resulting from local base substitutions in 7M v/s WT.
The test was performed for each position along the V k  gene in the wild type and the 7M 
mutant for the clones sequenced (239 and 75 respectively) with the number o f mutations 
found. For significance at the 5% level, the Chi-square need to be greater than 3.84 
(shown by a dashed line).
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The absence of mutations in Ser31 as TCA was significant confirming that the sequence 
m otif has an im portant role in the origin of the hotspots. This finding is in line with 
previous observations that Ser as TCN triplets (N:A/T/C/G) mutated less than the AG Y 
(Y:T/C) encoded ones (Schwager et al., 1989; Reynaud et al., 1995; W agner et al., 
1995). Those studies showed a strong bias for Ser as AG Y to be used in the CDR 
regions and Ser as TCN to be used in the frameworks. The results shown here indeed 
confirm ed that the ground for this bias are the m otif preferences o f the mutational 
machinery. They support the idea that during the germline V genes evolution they have 
evolved in response to selection for sequences which favour mutability in the CDRs and 
less favourable ones in the frameworks.
The comparison o f 7M and 7M/TCA databases using the Pearson's Chi-square test (Fig. 
4.8) revealed that basically the distribution of m utations in both m utants are similar 
except in the second and the third base of Ser31 due to the lack o f mutations in Ser31(II) 
as TCA and the new hotspot in Ser31(III) as AGC.
In addition, although with lesser significance, differences in the mutations in W35(II1) 
and 175(1) were found. These position are more mutated in TCA than in 7M, but when 
TCA was com pared with the W T they were not significant because these positions are 
hotspots in the large database. Therefore that reflect the necessity o f large databases to 
avoid mistakes in the assessment.
4.4.3 'TA' motif as mutational target
The TA' m otif is found hypermutated in Val30, Tyr36, Ser93 and Asn94. The change in 
the Tyr32 (TAC for TAX) introduced a new TA' core m otif because the first base of 
Met33 (ATG) was mutated in 7% more 7M /TCA clones and in 4% more 7M clones 
compared to the WT. These differences were significant at the 5% level by the Chi-test 
for 7M/TCA v/s W T (6.5) and suggestive but not significant (2.7) for 7M v/s WT.
Figure 4.7. Pearson's Chi-square statistic test for the differences (increase/decrease) 
in the mutability resulting from local base substitutions in 7M/TCA v/s WT.
The test was performed for each position along the V k gene in the wild type and the 
7M/TCA mutant for the clones sequenced (239 and 61 respectively) with the number of 
mutations found. For significance at the 5% level, the Chi-square need to be greater than 
3.84 (shown by a dashed line).
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The difference between the TA' m otif in both mutants could indicate that there are other 
elements like the palindromic structures, that may help in the targeting. Indeed, the DNA 
secondary structure around these residues is different between the two mutants (see Fig. 
4.2). Tyr32 and M et33 codons in 7M /TCA can form a very small loop which may 
expose the TA' core for mutability. However, in the TA' core o f the 7M mutant there is 
another loop more stable that competes.
4.5 The secondary structure has a lesser effect in the definition on hotspots
It is very difficult to assess the effect o f hairpin loops independently o f the effect of the 
DNA sequence m otif on hotspots since in order to change the consensus sequences it is 
unavoidable to disturb the palindrom ic structures and vice versa. For exam ple, the 
hairpin loop containing the Ser31 A CT is very stable in the CD Rl wild type. As G is at 
the tip of the loop, it is the most exposed base. This coincides with the fact that it is also 
the most mutated base of this triplet.
In the 7M mutant (Ser as AGC), the loop looses stability. However, both G and C are 
equally exposed at the end of the loop (see Fig. 4.2). The mutations in this case occur 
equally in both bases. On the other hand, the new TA core formed in the Tyr32-M et33 of 
the C D R l m utants was more m utated when part o f a putative loop. Therefore the 
palindromic structures may make the nucleotides accessible for hypermutation.
Figure 4.8. Pearson's Chi-square statistic test for the differences (increase/decrease) 
in the mutability resulting from local base substitutions in the 7M/TCA v/s 7M.
The test was performed for each position along the V k gene in the 7M/TCA and the 7M 
mutants for the clones sequenced (61 and 75 respectively) with the number o f mutations 
found. For significance at the 5% level, the Chi-square need to be greater than 3.84 
(shown by a dashed line).
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4.6 DNA sequence modifications and affinity maturation
Hybridomas were generated from the L k(WT&7M), L kNG  and LK7M/TCA&A[Li]. The 
V k segm ent was am plified and cloned as described in M aterials and M ethods. The 
sequences are shown in the Appendix IV A, B and C respectively.
The analysis of these sequences revealed that the mutations introduced in the C D R l did 
not disturb the introduction and selection o f the characteristic aminoacid substitutions at 
H is34 (by Gin or Asn) or Tyr36 (to Phe) observed in m ost o f the antibodies o f a 
secondary or tertiary immune response to phOx resulting in a ten-fold increase in affinity 
(Berek and Milstein, 1987). These mutations were often found in L k7M of Lk (W T&7M) 
and L k7M /TCA hybridomas. They were found less frequently in the L k7M transgenes 
of L kNG  hybridomas in spite of the change in His34 (CAC for CAT) (Appendix IV).
It was notable that, even within a single cell, there was a considerable difference in the 
num ber of accum ulated m utations in individual transgene copies (Table 4.4). This 
phenomenon was well illustrated in the L kNG hybridomas, not only amongst L k and 7M 
but also in LK-Vgpt* and L k-V neo*AfXS]i transgenes. The latter exclude a skewing 
effect of antigen selection. Contrasting the m utations in e.g. CIO.5.4 and C23.1.5 
hybridomas, it is evident that this phenomenon is not inherent to the transgene itself as in 
one hybridoma one transgene accumulates more mutations and in the other hybridoma it 
is the other transgene.
A nother intriguing observation was that the am inoacid substitutions characteristic for 
antibodies with increased affinity for phOx were not found random ly distributed in all 
the transgene copies. For example, both aminoacid substitution are present only in the 
7M transgene and not in the W T transgene o f the D3.3.3 and C l2.1.3 hybridom as 
(which secrete only transgene light chain) derived from L k(W T&7M) line(Table 4.4). In 
the hybridom as form L kNG line the distinctive aminoacid substitutions o f antibodies 
with increased affinity for phOx were found in 7 out o f 9 hybridomas. Only one 7M 
transgene (in hybridom a B20.6) was found with one o f  the typical am inoacid 
substitution (Tyr36 for Phe). W hile in another (D l.5 .5 ) with one o f the substitution 
(Tyr36 for Phe) in a 7M copy also contained a W T copy with both, H is34 and Tyr36 
substitutions. The other 5 hybridom as had both am inoacid substitutions in the W T 
copies.
The finding o f those m utations in specific copies may reflect differences in the 
transcription o f those copies. In the L k(W T&7M) line the fact that one o f the copies is 
truncated and does not contain 3' enhancer may be a reason for differential transcription. 
In the L kNG line there is evidence that some copies may not contain the 3' enhancer.
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T able 4.4 Sequence analysis of the  transgene  V regions of the hybridom as from  
L kN G, L k(W T & 7M) an d  LK7M/TCA&A[Li] transgen ic  mice.
L kNG L kABWT L kABIM  L kAB7M C PCRe LKVneo LKVgpt
C15.2.7 8(Q-F) 6 7 3 3 37 2 7 5 3 0 6
CIO.5.4 5(N-F) 8 6 1 1 23 9 9 7 3 0 1
A 6.8t 3 3 1 0 18 5 6 4 2 nf 3
C23.L5 7(N-F) nf nf 2 2 42 1 2 0 8
D l.1 .5 10(N-F)0 nf 10(F)0 25 3 3 1 0 0
B20.6 4 0 2 4(F) 0 19 2 2 0 0
C6.3.6 8(Q-F) nf 4 5 2 14 1 0 0
D12.3.8 0 0 2 0 0 29 2 0 1
C4.6.8 0 0 2(F) 0 0 12 1 0 1
D23.4 1 0 1 1 0 26 3 0 0
L k(W T& 7M ) L kWT C L k7M c
D3.3.3§ 3* 7 7CN-F) 5
C12.1.3§ 5* 4 7(Q-F) 6
EH2.5 0 3 4 3
RB3.6 0 3 3 3
EA8.7 0 5 1 3
C323.2 0 2 0 5
C ll.4 .8 .8 0 4 0 4
L k7M /TCA L k7MATCA c PCRe
B2.4.4 3 15 1
C14.1.9 6(N-F) 37 1
A20.5.2 4(N-F) 2 0
T h e  ta b le  s u m m a r is e s  th e  s e q u e n c e  re s u l ts  o b ta in e d  fro m  th e  L k N G , L k (W T & 7 M ) an d  
L K 7M /T C A & A [L i] hyb ridom as. T h e  re su lt fo r LK V neo an d  L K -V gpt (Y élam os e t a l., 1995) a re  in c luded  
for com parison . T he n u m b er o f  m u ta tions is g iven  fo r each  tran sgen ic  copy . W hen  no  m u ta tions a re  found 
in severa l M 13 c lones, they m ay derived  from  m ore than o n e  unm uta ted  copy .
C , n u m b er o f  c lones found  fo r each  copy . M utan ts a re  defined  by a  m in im um  o f tw o id en tica l sequences. 
F o r L k AB (7M  an d  W T ) in L kN G  a m in im um  o f  15 c lo n es  w ere  seq u en ced , b u t o n ly  the  n u m b ers  o f  
c lones co m ple te ly  read  is show n,
nf, the  ex p ec ted  co p y  w as n o t fo und  am o n g  a  m in im um  o f  25 c lo n es . A b sen t co p ies  co u ld  re su lt from  
instab ility  o f  th e  transgen ic  D N A  in B ce lls  in the derived  hybridom as.
P C R e, the  n u m b e r o f  m u ta tio n s  a ttrib u ted  to  e rro n e o u s  PG R  am p lif ic a tio n s , s in ce  each  o f  them  w as 
observed  in a  sing le  sequence  on ly .
* T hese  co p ies  carry  d e le tions w hich  resu lt in a  co d in g  sequence  o u t o f  fram e.
t T h e LkAB tra n sg e n e  co p ie s  d o  n o t p ro v id e  the  lig h t ch a in  o f  th e  p h O x  an tib o d y  sec re ted  b y  th is  
hybridom a. T he res t o f  the LkNG hybridom as secre ts  on ly  transgen ic  ra t k.
§ In these  L k (W T & 7M ) hyb ridom as the ligh t chain  o f  the  phO x an tibody  secre ted  is on ly  p ro v id ed  by  the
transgene. T he res t o f  the hyb ridom as secre t bo th , tran sgene ra t k and  en dogenous m ouse  k chains.
T he am in o -ac id  su b stitu tions ch arac te ris tic  o f  an tibod ies  w ith  increased  affin ity  fo r phO x a re  ind ica ted  as 
H 34 fo r N  ( N )  o r  fo rQ (Q )  and  Y 36  fo r F  (F).
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4.7 Discussion
All the m ice used for the studies above contained m ultiple transgenes. This was 
particularly useful in the case o f the L kNG line because the L k transgenes served as 
internal control (mainly for analysis o f mutation rates) o f the non im m unoglobulin 
transgenes.
V k  mutants with alterations of DNA sequence in the CD R l were able to hypermutate at 
the same level and with the same intrinsic preferences as the wild type. This is in spite of 
the finding that one of the lines (Lk(W T&7M ) contains a truncated copy which lacks the 
3' enhancer. Thus, it seems that the 3' enhancer o f the intact neighbour copy is able to 
drive hypermutation independently o f its downstream position with respect to the V-C 
elem ents. W hile these results indicate that the usual 3' enhancer position in the k  
transgene is not required to achieve a high level of m utations, the hybridom a results 
suggest a slightly different picture (see below).
Some of the C D R l modifications produced important changes in the well characterised 
hotspots o f the V k Ox I C D R l. The second base of Ser31 AGT T is the m ajor intrinsic 
hotspot within the mouse V k Ox I gene. It matches the Pu-G-Py-A/T consensus in which 
the most favoured base for mutations is the G. W hen Ser31 (AGT) was changed (for 
AGC) in the 7M, not only the second base but also the third is a hotspot. Ser26 is 
another intrinsic hotspots in the CD Rl of V kOx I encoded by the AGCT consensus. Also 
in this case both bases, the G and the C, are mutated. Another exam ple is the major 
hotspot found in the Vgpt gene, which match the G AG CTC consensus. The third base 
of Glu70 and the first base o f Leu71 also mutate equally well (Yélamos et al., 1995).
The formation o f the new hotspot in the third base o f Ser31 indicates the importance of 
the prim ary DNA sequence for the targeting of specific nucleotides for mutation. This 
was further supported by the findings that Ser31 TC A  was not a hotspot. A preference 
for the usage of AGY codons in the CDRs (particularly in the C D R l) and for TCNs in 
the fram eworks have been observed in human V genes (W agner et al., 1995) an also in 
Xenopus and sheep (Schwager et al., 1989; Reynaud et al., 1995). It suggests that the 
DNA sequence o f germ line V genes has evolved in response to selection for 
appropriately targeted mutability (W agner et al., 1995). The results shown here indeed 
confirm the mutational machinery preferences for AGY encoded Ser and the bias against 
TCA encoded Ser as target for hypermutation. The 7M /TCA mutant dem onstrates that 
the codon bias exists and that it correlates with the local nucleotide sequence 
Not all the hotspots conform to the consensus above. For example, Val30(III), Tyr36(II), 
Ser93(I) and N94(I) are intrinsic hotspots that have a common TA' core with A being 
the m utated base. Indeed there are several exam ples am ongst hotspots of X chains 
(Gonzalez-Fernandez et al., 1994b). One o f the modifications introduced in the CD R l 
mutants was a change of Tyr32 (TAC for TAX)- This generates a new TA' core motive 
as the first base o f M et33 (ATG) was found mutated in 7M/TCA clones but not in the
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7M ones. Further analysis is required to find a bigger consensus sequence, which 
includes the T A ' core. No consensus has emerged from a prelim inary analysis o f the 
bases flanking the TA' core o f the mutants.
On the other hand, these observations support the idea that hotspots are only partially 
created by local DNA sequence. Other structural features, such as palindromes, may well 
be im portant (G onzalez-Fernandez et al., 1994b). The palindrom ic structures around 
Tyr32 and Met33 codons are different between the two mutants. Tyr32 and Met33 in the 
7M /TCA m utant can form a very small loop which allows the TA' core to be more 
"exposed" while in the 7M the TA' core is also contained in another more stable loop. 
However Ser31 in the W T is located at the tip o f a very stable hairpin loop that becomes 
unstable in the 7M  mutant, yet it m utates even more in spite to the apparent loss of 
stability of the loop. I conclude that while the hairpin loops do not seems to be important 
to define which base is going to be targeted, they may have an enhancem ent role by 
making the 'favoured' nucleotides accessible for hypermutation.
In the hybridom as from the L kNG  line a considerable difference in the num ber o f 
accumulated mutations in individual transgene copies was observed in selectable and not 
selectable transgenes. This results confirm ed the skew ing previously noted using 
selectable transgenes (Rogerson et al., 1991) and demonstrated that it is not attributable 
to antigen selection.
On the other hand, the analysis of the am inoacids substitutions that increase antibody 
affinity in L k (W T&7M) and L kNG  hybridom as suggested that those mutations occur 
more frequently in some transgenes than in others, e.g. in W T transgenes o f L kNG  line 
or in 7M transgenes of L k(WT&7M) line.
In Peyer's patch cells the differences in the frequency o f mutations between the W T and 
7M copies in both (Lk(WT&7M) and L kNG) lines correspond to results for hybridomas. 
They are however not very significant. In addition, the hybridoma analysis is based on 
differences collected from a small database. The variation of the preferential targeting of 
the m utations associated with the affinity m aturation in these copies suggests that it 
could arise from a difference in the efficiency of transcription of those copies. This could 
be confirmed with the analysis o f the transcription levels of both (7M and W T) copies in 
several hybridomas from Lk(WT&7M) line.
There are no extensive studies indicating that all the L k  copies (without stop codons) are 
equally transcribed in the transgenic mice. Indeed some such differences have been 
noted in transgenes with premature stop codons in hybridomas (Lozano et al., 1993). It is 
also unknown whether tail-to-tail tandem integrations, which bring the two 3' enhancers 
relatively close, are better expressed than others.
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Chapter Five Controlling elements in the k  locus
5.1 Controlling elements in the J -C  k  intron
Over the last decade our knowledge o f somatic hypermutation has grown considerably. 
L ittle, however, is known about the m olecular m echanism  driving this process. The 
observation of hypermutation o f rearranged k  transgenes in many different transgenic 
lines suggests that hypermutation depends on c/5-acting elements in the k  locus and is 
largely independent of chromosomal position.
It has been shown that multiple cis-âcûng  DNA elements are involved in the regulation 
of somatic hyperm utation (Betz et al., 1994). Both, the J-C k  intron enhancer/M AR 
region and the 3' enhancer dow nstream  of the C k  region are required  for full 
hyperm utation. The requirem ent for these elem ents suggests that m utation correlates 
w ith an "open" DNA structure associated with the potential for transcrip tion. 
Hyperm utation seems to occur only in germinal centre centroblasts, which express no 
surface IgD. There is, however, no evidence which directly connects hypermutation to 
the im m unogloblin transcription rate in these cells. The role o f the enhancers and 
transcription in hypermutation remains unclear.
The J-C  K  intron contains a matrix attachm ent region (M AR) (Cockerill and Gallard, 
1986) and the k intron enhancer (Ei) (Queen and Baltimore, 1983; Picard and Schaffner, 
1984a). To delineate cw-acting DNA elements within the J-C intron required to target 
hyperm utation two constructs were designed to generate transgenic m ice harbouring 
independent deletions o f intron enhancer (LKABA[Ei]) and m atrix attachm ent region 
(LkABA[MAR]) (Fig. 5.1). Detailed description o f these constructs can be found in 
M aterials and Methods.
L kABA[E1] carries the deletion o f the region which contains the kA, kB, E l ,  E2, E3 
sites. These sites were characterized both functionally and in binding studies and were 
shown to be crucial for the activity of this enhancer (Lenardo et al., 1987; Nelms et al.,
1990). O ther less well characterized sites, including a silencer region (Pierce et al.,
1991), a non consensus octamer binding site (Currie and Roeder, 1989) and the kNE  and 
kBS sites (Sak sela and Baltim ore, 1993) are also included in the deleted area of 
L kABA[E1].
The other m ayor DNA element in the J-C k  intron, the matrix attachm ent region was 
deleted in LKAB A [M AR]. M ARs are 70% A-T rich sequences that m ediate the 
association o f the nuclear DNA with the nuclear m atrix (scaffold) and they are
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Figure 5.1 a Structure of transgenes. The constructs are modified versions of L k  
(Sharpe et al., 1991).The MAR (H indlll-H infll) and the k  intron enhancer (Alul-Alul) 
regions in the LKABam are shown enlarged for reference. The constructs containing 
the deletions are all analogous to LxABam, differing only in the region between the 
H indlll and Hpal sites, as shown in the enlargements. R, EcoRI; H, H indlll; Hp, Hpal; 
B, BamHI; N, Notl; A, Alul; Hf, HinfT; Af, Aflll.
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preferentially bound and cleaved by Topoisomerase II. Several DNA motip have been 
found in MARs of different species. These motives are repeated several times along the 
MAR and are also found in origins of replication, and in the recognition site o f several 
homeodomain proteins. The sequences are: AATATTTT or subsets thereof (Cockerill 
and Garrard, 1986); TT/TTT/ATTT/ATT, and streches o f A TATTT -together with its 
variants, ATATTTTT and ATATT-, ATTA, ATTTA (Boulikas, 1993).
As M ARs are defined by physical rather than functional characteristics, their functions 
(other than to anchor chromatin to the nuclear matrix) may be heterogeneous. MARs 
have been associated with transcription (Blazquez et al., 1989; S tief et al., 1989; 
Forrester et al., 1994), replication (Cockerill and Garrard, 1986; D ijkwel and Hamlin, 
1988), recombination (Sperry et al., 1989), déméthylation of the K gene (Lichetenstein et 
al., 1994), position-independent expression to heterologous genes (M acKnight et al.,
1992) and regulation o f the cell type specificity  o f  the Ig H intron enhancer 
(Scheuerm ann and Chen, 1989; Zong and Scheuerm ann, 1995). Its potential role in 
somatic hypermutation is analysed in this Chapter.
5.1.1 H y p erm u ta tio n  o f  AEi k transgenes
Hyperm utation of AEi transgenes was analysed by polym erase chain reaction (PCR) 
am plification from a population of germinal centre cells from Peyer's patches with the 
oligonucleotides VKOXFOR and VKOXBACK (Appendix II) using Pfu polymerase. 
PCR products were cloned into M 13m pl8 as described in M aterials and Methods. 
Sequences from two mice were analysed: the founder AEi 9628 (5 months and 26 days 
old) and one of its offspring AEi 9701 (4 months and 14 days old). The sequencing 
prim er was the oligonucleotide JK5. The PCR error frequency (0.13 xlO'^ per base) was 
de term ined  by sequencing  transgenes from  hybridom as ob ta ined  from  the 
LK7M/TCA&A[Li] transgenic line (see Chapter 4).
The sequence analysis o f AEi V k regions revealed that the transgene had been a 
substrate for hypermutation. The sequences with one or more mutations are shown in the 
Appendix III A. Almost 20% of the 164 sequences were mutated with 12.2% carrying 
more than one mutation (Table 5.1 and Fig. 5.2).
The m utation frequency of all mutated clones and amongst those clones carrying more 
than one mutation are the usual quantitative values em ployed to compare the levels of 
hypermutation achieved by the transgenes. In order to have an additional indicator the 
num ber of mutations per clone (of all mutated clones and above and those carrying 2 
mutation) was also included.
The m utation frequency based on the total number of clones (MFt) was corrected for 
errors introduced during the PCR am plification by subtracting directly the PCR error 
rate from  the mutation frequency. This allows the comparison with mutation frequencies
100
LkA[Eü LK(W T)in Lk (W T « 7 M )
L kA[MAR] L kAB(W T) in  LkNG
Lk A[3'EC]
PCR error 
A
PCR error 
B
Figure 5.2 Mutations in the transgenic V region. E a c h  p ie  c h a r t  d e p ic ts  th e  p ro p o r tio n  o f  
se q u e n c e s  w ith  th e  sp e c if ie d  n u m b e r  o f  m u ta tio n s . A ll th e  e x p e r im e n ts  p e r f o m e d  w ith  th e  s a m e  
p o ly m e ra s e  a re  g ru p e d  in  c o lu m n s . A  p ie  c h a r t  s h o w in g  th e  c o n tro l fo r  P C R  e r ro rs  o f  e a c h  s e t o f  
e x p e r im e n t is in c lu d e d  fo r  c o m p a r is o n . A ) P C R  w ith  P fu  p o ly m e ra s e . P C R  e r ro r  m e a s u re d  b y  
s e q u e n c in g  L x V M /T C A & [L i]  t r a n s g e n e s  f ro m  c h a ra c te r iz e d  h y b r id o m a s . B ) P C R  w ith  T a q  
p o ly m e ra s e . P C R  e r ro r  m e a s u re d  b y  s e q u e n  c in g  L k N G  tra n s g e n e s  f ro m  c h a ra c te r iz e d  h y b r id o m a s . 
C ) T h e  re s u lts  fo r  L k A [E 1/M A R ] a n d  L k A [E 3 '] (B e tz  e t  a l . ,  1 9 9 4 ) a re  in c lu d e d  fo r  c o m p a r is o n .
T h e  re s u lt  fo r  L k [E 3 '] (P N A  low  B c e lls )  h a s  th e  s a m e  v a lu e  a s  th e  e s t im a te d  P C R  e r ro r  (0 .7 x 1 0
(D
LKA(Ei/MAR]
LkA[E3'] (PNA low B cells)
obtained for other transgenes independent of the PCR amplification conditions used. The 
data from the LKA[Ei/MAR] transgene (Betz et al., 1994), which carries the deletion of 
both the intron enhancer and the m atrix attachm ent region, are also included for 
comparison in Table 5.1.
Table 5.1 AEi and AMAR transgene mutations in PCR clones derived from Peyer's 
patch B cells (PNA^*).
Transgene ....
Clones^ 
Total =1 >1
Mutations*
Total
M ut./clone° 
>1 >1
M utations/10^base pairlt 
MFt MF(>1)
AEi 164 12 20 109 3.4 4.8 2.3 (2.2) 17.2
AMAR 42 2 0 2 1 0 0.16 (0.03) -
PCR errort 52 2 0 2 1 0 0.1
LK(WT)! 147 28 67 381 4 5.2 9.2 (8.8) 18.7
PCR error0 245 27 1 29 0.9 2 0.4 7
LKA[Ei/MAR] 0 7 5 7 3 16 1.6 3 0.76 (0.06) 10.7
PCR error* 0.7 7
# Total number of PCR-generated clones and the number of those carrying one (=1) or 
more than one (>1) mutations.
* Sum of mutations in all clones.
a  The num ber of mutations per clone was calculated using either the number o f clones 
carrying mutations (>1) or only those carrying more than one mutation (>1).
H The frequency o f mutations per 10^ base pairs was calculated using either the total 
number of clones (MFt) or only those clones carrying more than one mutation (MF(>1)). 
The values after correction o f the PCR error are given in parentheses.
 ^The LKA[Ei/MAR] data originate from Betz et al., 1994. The number o f nucleotides 
sequenced was 279/clone.
4 The PCR error in this experiment was theoretically estimated. The MF(>1) for the PCR 
errors (7) was calculated for a minimum of one clone with 2 mutations.
Clones obtained from hybridomas of LK7M/TCA&A[Li] transgenic line.
1 Clones obtained from L kNG and Lk (W T&7M) transgenic lines.
0  Clones obtained from hybridomas of Lk NG transgenic line.
103
en
?un
Io
<Nen
!
o
CNJ
O,
■O
H
z z
i* 66 L
.18 L
s z z  L
s
<
î« -9  l
fC/D
-g Q
LO LOOLO
ë
o0 
a\ en en
1
LO O
CM
(%)
The mutation frequency amongst AEi clones carrying more than one mutation was 17.2 
X 10'3 mutations per base pair. This value is com parable to the frequency o f mutations 
observed in L k transgenes (18.7 x 10^ mutations per base).
The overall mutation frequency was 2.35 x lO'^ mutations per base pair, a value 4 times 
lower than the value obtained for L k(WT) and 36 times higher than the value observed 
for L kA[E1/MAR]. This suggests that the rem oval o f the k intron enhancer does not 
result in the dramatic fall in hypermutation o f the LKA[Ei/MAR].
This low overall mutation frequency is due to an increased proportion o f unm utated 
clones rather than to a decreased number of highly mutated clones.
This line has more than 6 copies o f the transgene inserted in different places o f the 
mouse genome, and some copies may not be able to mutate. This has been observed 
previously in the LkN G line, where one of the four copies of the Vneo transgene did not 
mutate (Yélam os et al., 1995). There is another exam ple w here the num ber o f non 
m utated  V k  sequences found is large fo r unknow n reasons. In the line 
LK7M/TCA&A[Li], which carries at least 1 copy o f Lk7M /TCA, 65% of the sequences 
analysed were found unmutated (see Chapter 4). This value is however lower than that 
obtained with LKAEi (80%).
In spite of the low frequency of LKAEi V k  mutated clones, the majority o f these carry 
more than one m utation (see Fig. 5.2). Indeed the accum ulated m utations am ongst 
multiple mutated clones in LKAEi (4.8) and Lk(W T) (5.2) is similar, although there are 
fewer highly mutated clones in LKAEi. These results show that hyperm utation is not 
impeded when the Ei is absent as it is in LKA[Ei/MAR] where the number of mutations 
per clone (>1) is only 1.6.
The distribution o f somatic mutations along the L kA[E1] transgene is shown in Fig. 5.3, 
where the variability is given as the percentage o f sequences that carry a mutation at 
each particular nucleotide o f the V k region. The segment analysed includes 282 bp using 
as the starting point the first coding nucleotide for the mature variable region.
Figure 5.3 Distribution of mutations in the LKA[Ei] transgene (opposite page). The
distribution o f mutations amongst the transgenic V regions clones isolated from Peyer's
patch PN A ^i B cells from the L kA[E1] transgenic line is shown. Variability at each 
nucleotide position is com puted as the percentage o f sequences carrying one or more 
mutations which are mutated at that position. Hotspots are indicated. The distribution of
mutations on L k(WT) transgenes is provided for comparison.
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A large com pilation o f transgenic L k (WT) sequences from  Peyer's patch B cells (see 
Chapter 4) is used for com parison to assess w hether the distribution o f m utation is 
affected when the Ei was deleted.
The com pilation o f mutations in the LKAEi transgene shows the expected non random  
distribution of m utations and the presence o f hotspots preferentially around C D R l. 
Although the number o f mutations is relatively small, it is possible to find some o f the 
most dominant intrinsic hotspots previously identified in the large data base for the same 
gene: the third base o f Ser-26, the second base o f Ser-31 and the second base o f Ala-60 
(Betz et al., 1993b)). There are other apparent hotspots (the third base of Trp-35, the 
third base o f Thr-42, the second base o f Ser-43, the third base o f Tyr-71 and the fist base 
of Ile-75) that are less prominent in the large L k  database (Fig. 5.3).
The nucleotide substitution preferences of m utations in LKAEi Peyer's patches (Table 
5.2) is com parable to the previously defined substitution data from L k6 Peyer's patches 
(Gonzalez-Fernandez and Milstein, 1993).
Table 5.2 Nucleotide substitution in mutated LKAEi transgenes from Peyer's patch 
PNA**' B cells.
From T
To
C A G
Total mutations*
T - 10 (0.59) 3(0.18) 4 (0.23) 17(0.17)
C 27 (0.73) - 4(0 .11) 6(0 .16) 37 (0.30)
A 10 (0.34) 3(0 .10) - 16 (0.55) 29 (0.27)
G 4(0 .15) 5(0 .19) 17 (0.65) 26 (0.26)
The proportion o f m utations in each base corrected for the base com position o f the 
region analysed is shown in parentheses.
* Number o f mutations obtained for each of the four bases.
The predominant substitutions show the bias of transitions (70 changes out o f 109) over 
transversions (39 changes out of 109). The bias against mutations in pyrimidines, which 
indicates the polarity of the hypermutation machinery, is unambiguous only for T, since 
C mutated more than G and A. This discrepancy with previously reported data is likely 
to be due to the small number of mutated clones in the LKAEi database.
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5.1.2 Hypermutation o f AMAR k  transgenes
Germinal centre PNA**' B cells from Peyer's patches were collected from one o f the 
descendants (9583) (4 months and 25 days old) to analyse hypermutation as described in 
M aterials and M ethods. The Vk 0x1 gene segment was amplified with Pfu polymerase 
using the o ligonucleo tides BEA LEA D ER and V K O X FO R  (A ppendix II). For 
sequencing the prim er JK5 was used. The PCR error frequency was the same as 
described in section 5.1.1. The sequences with one or more point mutation are shown in 
the Appendix III B.
The sequence analysis o f the AMAR V k  region revealed that 95.4% of the sequences are 
unmutated (see Table 5.1 and Fig. 5.2). There were no clones carrying more than one 
m utation am ong 42 clones sequenced. The AM AR transgene was therefore not a 
substrate for hypermutation. The low overall mutation frequency (MFt) (0.16 x 10^ per 
base pair) is the same as the error frequency of the PCR procedure itself and it is more 
than 100 times lower than the mutation frequency for the L k  (WT).
These results are even m ore extrem e than those prev iously  obtained  for the 
LKA[Ei/MAR] transgenic line carrying the deletion o f both, M AR and Ei (Betz et al., 
1994). In both cases the M Ft is very low, in the range o f the value obtained for the PCR 
error. The MF amongst the A[Ei/MAR] mutated clones was 10.7 x 10  ^per base pair, but 
it should be noticed that it is less than two times higher than the minim um  theoretical 
value (7 x lO '^per base pair). However, there were three clones carrying more than one 
mutation in the LKA[Ei/MAR] but none in L kA[MAR]. This indicates that even when 
hypermutation is severely affected it is still possible to find some mutated clones.
The hypermutation analysis of AMAR transgenes indicates a crucial role of M AR on this 
process.
In both (LKA[Ei] and L kA[MAR]) transgenic lines a num ber o f clones with deletions 
were found. The frequency of deletion in LKA[Ei] and L kA[MAR] was compared with 
that in other transgenic lines (Table 5.3). The frequency o f deletions observed in 
LKA[Ei] and L kA[MAR] clones are not significantly higher than in other transgenic 
lines. None of the clones sequenced carried insertions.
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Table 5.3 Transgene deletions in PCR clones derived form  Peyer's patch B cell
(PNA**') in d ifferen t tra n sg en ic  lines.
Transgenic Clones with deletion^ Clones Frequency o f deletions
line Ibp > lbp analysed* (per 10* bases) J
LKA[Ei] 1 4 164 1.1
L kA[MAR] 2 0 42 1.7
LKTMyrCA 2 1 172 0.6
L k in L k(WT&7M) 0 1 88 0.4
L k7M  in L k(WT&7M) 1 0 81 0.4
L kAB7M in L kNG 3 0 26 4.1
L kAB in L kNG 1 1 59 1.2
L kA[3’EC] 0 0 45 0
L kA[F13’EC] 0 0 101 0
LK-Vgpt§ 1 0 67 0.5
LK-VneoA[XS]i§ 0 0 57 0
L k6H 1 0 222 0.1
L k3H 0 1 76 0.5
L k[3’F]H 2 0 65 1.1
L kA[E3']H 0 0 37 0
LKA[Ei/MAR]H 0 0 75 0
L kAB in ENGl 0 1 20 1.7
LK[p5]PC# 0 0 96 0
Lis 1718# 0 0 94 0
Lis 1922 1 0 141 0.2
t  The number of clones carrying deletions (either Ibp or more than Ibp) is indicated. 
The num ber o f clones carrying deletions found in transgenic lines that I have not 
analysed is included for comparison.
* Total number o f clones sequenced.
J Frequency o f deletions is given as the number of deletions found per 10^ bp sequenced. 
§ J. Yélamos, personal communication.
^ A. Gonzalez-Fernandez, personal communication.
#  C. Rada, personal communication.
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Figure 5.4 a Structure of transgenes. The co n struc t are modified versions of Lk 
(Sharpe et al., 1991).The Xhol-Notl fragment [containing the 3' enhancer (Sacl-Xba ) 
region and its core (NcoI-BstXI)l in the LKABam are shown enlarged for reference. 
The constructs, containing the deletions of the core enhancer or its flanking regions 
are analogous to LKABam. They differ only in the region between the Xhol and Notl 
sites as shown in the enlargements. R , EcoRI; H, Hindlll; Hp, Hpal; B, BamHI;
N, N otl; X, Xbal; Xh, Xhol; S, S ad ; Nc, Ncol; Bs, BstXI; Bp, BspMI.
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5.2 Controlling elements in the k  3 ’ enhancer
The 3’ enhancer is one o f the elements that regulate the cell specific and developmental 
expression o f the K light chain. This enhancer was found 8.5kb dow nstream  o f the 
constant region exon and is stronger than the K intron enhancer (M eyer and Neuberger, 
1989).
Transient transfection assays using reporter genes revealed that m ost (75%) o f the 
enhancer activity is localised in a 132 bp core (M eyer et al., 1990; Pongubala and 
Atchison, 1991) (Fig. 5.4). However the core enhancer only accounted for 30-50% of the 
activity when assayed in stable transfected S I07 cells with the L k and L kAB constructs 
carrying the core instead o f the whole 3' enhancer (see Chapter 3).
The involvement o f HLH proteins in the regulation of this enhancer was substantiated by 
repression of the enhancer through the HLH-inhibitory protein Id (Benezra et al., 1990; 
Pongubala and Atchison, 1991). Transient transfection assays with the core enhancer 
revealed that it contains at least three functional DNA sequences (PU.1/NF-EM 5, E2A 
and kE 3'-CRE) (Pongubala and Atchison, 1991; Pongubala et al., 1992; Pongubala et al., 
1993; Pongubala and A tchison, 1995). However, the flanking regions o f the core 
enhancer seem to be involved in the developmental control o f the 3' enhancer activity 
(Pongubala and Atchison, 1991; M eyer and Ireland, 1994).
The same DNA region that contains the 3' enhancer was shown to be essential for 
hyperm utation and a link between transcription of the im m unoglobulin gene and the 
hyperm utation machinery was suggested (Betz et al., 1994; M ilstein and Rada, 1995; 
N euberger M. S. and M ilstein, C., 1995; Peters and Storb, 1996). The L k  construct, 
which encodes an immunoglobulin k  light chain and includes 9kb o f DNA downstream 
of the C k , was the first k  transgene shown to undergo hypermutation at the same level as 
in the endogenous genes (Sharpe et al., 1991). In contrast the transgenes used in previous 
studies (O 'Brien et al., 1987, Sharpe et al., 1990), mutated only at a very low level. 
These results suggested that the 3' flanking region o f the k  locus contained control 
elem ents for both hypermutation and transcription. This was confirm ed when the k  3' 
enhancer was deleted resulting in a large reduction o f somatic m utation (Betz et al., 
1994).
None o f these studies showed w hether the 3' enhancer core includes the necessary 
elem ents to target somatic hypermutation. To extend the systematic delineation o f the 
cis- acting DNA elem ents within the 3' enhancer, which are involved in control of 
hypermutation, two transgenic lines harbouring independent deletions o f the enhancer 
core (LkA[3'EC]) or the flanking regions o f the 3' enhancer core (Lk[F13'EC]) (Fig. 5.4) 
were made. Detailed description of these constructs can be found in M aterials and 
Methods.
I l l
5.2 1 Hypermutation of LkA [FI3'EC] transgenes
Hypermutation in the V k  region of the LkA[F13'EC] transgenes, which lack the flanking 
regions around the 3' enhancer core, was analysed in germinal centre cells o f Peyer's 
patches by amplification with the oligonucleotides VKOXFOR and VKOXBACK using 
Pfu polymerase. PCR products were cloned in M 13m pl8. The oligonucleotide JK5 was 
used as the sequencing primer. Sequences from two transgenic mice were analysed: the 
A[F13'EC] 4256 (5 months and 13 days old) and A[F13'EC] 4272 (4 months and 15 days 
old). The PCR error frequency (0.13 x IQ-^ per base) was determ ined by sequencing 
transgenes from  hybridom as obtained from the LK7M/TCA&A[Li] transgenic line 
(Chapter 4).
The sequence analysis of the A[F13'EC] V k  regions revealed that the transgene had been 
a substrate for hypermutation. The sequences with one or more point m utations are 
shown in the Appendix III. C. Almost 27% of the 101 sequences were mutated and 14% 
carried more than one mutation (Table 5.3 and Fig. 5.2).
The m utation frequency based on the total number of clones (MFt) was corrected for 
errors introduced during the PCR am plification by subtracting directly the value 
obtained for the PCR errors (Table 5.4) to allow the com parison with m utation 
frequencies obtained for other transgenic lines independent o f the PCR conditions used 
in their am plification. The data are com pared with those o f the L kA[E3'] transgene, 
where the whole 3' enhancer was deleted (Betz et al., 1994).
The mutation frequency amongst clones carrying two or more mutations was 14.4 x 10^ 
per base pair. This value is lower but comparable to that observed in L k  (WT) transgenes 
(18.7 X 10-3 mutations per base) but higher than that obtained in LkA[E3'] (9.5 x 10^ 
mutations per base).
The corrected overall mutation frequency (2.3) is more than ten times higher than the 
PCR error, indicating that the removal of the flanking regions around the 3' enhancer 
core does not result in the drastic decrease o f hyperm utation rate  found with 
LKA[Ei/MAR] and L kAMAR (see previous section). It is however 3.8 times lower than 
the value obtained for L k (WT) transgenes.
This low overall m utation frequency could be due to an increased proportion o f 
unmutated clones that originate from truncated transgene copies not able to mutate. In 
this line only 2 copies contain the 3'E fragment, which leaves about 4 V k fragments 
which are possibly unable to mutate (for details see Chapter 3). Indeed only 27% of all 
L kA[F13'EC] transgene clones sequenced (Fig. 5.2) were m utated while 52% of the 
mutated clones carried more than one mutation. Several clones were highly mutated (up 
to 14 mutations) and the population of clones carrying more than one mutation contained 
an average o f 4.1 mutations per clone. This value is com parable to that obtained in the 
L k(WT) (5.2). In L kA[E3'] transgene, where the full 3' enhancer was deleted, only one
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clone with 5 mutations (also the highest mutated) was found. The num ber o f mutations 
per clone (in clones carrying more than one mutation) was 2.7.
These results suggest that the 3'E flanking regions are much less im portant for somatic 
mutation than the whole of the 3' enhancer.
Table 5.4 L kA[FI3'EC] and LkA[3'EC] transgene mutations in PCR clones derived 
from Peyer's patch B cells (PNA***).
Clones# M utations’^  M ut./clone° Mutations/10^base pair^
Transgene .........................................................................................................................................
Total =1 >1 Total >1 >1 MFt MF(>1)
L kA[F13'EC] 101 13 14 70 2.6 4.1 2.4 (2.3) 14.4
P C R erro rt 52 2 0 2 1 0 0.1 0
L kA[3'EC] 45 13 5 31 1.7 3.6 2.4 (2) 12.8
Wt I  147 28 67 381 4 5.2 9.2 (8.8) 18.7
PCR erroii  ^ 245 27 1 29 0.9 2 0.4 7
L kA[3'E]0 37 7 6 23 1.7 2.7 2.2 (1.5) 9.5
PCR error^ 0.7 7
# Total number of PCR-generated clones and the number of those carrying one (=1) or 
more than one (>1) mutations.
* Sum of mutations in all clones.
0 The number o f mutation per clone was calculated using either the num ber o f clones 
carrying mutations (>1) or only those carrying more than one mutation (>1).
 ^ The frequency o f mutations per 10^ base pairs was calculated using either the total 
number o f clones (MFt) or only those clones carrying two or more mutations (MF(>1)). 
The values after correction o f the PCR error are given in parenthesis.
 ^ The L kA[3'E] data was taken from Betz et al., 1994 The num ber o f nucleotides 
sequenced was 279/clone.
$The PCR error in this experiment was theoretically estimated. The MF(>1) for the PCR 
errors was calculated for a minimum of one clone with 2 mutations.
t  Clones obtained from hybridomas of LK7M/TCA&A[Li] transgenic line.
1 Average obtained from L kAB and L k clones from L kNG  and L k(W T&7M) transgenic 
lines (Chapter 4).
0  Clones obtained from hybridomas o f L kNG transgenic line.
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5.2.2 Hypermutation of LkA [3'EC] transgenes
In the case of the L kA[3'EC] transgenic line (founder A[3'EC] 21), which lacks the 3' 
enhancer core, a population of germinal centre PNA**' B cells from Peyer's patches was 
collected from two o f the animals (they were identical to the founder by Southern blot 
analysis): A[3'EC] 26 (4 months and 22 days old) and A[3'EC] 57 (5 m onths old) to 
analyse hyperm utation as described in M aterials and M ethods. The V k 0 x 1  gene 
segm ent w as am plified  using o ligonucleo tides V K O X B A C K  and V K O X FO R 
(Appendix II) and Taq polymerase. JK5 was used as sequencing primer. The PCR error 
frequency (0.4 x 10^ per base) was determ ined by sequencing transgenes from 
hybridomas of L kNG  transgenic line (see Chapter 4).
The sequences with one or more point mutation are shown in the Appendix III D. The 
sequence analysis of the L kA[3'EC] V k region revealed that 60% of the sequences were 
unmutated (see Table 5.4 and Fig. 5.2).
The mutation frequency amongst clones carrying two or more m utation is 12.8 x 10^ 
mutations per base pair. This value is only 1.8 times higher than that for the PCR errors 
(7) and therefore is an intermediate rate between that obtained for L k(WT) (18.7) or 
L kA[F13'EC] (14.4) and L kA[3'E] (9.5).
The m utation frequency calculated for all clones (2.4) is six tim es higher than the 
m axim al PCR error, indicating that the rem oval of the 3' enhancer core does not 
com plete ly  abolish hyperm utation. H ow ever it causes a big decrease  in the 
hyperm utation frequency. Only one clone with 5 m utations was found (as the most 
strongly mutated). A sim ilar effect on hypermutation is observed when the whole 3' 
enhancer is rem oved in L kA[E3']. In both transgenic lines the mutation frequency was 
reduced but not to the same level as in L k [MAR] line, suggesting that the machinery is 
still able to produce mutations at a "basal level".
The distribution of mutations (Fig. 5.2) differs significantly from the one obtained in L k 
(WT) transgenes. Only 11% of the mutated clones carry more than one mutation, which 
is lower than the proportion obtained in L kA[F13'EC] (52%). It is im portant to point out 
that one of the two clones carrying four mutations shares the mutations with the clone 
that carries five, indicating that they might be clonally related. There were also two more 
pairs which shared one mutation not located in a hotspot. All o f them have been included 
in the calculations. Therefore, there were almost four lineages carrying more than one 
mutation out o f the 101 sequences analysed.
114
C D R l CDR2 CDR3
1 2
10
8
6
4
2
G
Lk A [3 'E C ]
^  15
8
§ 12
O '0)(/) 9
"O
(0 «
E
o 3
Lk A [F I3 'E C ]
0
Lk A [E iJ
Lk(WT
N u c l e o t i d e  p o s i t i o n  in t h e  V k  g e n e
5.3 Discussion
D erivatives of the L k  transgene were used to analyse the effect o f the deletion of 
regulatory sequences on hypermutation. In K chains, at least two DNA fragments were 
shown to be required for full hypermutation (Betz et al., 1994). One is located in the J-C 
intron, including the matrix attachm ent region and intron enhancer, the other in the 3' 
enhancer located about 9 kb dow nstream  of the C k exon. The 132bp core fragm ent 
within the 3' enhancer is responsible for up to 52% of the activity o f the whole enhancer 
(Chapter 3). The ability of four different transgenes, lacking either the matrix attachment 
region, the intron enhancer region, the 3' enhancer core or its flanking regions to undergo 
somatic hypermutation was analysed in germinal centre cells from the Peyer's patches of 
the transgenic mice.
The results suggest that the k  intron enhancer is not crucial to achieve high levels of 
somatic hyperm utation since highly m utated clones were found, although at a lower 
frequency than in L k . The increased proportion o f unmutated clones may reflect the 
relation between levels of transcription and hypermutation, since (as shown in Chapter 
3) the K transgene expression in the A[Ei] mouse sera is lower than in L k 6  line (which 
carries the intact construct). Alternatively, this could be due to the presence o f transgenic 
copies which are not able to mutate. This has to be confirmed through analysis o f other 
founders of LKA[Ei].
The sequence analysis o f the transgenic lines LKAfFB’EC] (lacking the flanking regions 
o f the 3' enhancer core) and LKAf3'EC] (lacking the 3' enhancer core) revealed that 
hypermutation was impaired in both of them, but more so when the enhancer core was 
deleted. The low overall mutation frequency and the fact that few highly mutated clones 
were found in the transgenic line containing the enhancer core alone suggest that, even 
though the level o f hypermutation is not significantly decreased, the flanking regions 
around the 3' enhancer core are somehow required for full activity o f the mutation 
machinery.
However, in the LkA[F13’EC] line I found (at least four) transgenes fragm ents which 
contain the 5' segment o f the transgene (including the V-C k  elements) but lack the 3' 
segm ent (see Chapter 3). The incomplete copies are likely to increase the num ber of 
clones carrying unmutated V k  sequences. If the results obtained for the LkA[F13'EC] 
line are affected for this reason, the 3' enhancer core alone may account for the effect of 
the 3' enhancer on hypermutation. This has to be confirm ed through analysis o f other 
founders of LkA[F13'EC].
In addition to the low overall mutation frequency the lack of highly mutated L kA[3'EC] 
and L kA[E3'] clones is similar. These results point to the 3' enhancer core as the 
principally responsible for the im portance of the 3' enhancer in hyperm utation, even 
though the absence of either does not completely abolish it.
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The results further suggest a link between level o f transcription and hypermutation. The 
deletion o f the regions flanking the core 3' enhancer reduced the K  transgene expression 
in the mouse sera 3 to 13 fold relative to the L k6 (wild type). Hypermutation was also 
affected but several highly mutated clones were found. On the other hand the deletion of 
the 3' core enhancer and the whole enhancer resulted in a larger reduction o f the k  
transgene expression (see Chapter 3) and hypermutation.
A crucial finding is that the matrix attachment region seems to be more critical, since its 
deletion abolished hypermutation. These results agree with findings for LKA[Ei/MAR] 
transgenic line (Betz et a l ,  1994) harbouring a deletion that includes both the Ei and the 
MAR. This further suggests that in LicA[Ei/MAR] the DNA element responsible for the 
fall in hypermutation was the MAR. So far, these results are only based on sequences 
from a single founder. It is essential to obtain and analyse more founders to verify these 
observations.
The connection between the level of transcription and hypermutation becomes therefore 
even more persuasive. The k  enhancers seem to provide levels o f transcription necessary 
for the mutational machinery. The k  3' enhancer is stronger than the k  intron enhancer 
(M eyer et a l ,  1989) and its core is able to drive up to 52% of the activity o f the whole 
enhancer (Chapter 3). Removal o f the Ei did not affect hyperm utation as much as 
removal of the 3' enhancer elements. It has been shown that both the k  3' enhancer and 
the K  intron enhancer drive transcription in a synergistic way. The sum of the levels of 
transcription produced by them in independent constructs do not account for the level of 
transcription observed when they are in the same construct. The same effect is observed 
here when the hypermutation is analysed in the different constructs carrying deletions of 
either enhancer. Therefore hypermutation seems to depend on the level o f transcription 
provided by the enhancers.
Only when the MAR was removed the somatic mutation was completely abolished, even 
though the transgene is still reasonably well transcribed. It seems therefore that the role 
of MAR in hypermutation is not only linked to transcription.
These findings confirm  the idea that transcription is necessary but not sufficient for 
somatic mutation. It seems that hypermutation depends on transcription but is recruited 
by different elements. These elements could be localised within the M AR region and/or 
require the K  locus to be attached to the nuclear m atrix for o ther reasons than 
transcription, perhaps targeting the chromatin to a specific subnuclear location enriched 
for the hypermutation machinery.
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Chapter Six Discussion
6.1 The core of the k  3’ enhancer is able to drive expression and hypermutation of 
the K  light chain but its flanking regions are not essential for either of these 
processes
The role o f the 3' enhancer core in the transcription of the k  chain was studied in stably 
transfected S107 mouse myeloma cells. These experiments showed that the core of the 3' 
enhancer was able to drive transgene K  expression by itself. The 3' enhancer core 
retained up to 30% of the whole enhancer activity. This value increased to 52% when a 
5kb fragment was removed between the C k and the 3' enhancer. This increase however 
was not observed when the intact enhancer was tested. On the contrary, the expression 
level obtained was lower when the 3' enhancer was brought closer to the V region. A 
similar transcriptional suppression effect was reported for the Ig heavy 3' enhancer when 
it was brought closer to the |i intron enhancer (M ocikat et al., 1995). The flanking 
regions o f the K 3' enhancer core may be necesary for the enhancers cooperation. 
Alternatively, this effect may be due to the presence of a silencer in the deleted fragment 
that acts in conjunction with the 3' enhancer core but not with the full enhancer.
The rem oval o f the 3' enhancer core flanking regions reduces the k  expression in the 
serum of the A[F13'EC] transgenic mice (which carry 2 complete copies o f the transgene) 
com pared to the level observed in L k6  line (which carries 5 copies). H ow ever the 
expression level is similar to the one observed for the Lk(W T& 7M ) line, which carries 
only one intact copy of Lk transgene. Hypermutation was affected but not as much as 
when the whole 3' enhancer was removed (Betz et al., 1994). The flanking regions of the 
3' enhancer core are therefore essential neither for expression nor for hypermutation. The 
results dem onstrate that the K 3' enhancer core - as the principal elem ent o f the 3' 
enhancer - plays a leading role in regulating the k  gene expression in vivo  and retains 
the capacity to drive hypermutation of the immunoglobulin K  gene.
The lack o f transcriptional activation by the 3' enhancer core flanking regions was 
previously described by M eyer et al. (1990) and Pongubala et al. (1991), but it was 
unknown w hether these regions were im portant for hypermutation. The ability o f the 
flanking regions to drive hypermutation was studied here in transgenic mice.
W hen the enhancer core was removed the k  expression in the serum o f the mice was 
severely reduced. D iscrepancies between the level o f transgene k  expression in the 
serum of the founder and its offspring are probably produced by an upregulation o f the k  
expression in the offspring, which underwent transgene rearrangem ents due to the
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intrinsic instability of inverted repeat structures (detected as deletions). Hypermutation 
was severely reduced (but not abolished) in the absence o f the enhancer core (in mice 
with the same DNA configuration as the founder). This indicates that the flanking 
regions do not retain the ability o f targeting hypermutation.
6.2 The deletion of the k  intron enhancer did not abolish expression or 
hypermutation
The deletion o f the intron enhancer produces a large decrease in the transgene expression 
in stably transfected NSO cells. The levels of expression were also reduced in the serum 
o f the A[Ei] transgenic m ice but not annulled as observed after deletion o f the 3' 
enhancer (Betz et al., 1994). Hypermutation was also affected but it did not exclude the 
generation of highly mutated clones. This result indicates that the intron enhancer is not/ 
responsible for the severe decrease of hypermutation o f the LKA[Ei/MAR] transgen?.*
6.3 The MAR is essential for hypermutation
The expression levels in NSO cells stably transfected with A[MAR] transgenes and in the 
serum of the A[MAR] transgenic mice were lower than that those observed in L k6 or 
L kNG lines, but the transgene was still transcribed. However, the A[MAR] transgene did 
not undergo hypermutation. Thus, these results demonstrate that M AR m ust have been 
the elem ent responsible for the very low frequency o f m utations observed in the 
LKA[Ei/MAR] transgene.
This finding confirm s the idea that transcription is necessary but not sufficient for 
somatic mutation. It seems that hypermutation depends on transcription but is recruited 
by other elements. MARs might be important for the anchorage o f the gene in a region 
rich in the factors necessary for the m utational m achinery. A lternatively, specific 
sequences in M AR might be directly im plicated in recruiting factors necessary for 
hypermutation while still requiring active transcription.
The idea that the IgK light chain MAR could be involved in other functions besides DNA 
anchorage, e.g. in B cell specific dém éthylation and in V k-Jk rearrangem ent, is 
relatively  new (Lichtenstein et al., 1994; Xu et al., 1996). The ro le o f M AR in 
hypermutation may be related to its role in the dém éthylation o f the locus. There are 
only a few exam ples of MAR binding proteins (Dickinson et al., 1992; Zong and 
Scheuermann, 1995; M üller et al., 1996) and therefore it is difficult to speculate which 
could be the specific factor related to hypermutation.
A nuclear matrix binding protein has been identified (M A R-BPl), which binds to the Ig 
heavy chain enhancer MARs (Zong and Scheuermann, 1995). Binding o f M A R-BPl to 
the IgH enhancer MARs requires all four nuclear factor-|i negative regulator (NF-pNR) 
binding sites. Thus, binding o f M A R-BPl and N F-|iN R is m utually exclusive. These
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results are consistent with a model for cell type-specific regulation (Scheuermann and 
Chen, 1989) where the NF-|iNR repressor binding to the IgH enhancer MARs prevents 
nuclear matrix attachment by interfering with MAR-BP 1/MAR interaction. In this model 
an important aspect of the MAR function in B lymphocytes would be to attach the heavy 
chain locus to the nuclear matrix thereby bringing the gene into regions o f the nucleus 
that contain high concentrations o f transcription factors, RNA polymerase, 
topoisomerases, etc. However, in inappropriate cells (other than B lymphocytes) NF- 
pNR would be expressed and would bind to its recognition sites in the MAR flanking the 
enhancer, thereby preventing nuclear matrix attachment.
This is in agreement with the fact that MARs have been found to stimulate transcription 
from defîned promoters in a number of systems, but only when the test construct is 
stably integrated (Blazquez et al., 1989; Xu et al, 1989; Klehr et al., 1991; Forrester et 
al:, 1994); This suggests that MARs are important for the anchorage of expressed genes 
in a region of high transcription factor concentration around the nuclear matrix.
Recently it was shown in vitro that a p53 mutant binds the Ig heavy chain MAR element 
with high affinity. The binding to the MAR is a possible mechanism by which the 
mutant p53 activates the expression o f genes involved in cell proliferation and 
tumorigenesis (Müller et al., 1996).
6.4 T h e  ro le  o f th e  p rim ary  DNA sequence an d  h a irp in  loops on ho tspo ts
The role of the primary DNA sequence and hairpin loops in the formation o f hotspots 
was studied in several transgenic mouse lines carrying synthetic V k regions with altered 
DNA sequence in the CDRl. This analysis was performed using mice carrying multiple 
transgenes and this was particularly useful because several transgenes could be analysed 
in the same mouse and some transgenes served as internal control (in particular for the 
mutation rate) for the other transgenes.
In order to assess whether the distributions of mutations in the transgenes carrying the 
mutagenised CDRl have changed with respect to the distribution in the WT transgenes I 
collected a database with all the WT clones (239) of Lk and LkAB transgenes sequenced 
here and previously from Peyer's patch B cells (Chapter 4). The number of mutations at 
each position along the Vk segment sequenced between the WT database and the mutant 
was compared. The statistical significance of the differences in the mutability in each 
position was examined by the Chi-square test to assess the effect o f modifications 
carried by a transgene on hypermutation.
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6.4.1 The primary sequence is important for the specific location of hotspots
Not only the second base but also the third is a mutational hotspot when Ser31 (ACT) 
was changed (to AGC) in 7M. The formation o f this new hotspot indicates the 
importance of the primary DNA sequence for targeting specific nucleotides. This was 
further supported by the finding that Ser31 as TCA was not a hotspot The results shown 
here confirm that the mutational machinery has a preference for AGY encoded Ser and 
the bias against TCA encoded Ser as targets for hypermutation. The 7M/TCA mutant 
demonstrates that the codon bias exists and is caused by the nucleotide preferences of the 
hypermutation process.
6.4.2 The secondary structure has a lesser contribution on hotspots
Hairpin loops do not seem to be important for the definition of which base is going to be 
targeted. However they may make the favoured' nucleotides accessible for 
hypermutation by generating pauses during transcription that can activate the repair 
mechanism (see below).
6.5 The downstream position of the 3' enhancer with respect to the target area is 
not essential for hypermutation
In the Lk(WT&7M) transgenic line both Vk (the WT and the 7M) were mutated at the 
same level and with the same intrinsic preferences described previously for the same 
gene. This is in spite of the fact that one of the copies is truncated and does not contain 
the 3' enhancer. Therefore the 3' enhancer of the intact neighbour copy is able to drive 
hypermutation from a 5' position with respect to the V-C elements. This result indicates 
that the downstream position of the 3' enhancer with respect to the V region is not 
required to achieve high levels of mutations.
6.6 Not all the transgene copies accumulate the same amount and type of mutations
The analysis of somatic mutation in hybridomas derived from transgenic lines made with 
a mixture o f different transgenes made it possible to study in detail how individual 
transgene copies mutated. This analysis in the LkNG line showed a considerable 
difference in the number of accumulated mutations in individual transgene copies both 
in selectable and non selectable transgenes. These results are in keeping with previous 
observations for selectable transgenes (Rogerson et al., 1991) and demonstrate that it can 
not be attributed to antigen selection.
The analysis of the aminoacid substitutions in hybridomas from Lk(WT&7M) and 
LkNG lines that define antibodies with increased affinity suggested that those mutations 
occur more frequently in some transgenes than in others. The preferential targeting of the 
replacement mutations associated with the affinity maturation in these copies could be 
due to a difference in the transcription. Further experiments are required to confirm this
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proposal. The mRNA levels of each copy could be studied in some of the Lk(WT&7M) 
hybridomas and should provide a clear answer to this question.
6.7 The mechanism of somatic mutation
Ig genes have to be actively transcribed in order to be targets for somatic mutation. 
Unrearranged V k  genes that are not transcribed (Mather and Perry, 1981) are not 
mutated (Seising and Storb, 1981; Gorski et al., 1983). However, unrearranged VX. genes 
that are transcribed (Picard and Schaffner, 1984b) are mutated (Motoyama et al., 1991, 
1994; Weiss and Wu, 1987). In addition, the L k  transgene carrying deletion of the 3' 
enhancer was poorly expressed and hypermutation was severely affected (Betz et al., 
1994). The results shown here are in line with these findings and further support the idea 
that the rate of transcription may be tied to the rate of somatic mutation. It is possible 
that a specialised repair-like system coupled to transcription could account for the 
described phenomena.
Amongst the proposed models the error-prone DNA synthesis' (Brenner and Milstein, 
1966) encompasses the possibility o f a direct link between transcription and 
hypermutation. Several lines of evidence support the idea that the nucleotide excise 
mechanism is coupled to transcription, e.g. the preferential repair o f the transcribed 
DNA strand (Hanawalt and Mellon, 1993) and the requirements of components o f the 
I’hilH  factor, also necessary for transcription initiation, for nucleotide excision repair 
(Bootsma and Hoeijmakers, 1993). There is indeed evidence that the rate of spontaneous 
mutagenesis in yeast increases when the transcription rate is increased (Korogodin et al., 
1991).
The presence of DNA nicks or specific proteins involved in signalling hypermutation 
may cause the RNA polymerase to pause, or to enhance the natural tendency o f the 
polymerase to halt. This could induce the recruitment of factors involved in the error- 
prone DNA repair (Neuberger and Milstein, 1995). This model involves the introduction 
of mutations (in the transcribed DNA strand) which must not be repaired back to the 
original sequence. Several of the DNA polymerases involved in DNA repair indeed lack 
the proofreading 3' -to- 5' exonuclease activity and therefore manifest a higher degree of 
misincoiporation.
This model accounts for most of the aspects discussed here. The k  enhancers seem to 
provide levels of transcription necessary for the mutational machinery. They also may be 
responsible for the gene and cell specificity of the hypermutation. The deletion of the Ei 
or the F13'EC decreases the transcription level and therefore the possibility that 
hypermutation occurs, but the error-prone DNA repair mechanism is still active because 
several highly mutated clones were found. The deletion of the 3' enhancer or its core 
further reduces transgene transcription, and even fewer mutated clones were found.
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When the MAR was deleted the hypermutation was abolished. Therefore MAR could be 
the entry site for the specific proteins required for hypermutation or the factor required 
for mutations could be loaded onto the initiation complex if the MAR binding proteins' 
are involved. Alternatively MAR may encourage the formation of local or regional 
single strand nicks (Neuberger and Milstein, 1995).
This model also could explain the fact that the hypermutation domain starts downstream 
of the promoter. The existence of mutational hotspots is compatible because the rate of 
delays and errors could depend on the primary DNA sequence and secondary structures. 
The elongation-termination decision of the transcription machinery is a process that 
depends on DNA and RNA sequences and on the interaction o f the transcription 
complex with extrinsic protein factors. The hairpin loops could play an important role by 
inducing transcription stalling through destabilization of the elongation complex (von 
Hippel and Yager, 1992). The transcription coupled repair could operate in the absence 
of DNA lesion. A pause site could make the RNA polymerase to trigger a repair 
reaction. This could lead to high levels of spontaneous mutagenesis in a frequently 
transcribed gene (Hanawalt, 1994,1995).
6.8 Conclusions and outlook
In this work I have systematically dissected the cis- acting DNA elements involved in 
the regulation of somatic hypermutation. One of the most important conclusions to be 
drawn from this study is that the intron enhancer and the 3' enhancer elements may 
contribute to hypermutation alone through their role in the k  light chain gene expression. 
In contrast the MAR seems to be necessary for reasons other than transcription.
So far, these results are only based on sequences from a single founder mouse. It is 
essential to obtain and analyse more founders to verify these observations. One o f the 
conclusions to be drawn from this study is the necessity of alternatives to the use of 
conventional transgenic mice, e.g. gene targeting.
Somatic hypermutation occurs during a very short time in the life of the B cell. The 
attempts to purify a large amount of hypermutating' cells to study the Ig transcription 
levels has not succeeded so far. There is therefore an increasing necessity for in vitro 
systems which would allow to answer specific questions which are too complex in the 
transgenic animals. Recent advances in cell-free assays which reconstitute mammalian 
DNA nucleotide excision repair should help to reproduce hypermutation in vitro. These 
systems should help to identify specific factors necessary for mutation. They should also 
simplify the further dissection of the role of the MAR and the enhancer elements in 
hypermutation and thus improve our understanding of its molecular mechanism. The 
results shown here point to a direct link between transcription and hypermutation. This 
implication should be kept in mind when designing those systems because such cell-free
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assays should contain all the necessary elements to allow the transgene transcription and 
the repair mechanism to act simultaneously.
As the role o f MAR in hypermutation may be related to its role in the déméthylation it 
would be interesting to study the méthylation pattern in all the transgenic lines - 
principally in A[MAR] - to determine the extent at which those processes are related. It 
would also be interesting to study whether a MAR from another origin could target 
hypermutation. A Lk transgene derivative in which the MAR is replaced by another 
MAR sequence could answer this question.
The specific downstream location of the 3' enhancer with respect to the promoter and V 
elements did not seem to be essential for hypermutation. This finding leads one to 
consider what will be the effect on hypermutation of moving the MAR to a 5' position 
with respect to the target area.
The work described here also demonstrates the importance o f the primary DNA  
sequence for the formation of hotspots. The use of transgenes carrying Vk region with 
altered CDRl has confirmed the intrinsic preferences of the mutational machinery for 
AGC cudcd serine over TCA serines. Witli regard to die secondary structure they may 
not be essential hotspot defining elements. However they may influence the accessibility 
of the 'favoured' nucleotide for mutation, e.g. by generating pauses in the transcription 
process necessary to trigger the error-prone DNA repair. The size o f the hairpin loop to 
be most thermodynamically effective to induce stalling and the position of the consensus 
sequence with respect to the loop are some of the key elements that need to be defined.
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Appendices
Appendix I A  List of oligonucleotides used to generate the CDRl mutants.
Appendix I B  List of the selected CDRl mutants and the mutations they carry.
Appendix IIA  List of other oligonucleotides used.
Appendix n  B Sequence of the relevant regions in the Lk construct.
Appendix IQ A Sequences with one or more mutations or deletions found in the
transgene V k regions of the germinal centre B cells from 
Peyer's patches from LxA[Ei] transgenic mice.
Appendix IQ B Sequences with one or more mutations or deletions found in the 
transgene V k regions of the germinal centre B cells from 
Peyer's patches ffqm LkA[MAR] transgenic mouse.
Appendix IQ  C Sequences with one or more mutations or deletions found in the . 
transgene V K regions of the germinal centre B cells from 
Peyer's patches from LkA[F13'EC] transgenic mice.
Appendix IQ D Sequences with one or more mutations or deletions found in the 
transgene V k regions of the germinal centre B cells from 
Peyer's patches from LkA[3'EC] transgenic mice.
Appendix IQ E Sequences with one or more mutations or deletions found in the Lk 
transgene V k regions of the germinal centre B cells from 
Peyer's patches from Lk(WT&7M) transgenic mice.
Appendix IQ F Sequences with one or more mutations or deletions found in the 
Lx7Mtransgene Vk regions of the germinal centre B cells from 
Peyer's patches from Lk(WT&7M) transgenic mice.
Appendix EH G Sequences with one or more mutations or deletions found in the 
LkAB transgene V k regions o f the germinal centre B cells from 
Peyer's patches from L i^ G  transgenic mice.
Appendix m  H Sequences with one or more mutations or deletions found in the
LkAB7M transgene V k regions o f the germinal centre B cells from 
Peyer's patches from LkNG transgenic mice.
Appendix m  I Sequences with one or more mutations or deletions found in the
LicAB7MyTCA transgene V k regions o f the germinal centre B cells 
from Peyer's patches from LK7M/TCA&A[Li] transgenic mice.
Appendix IV A Sequences o f the LkWT and Lk7M transgenes Vk regions of 
anti-phOx hybridomas from Lk(WT&7M) transgenic mouse.
Appendix IV B Sequences of the LxABWT and LkAB7M transgenes Vk regions 
of anti-phOx hybridomas from LkNG transgenic mouse.
Appendix IV C Sequences of the LKAB7M/TCA transgene Vk regions
of anti-phOx hybridomas from LK7M/TCA&A[Li] transgenic 
mouse.
Appendix 1B
DNA sequence at the CDR 1 of the mutants selected to make trangenic mice.
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5' -c
1
TGC AGT GCC AGC TCA AGT GTA AGT TAC ATG CAC TGG TAC ,c-
PstI S a d Xhc. I Nsil Kpnl
CDR1M25 c TGC AGT gcg AGC TCA AGC GTA AGC TAT ATG CAC TGG TAC C
CDR1M31 c TGC AGT GCC AGC TCG AGC GTA AGC TAT ATG CAC TGG TAC C
CDR1M28
CDR1M30
c TGC AGT GTG AGC TCG AGC GTA AGC TAT ATG CAC TGG TAC C
c TGC AGT GCC AGC TCG AGC GTA AGC TAT ATG CAT TGG TAC C
CDR1M36 c TGC AGT AGC GTT AGC TAT ATG CAC TGG TAC C
CDR1M7
CDR1M60
c TGC AGT G C T t AGC TCG AGC GTT AGC TAT ATG CAT TGG TAC C
c TGC AGT GCC AGC TCA AGT GTA TCA TAC ATG CAC TGG TAC C
CDR1M72 c TGC AGT gcg AGC TCG AGC GTT TCA TAT ATG CAT TGG TAC C
The base changes as well as the new restriction sites introduced appear in red. The 
restriction sites are underlined.
Appendix IA
Oligonucleotides used to generate the CDR 1 mutants derivatives of Lk .
aa/position C23 S24 A25 S26 S27 S29 V3O S3 I Y32 M3 3 H34 W35 Y36
CDRIMI 5' -Q T GCG AGC JCCG AGC GTT AGC TAT ATG CAT TGG 7 ^ -  3
CDR1M2 3 ' -hQ Q TCA CGC TCG AGC TCG CAA TCG ATA TAC GTA A£- 5'
CDR1M3 5' -Q T GCS AGC TCR AGC GTW AGC TAT ATG CAY TGG 3
CDR1M4 3 ' -ACG TCA CGS TCG AGY TCG CAW TCG ATA TAC GTR A£- 5'
CDR1M4 5' --TLCG-AfiC GTT TCA TAT ATG CAT TGG TAC- 3
CDR1M5 3 ' -CG CAA AGT ATA TAC GTA A£- 5'
CDR1M7 5' -£T GCC AGC TCA AGT GTA TCA TAC ATG CAC TGG TAC- 3
CDR1M8 3 ' TCA CGG TCG AGT TCA CAT AGT ATG TAC GTG A Q - 5'
aaiamino acid; W: A and T; Y: T and C; R: A and G; S: C and G.
Appendix IIA
List of oligonucleotides used in this study.
Primers for sequencing
VKOx212: 5' -CTCATTCTCCAGGGTCTGGGTGA- 3'
M13-20 5’ -CATTTTGCTGCCGGTCA- 3'
B g in
JK5FOR: 5’ -CGTTagAtCTCCAGCTTGGTCCCAG- 3'
INJK5: 5' -TAACATGAAAACCTGTGTCTTACACATA- 3’
Oligonucleotides used for PCR amplification
Primers used for direct PCR amplification of the transgene
BamH I
LKFOR: 5' -cgcggAîCCCTTTTCTATCCTGAAGlTCCT- 3’
EcoR I
VKOxBACK: 5' -ccgGggaATTCTCAGCTTCCTGCTAATCA
EcoR I
BEALEADER: 5’ -GGGAATTcGAGATCAGAATACAACCAA- 3'
Primer used to screen M13 clones
AFR3: 5' -CCCACTTAAACGTCTAGAGGATCT- 3'
(recognises transgene)
P1400: 5' -ACGTCTAGAAGACCACGCTACCTGCAGTCAGACCC- 3'
(recognises germline)
Primers used to PCR screen the deletion of the intron enhancer
Hind m
MARI : 5’ -TATTAAAAGCTTAATGTATATAATC- 3'
MARBSEQ: 5’ -CCTGTCTCTTCCAAGAATACTCTG- 3’
Primers used to PCR screen the deletion of the MAR
lEBSEQ: 5’ -CCTTATTTAATTTCTATTGGGAATTAG-3'
IE5: 5' -TATGGACAGGGCCTTAAGCCAGGGTCTGTATT- 3’
Appendix IIA (continued)
Primers used to amplify the MAR region 
MAR 1 : (described before)
Afin
MAR2: 5’ -TGACTCTtAAGTAGTTTCAAGAGTT- 3’
Primers used to amplify the DNA segment containing the Ei region
H indm
mi: 5’ -TTTATaAGCTTTTGTGTTTGACCC- 3'
Not I
RCKN127: 5' -nnngcGgcCgCGACTGwGGCACCTCCAG- 3’
Primers used to make the 3* enhancer derivatives
X hol
DINOl: 5 '-TTATctcGAGTGTCCCATGGACCAA-3'
Not I
DIN02: 5' -GGAGTGCggCfegCCAGGCIGTTGGAGG
Primer used for transgene detection in Northern blot 
RATCK18: 5’ -ATGATGTCTtATGAACAA- 3'
Primer used for P-actin detection in Northern blot 
MOUSEACT: 5' -TTGATGTCACGCACGATTTC- 3'
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E c o  R I  
I
- 9 2 0
I
- 9 0 0  
I
- 8 6 0  
I
- 8 4 0
I
rrJükT T C K*CCTCGGTACCAATCTTAœTCACTATCTCTCAATACATCTCAGTTGTTTTTCATAATAGTrCATTAAAAAAATGGAAGAAgrCTTTCATGAACGGAGGAATGACAAATCAT
- 8 0 0  - 7 8 0  - 7 6 0  - 7 4 0
I I I I I  I  I  I
TCCTAAGATCTACAGACATAfiTCATGCTTCATCATGGCTATGCAGACTTTAACATrATAGGAAGATAATTAAAAC 
- 3 2 0  - 3 0 0  - 2 8 0  - 2 6 0
I  I  I I  I I I I
- 3 4 0
/ /
-1 2 0 - 1 0 0
I
- 3 6 0
I I  I
 AGACTGTATCTTGCTATTTGCATATT
- 2 4 0  - 2 2 0
I - I I
M D F Q V Q i r
.......................................................................... c c flC g y a A TTCTC
ACATTTTCAGTAACCACAAATATCTCTCAGTTGGiriaûùSCAAACTACTTATCACAATACCAGTAATTACCTAGGGACCAAAATTCAAAGACAAAATGCATTTTCAACTCCASATTÏTC 
- 2 0 0  - 1 8 0  - 1 6 6  - 1 4 6
I I I I I I I I
8 F L L I B A 8  _ / s p l i c e
AGCTTCCTGCTAATCAG - >  VkOxBACK GGGAATTcGAGATCACAATACAA - >  BEALIDER
A6CTrCCTCCIAATCA6TCCCTCAœTAACAta«»KJ«XXyUkTTTCaÆATCAGAATACAACCAAAATTATTTTC(XT(XKX»ATTTGTGTCCAAAATACAGTTTTTTCTTTTTCTTTTA
- 8 0  - 6 0  - 4 0  - 2 0  1  2 0
I  I I I I I I  I  I  I I  I
s p l i c o W  I I B R 8 Q I V L T  Q S  P  A
TCTAAATGTT«Xrn»rATAAAATTATTTTTTATCTCTATTTCTACTAATCCCTCTCTCTATTTrCCTTTTTTCTAGTCAIAATATCCAaAa«CAAATTGTTCTCACCCACTCTCCACC
4 0  6 0  8 0  1 0 0  1 2 0  1 4 0
I I  I I  I I  I I I I I I
I M S A S P G E K V T I I T C S A S S S V S Y I I H W Y Q Q K S G T S P K R W I Y D
AATCATGTCTXXykTCTCCaCGOGACAAOCTCACCATGACCTGCACTXXXaGCTCAACTG®»GTMCATOCACTGGMCEAOCAGAACtCAGGCACCTCCCCCAAAACATGGATTTATGA
1 6 0  1 8 0  2 0 0  2 2 0  2 4 0  2 6 0
I I I I I  I I I  I I  I I
T S K L A S G V P A R F 3 G S C S G T S Y S L T I S S M E A E D A A T Y Y C Q Q  
< -  V k O x212  TCACCCAGACCCTGGAGAATGAG 
CACATCCAAACTGGCTTCTGGACTCCCTCCïCCCTTCAGÏCCCACTGCGTCYGOGACCTCTTACPCTCTCACAATCAOCACCATaGAOGCÏCAACATGCTGCCACTTATTACTGCCAGCA
2 8 0  3 0 0  3 2 0  3 4 0  3 6 0  3 8 0
I  I  I I I I  I I I I I I
W S S N P L T F G A G T K L E L K R K
< -J k 5 F 0 R  GACCCTGGTTCGACCTCtAoaTTGC < -  IM JkS  ATACACATTCTGTGTCCAAAACTACAAT
GTGGAGTACTAACCCACTCACOTTaKTOCTQGGACCAACCTOCACCTGAAAOTIAACTACACTmCTFATCrrTTTTTTATGTGTAACACACAGGTTTTCATGTTAGGACTTAAAGTCA
4 0 0  4 2 0  4 6 0  4 8 0  5 0 0  5 2 0
I I I I  I I I  I I I  I I
GTTCAGAAAATCTTGACAAAATGGAGAGGGCTCATTATCAGTTGACGTGGCATACAGTGTCAGATTTrCTGTTTATCAACCTAGTGAGATTAGGGGCAAAAAGAGGCTTTAGTTGAGAGC
5 4 0  5 6 0  5 8 0  6 0 0  6 2 0  6 4 0
I I  I I I I I I i  I I i
< -A F R 3  TCTAGGAGATCTGCAAATTCACCC < -  LkFOR TCCTTG
AAAGTAATTAATACTATGGTCACCATCCAAGAGATTCGATCCGAGAATAAGCATGAGTAGTTATTGAGATCgrCTAGACGTTTAAGTGGGAGATTTGGAGGGGATGAGGAATGAAGGAAC
P1400 w ercTBACTQCBw rBeraiWfCfrcT
I I  I  I
6 6 0  6 8 0
I  I I I I
AAGTCCTATCTTTTCCC CAggC0C
TTCACGATAGAAAAGGGCTGAAGTCAAGTTCAGCTCCTAAAATGGATGTGCGAGCAAACTTTGAAGATAAACTGAATGACCCAGACGATGAAACAGCGCAGATC  / /
1 5 2 0  1 5 4 0  1 5 6 0  1 5 8 0  1 6 0 0  1 6 2 0
I I I I I I I H i n d I I I  I I I I I
CCTTATTTAATTTCTATTGGGAATTAG - >  lE B SE Q  TATTAAAAGCTTAATGTATATAATC T - >  MARI
. .  CCTTATTTAATTTCTATTGGGAATTAGAAAGGGCATAAACTGCTTTATCCAGTGTTATATTA^AGdïAATGTATATAATCTTTTACAGGTAAAATCTACAGCCAGCAAAAGTCATG
1 6 4 0  1 6 6 0  1 6 8 0  1 7 0 0  1 7 2 0  1 7 4 0
I I I I  I I I I I I I J _ _
GTAAATATTCTTTGACTGAACTCTCACTAAACTCCTCTAAATTATATGTCATATTAAC'TCGTTAAATrAATATAAATTTGTGACATGACCTTAACTGGTTACGTAOGATATTTTTCTTCA
1 7 6 0  1 7 8 0  1 8 0 0  1 8 2 0  1 8 4 0  I 8 6 0
I  I I  I I I  I  I I I I I H i n d I I I
TTTATmACC
TCCAAAAATATGACTAATAATAATTTAGCACAAAAATATTTCCCAATACn TTAAT rCTGTGATACAAAAATGTTTAACTCAGCTACTATAATCCCATAATTTTGAAAACTATTTATTÛCC 
1 8 8 0  1 9 0 0  1 9 2 0  1 9 4 0  1 9 6 0  1 9 8 0  A l u I
I I I I I I I A f i n  I  I  I I I
ItTTGTGTTTGACCC - >  l E l  MAR2 < -  TTGAGAACTTTGATGAAtTCTCAGT ______
XnTGTCTTTGACCCTTCCCTGCCAAAGGCAACTATTTAAGGACCCTTTAAAACTCTTGAAACTACTTT*CASl£ATTAAGTTATTTAACCACTTTTAATrTAAAATGATCTCAATTCCC
H i n f l
2 0 0 0  2 0 2 0  2 0 4 0  2 0 6 0  2 0 8 0  2 1 0 0
I I I  I I  I I  I I I I  I
TTTTAACTATTAATTTATTTTAACCCOœUAAGGCTœrTCATAATTrTATTf.-ri'rm'TTrnTAAARAACTCIEaill 1 I I U U 1 IX  U C C A C C X C T O X C a C C U A U a iiiK A X C I C M  
2 1 2 0  2 1 4 0  2 1 6 0  D d e l  2 2 0 0  2 2 2 0
I NFKB I  I I I I I I I  I  I I
. .  m . ? . « « v . « .Mee^m« w w «mw^m am m »« » M M a c e m a M c c * r r r m a ü r m o aY a m r r r m m A « ACAaYTaA L L iW iiC iO G i M W CTmAAAAYTOF
2 2 4 0  2 2 6 0  2 2 8 0  2 3 0 0  2 3 2 0  2 3 4 0
I I I  I I I I I  I I I I
I E 5  < -  TATGTCTGGGACCGAATTCCGGGACAGGTAT A l u I
." ." r n .« « m m r T a » * e & m w e æ m a A ATATTTCTGCACACCCAAATACAGACCCTGGCTTAAGGrCCTGTCCATACAGTAGGTTTAGCrrGGCTACAC 
2 3 6 0  2 3 8 0  D d e l  2 4 0 0  2 4 2 0  A f l I I  2 4 4 0  2 4 6 0
I I I I I I I I I I I  I
MARBSBQ < -  GTCTCATAAGAACCTTCTCTGTCC 
CAAAGGAAGCCATACAGAGGCTAATATCAGAGTATTCTTGGAAGAGACAGGACAAAATGAAAGCCAGTTTCTGCTCTTACCTTATGTGCTTGTGTTCAGACTCCCAAACATCAGGAGTGT
2 4 8 0 2 5 0 0 2 5 2 0
I
2 5 4 0
I
2 5 6 0
I
2 5 8 0
I
CAGATAAACTGGTCTGAATCTCTGTCTGAAGCATGGAACTGAAAAGAATGTAGTTTCAGGGAAGAAAGGCAATAGAAGGAACCCTGACAATATCTTCAAAGGGTCAGACTCAATTTACTT
2 6 0 0  
I
2 6 2 0
I
2 6 4 0  
I
2 6 8 0
I
2 7 0 0  
I
2 7 2 0 2 7 8 0
I
1 2 6 8 0
TCTAAAGAAGTAGCTAGGAACTAGGCAATAACTTAGAAACAACAAGATTCTATATATGTGCATCCTOGCCCCATTGTTCCTTATCTGTACGGATAAGCGTGCTTTTTTGTGTGTCTGTAT
2 7 4 0  2 7 6 0   2 8 0 0  2 8 2 0
I I  I I I I
A  D A  A  P T  V S  I  F  P  P
ATAACATAACTGTTTACACATAATACACTQAAATCGACCCCTTCCTTGTTACTTCATACCATCCTCTGTGCTTCCTTCCTCACGGQCTGATGCTGCACCAACPGTATCCATCTTCCCACC
2 8 4 0  2 8 6 0  2 8 8 0  2 9 0 0
I  I I  I I  I I I
8 T E Q L A T G G A 8 V V C L 1 I M 1 I F Y P R D I S  
RCKN127 < -  G A C C T CCACG G W G TCAG CgCcgG cgIIIIII 
A1VCACTCACCAGTTAACAACTGCAGGTGCCTCACTCCTCTCCCTCAYCAACAACTÏCTAICCCACACACATCAOT .
1 2 7 8 S  1 2 7 8 0
I I
1 2 7 0 0  
I
/ /
8 a c l
 GAGCTCAAACCACCTTAGCCTACACA
U / ^ U  H p a i 12V«Ù 
I
1 2 8 0 0 12020
I
GAGAAACTATCTAAAAAATAATTACTAACTACTTAATAGGAGATTGGATGTTAAGATCTGGTCACTAAGAGGCAGAATTGAGATTCGAACCAGTATTTTCTACCTGGTATGTTTTAAATT
1 2 8 4 0
I
1 2 8 6 0
I
1 2 8 8 0
I
1 2 9 0 0
I
1 2 9 2 0 1 2 9 4 0
I
GCACTAAGGATCTAAGTGTAGATATATAATAATAAGATTCTATTGATCTCTGCAACAACAGAGAGTGTTAGATTTGTTTGGAAAAAAATATTATCAGCCAACATCTTCTACCATTTCAGT
1 2 9 6 0
1 3 0 8 0  
I
e c A T a sA c e A A  - ,  b i h s i
1 2 9 8 0  
I
1 3 1 0 0
1 3 0 0 0  1 3 0 2 0  1 3 0 4 0  1 3 0 6 0
I  I I I  X h o l  I
TTAT c  tcG AG TGTC
ATAGCACAGACTACCCACCCATATCTCCCCACCCATCCCCCATACCAGACTOGTTATTGATTTTCATGGTGACTGGCCTGAGAAGATTAAAAAAAGTAATGCTACCTTATTGGGAGTGTC
1 3 1 2 0  1 3 1 4 0  ..............
I I I
I
1 3 1 6 0 1 3 1 8 0  
I
DIM 03 f .  G G A œ
rC A T G O gCAACATACCAACTCTCATAGCTACCCTCACACTGCTTTCATCAAGAACACCCTrTGACCAACTCAAAACAGAACCTrACCCACATt.1 1 .1 1U . T1TCCCTCCCATCCTCCTCC
N c o l  1 3 2 0 0  
I I N o t l
TTGTCGGACC a cC aaC G TGAGG
1 3 2 2 0  
I
1 3 2 4 0
I
1 3 2 6 0
I
1 3 2 8 0
I
1 3 3 0 0  
I
B sp M I
»r»/yrTn«;TOTorftrTrrArArrPTTTrAAr.TTTCCAAACCCTCATACACCTCCTCCCTACCCCACCACCTCGCCAACGCTGTATCCAGCACTGQGATGAAAATGATACCCCACCT
B SC X I 1 3 3 2 0 1 3 3 6 0  
I
1 3 3 8 0  
I
1 3 4 2 0  
I
CCATCTTGTTTGATATTACTCTATCTCAAGCCCCAGGTTAGTCCCCAGTCCCAATGCTTTTGCACAGTCAAAACTCAACTTGGAATAATCAGTATCCTTGAAGAGTTCTGATATGGTCAC
1 3 4 4 0  
I
1 3 4 6 0 1 3 4 8 0  
I X b a l
lüUGLCCATAl A C C A  liïTAAOACATüT&WifiJ'iIYiTOTTTOATCSÎGCCCASa.':.* O C n e i à C À  •
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Appendix IIB  The sequence of the relevant region in the Lk construct (shown in 
the opposite page).
The sequence of the relevant region in the Lk construct and its derivative is shown. The 
relevant regions are shown in a different colour for better localisation.
In green is shown the leader region (-238 to -190 and -17 to 1).
The V/J (1 to 324) and the C (starting from 2792) regions are shown in dark blue.
In pink is shown the MAR (1572 to 1936, [Cockerill and Gallard, 198Q).
Within the whole intron enhancer (1864 to 2334, [Queen and Baltimore, 1983; Picard 
and Schaffner, 1984]), the intron enhancer core (2058 to 2269, [Fulton and Van Ness, 
1994]) is indicated in bright blue.
Within the whole 3' enhancer (12680 to 13485, [Meyer and Neuberger, 1989]), the 3' 
enhancer core (2058 to 2269, [Meyer et al., 1990; Pongubala and Atchison, 1991]) is 
indicated in cyan.
The promoter elements (octamer: ATTTGCAT, TATA Box: TTTAAA and the 
transcription initiation site: TAATTA [Parslow et al., 1984]) are indicated.
The sequence of all the oligonucleotides used are indicated. The oligo P1400 hybridises 
with the fragment of the J-C intron of BALB/c deleted in the L k  construct The arrow 
indicates the point of the deletion.
Some relevant restriction endonuclease sites are shown (underlined). The changes 
incorporated in the oligonucleotides to generate new restriction sites are shown in lower 
case.
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